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ABBREVIATIONS 
AB antibacterial therapy 
AM aseptic meningitis 
AST aspartat aminotransferase 
BBB blood brain barrier 
BM bacterial meningitis 
CK-BB creatine phosphokinase isoenzyme BB 
CPK creatine phosphokinase 
CSF cerebrospinal fluid 
EC enzyme committee 
GBS group B streptococcus 
GCS Glasgow coma scale 
GGT gamma-glutamyl transpeptitase 
Hib Haemophilus influenzae type b 
HSV Herpes simplex virus 
HSVE Herpes virus encephalitis 
ICNS infections of the central nervous system 
ICP intracranial pressure 
I Q  intelligence quotient 
LDH lactic dehydrogenase 
MM meningococcal meningitis 
MMR measles-mumps-rubella vaccine 
mo months 
MR mental retardation 
n number 
PICU pediatric intensive care unit 
PMNL polymorphonuclear leucocytes 
SNHI sensoneural hearing impairment 
TBE tick-borne encephalitis 
VZV varicellae zoster virus 
WBC white blood cells 
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INTRODUCTION 
Infections of the central nervous system (ICNS), especially bacterial meningitis 
(BM), are still being considered as one of the most important infectious 
diseases especially among children, still having a lethal outcome or leading to 
severe sequelae. The incidence rate of ICNS in Finland in the 1970s was 
105.2/100 000 children up to 15 years of age whereas occurrence of aseptic and 
bacterial meningitis was similar (Rantakallio et al. 1986). The incidence of 
ICNS in Estonia today is unknown, while only meningococcal infection, 
aseptic meningitis (AM) and tick-borne encephalitis (TBE) have been officially 
reportable diseases and only few studies have described epidemiology of BM, 
AM and TBE in Estonia thus far. The epidemics of AM in 1950s were first 
described by Raudam (1967), but due to poor facilities of virological services at 
that time the etiology of it was not defined. The epidemiology of TBE in whole 
Estonian population was investigated retrospectively by Raudam (1967) and 
Vassilenko et al. (1990), but there are no data concerning the epidemiology of 
TBE in children. A retrospective study of BM etiology, morbidity and mortality 
in Estonia was conducted from 1921 to 1958 by Tulmin (1961). 
The epidemiological pattern of BM is different in different countries 
whereas during the last decades it has changed remarkably over the world. If in 
the industralised countries BM is a disease of early childhood then in develop­
ing world half of the patients are older than five years (Tikhomirov 1990). The 
studies performed in the area of former Soviet Union expressed that the 
etiological stucture of BM might be differnt in the East from that in the West. 
In the USA and in the Nordic countries Hib became the leading cause of 
community acquired BM (Salwen et al. 1987; Wenger et al. 1990; Carter et al 
1990; Peltola et al. 1990), while in the former Soviet Union most cases were 
still caused by N. meningitidis (Cibiras et al. 1986; Kostjukova et al. 1992). 
Moreover, better socio-economic conditions and the introduction of newly 
available and effective conjugate vaccines against Hib infection decreased the 
incidence of BM especially in the developed world and only single cases of 
BM were registered during last years (Peltola et al. 1992; Adams et al. 1993). 
There are no studies on BM in Estonia, a country that used to be a part of the 
former Soviet Union and have had no vaccinations against Hib diseases. 
Not only incidence but also outcome of BM has changed recently. With 
the development of intensive care and antibacterial therapy the mortality of BM 
decreased during the last decades to less than 5% in the developed countries 
(Salwen et al. 1987; Valmari et al. 1987; Carter et al. 1990). However, a 
significant number of patients develop permanent sequelae, i.e. an average of 
17% of survivors in the developed countries and 26% in the developing world 
(Baraff et al. 1993). It has been shown by Klein et al. (1986) that there is a ten­
dency after BM of multiple defects to resolve with time. So far it is not clear 
whether all children or only some need careful follow up examinations after 
BM. No data about morbidity, mortality and long term outcome of BM in 
Estonia in the situation of using new antibiotics and sophisticated methods of 
intensive care have been published so far. 
3 
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In spite of numerous diagnostic methods, a differentiation between 
bacterial and aseptic meningitis sometimes presents a major diagnostic problem 
(Lindquist et al. 1988) and the outcome of patients with ICNS is often difficult 
to predict (Briem, 1982; Pasaglu et al. 1989). The chemical tests most com­
monly used for the differential diagnosis of meningitis are determination of 
CSF glucose, CSF protein and CSF/blood glycose ratio, these tests however are 
not truly specific for BM (Rodewald et al 1991). Estimations of intracellular 
enzymes such as AST, LDH, GGT, CPK and CK-BB are widely employed as 
valuable diagnostic aids in diseases involving necrosis or damage of tissues 
characteristically rich in these enzymes. The activities of these enzymes have 
been measured in the CSF of patients with a variety of neurological disorders 
(Riekkinen, 1970; Nelson et al. 1975; Landaas et al 1985; Tammpere et al 
1987; Talvik, 1992). However, the results obtained in patients with BM and 
AM are controversial and it is not clear which enzymes will be important in 
differential diagnosis and in predicting the outcome. 
Although antibiotics have been used in the therapy of BM for more than 50 
years and the number of efficacious antimicrobials has increased, no generally 
accepted standard for duration of treatment has emerged. A treatment period of 
7 days for meningococcal, 10 days for Hib and 14 days for pneumococcal 
meningitis are the recommendations in most manuals and standard publication 
(Feigin et al. 1992; McCracken et al. 1992; Klein et al 1992), but they are not 
based on controlled clinical trials. Some reports suggest that shorter treatment 
periods, especially in meningococcal meningitis, are sufficient and safe in un­
complicated cases (Lin et al. 1985; Tuncer et al 1988; Pecco et al 1991). A 
shorter course of antibacterial therapy will result in fewer days of 
hospitalisation and lower costs. 
A better knowledge of the epidemiological situation, an understanding of 
the prognostically important markers and introduction of treatment regimens 
based on controlled clinical trials will be important in order to improve the out­
come of ICNS in Estonia. 
AIMS OF THE STUDY 
— to study retrospectively the incidence, the etiologic pattern and the short-term 
outcome of ICNS in children in South-Estonia during the period of 1980-1989. 
— to measure the activity of AST, LDH, GGT, CPK and the concentration of 
its brain type isoenzyme CK-BB in the CSF in patients with and without the 
ICNS and to establish whether any of these intracellular enzymes would corre­
late with brain damage of different etiology and is prognostically important 
— to evaluate late sequelae (persisting more than three years) of bacterial 
meningitis and to establish which features of the acute illness predict long term 
outcome. 
— to determine whether the incidence of early complications of bacterial 
meningitis in children treated for 5 days with intravenous antibiotics is similar 
to that seen in children treated longer 
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PARTI 
EPIDEMIOLOGY OF THE INFECTIONS OF THE 
CENTRAL NERVOUS SYSTEM IN CHILDREN 
1.1. REVIEW OF LITERATURE 
1.1.1. Incidence of ICNS 
Infections of the central nervous system in childhood are still an important 
problem in pediatrics. There are considerable differences in registration of 
ICNS in different countries. Therefore it is difficult to compare the data on 
morbidity and mortality. 
Bacterial meningitis: The incidence of BM in Finland in 1978 was 
19.0/100 000 children up to 15 years (Valmari et al. 1987). Carter et al. (1990) 
comparing the incidence of BM in Scotland in 1946-1961 to that of 1971-1986 
found that it was rather similar at 16.9 and 17.8/100 000 children up to 13 years 
of age respectively. The incidence of meningococcal, H. influenzae and 
pneumococcal meningitis are usually characterised separately. The incidence of 
MM in some countries is shown in Table 1. The incidence of MM except New 
Zealand was not higher than 10/100 000 children in the late 1970s and early 
1980s. An outbreak of meningococcal infection of group A was registered in 
New Zealand in 1985-1986 and the attack rate of MM increased almost 10 fold 
(Lennon et al. 1989). A raised number of patients with MM in the middle of the 
1980s was also found in European countries — in Russia, in Scotland and in 
Norway (Voss et al. 1989; Devjatkina et al. 1989; Carter et al. 1990). 
T a b l e  1  
Incidence of MM in children in different countries 
Country (author) Years n of patients Incidence 
Sweden (Salwen et al. 1987) 1956-1980 201 6.2* 
Finland (Valmari et al. 1987) 1976-1980 164 2.0** 
New Zealand (Lennon et al. 1989) 1985-1986 211 30.4* 
Scotland (Carter et al. 1990) 1971-1986 274 5.3* 
* per 100 000 children 
** per 100 000 population 
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The importance of H. influenzae meningitis has grown during the last 20-
30 years world-wide. The incidence of this disease in Scotland being no higher 
than 1.5/100 000 children in 1940 to 1950 increased to 6.6/100 000 in 1986 
(Carter et al. 1990). The attack rate of H. influenzae meningitis in Nordic coun­
tries in the 1980s was even higher — 31.0 in Sweden; 20.0 in Finland; 19.0 in 
Norway and 16.0/100 000 children in Denmark (Trollfors, 1987; Peltola et al. 
1990). 
Neonatal meningitis: The occurrence of neonatal meningitis varies in 
different studies from 0.07 to 0.67 per 1000 live born babies (Bennhagen et al. 
1987; Bell et al. 1989; Zaki et al. 1990). 
Aseptic meningitis: The epidemiology of AM is not studied frequently. 
Beghi et al. (1984) in a retrospective study of AM in Minnesota through the pe­
riod of 1950 to 1981 provided the incidence rate of 10.9/100 000 person-years. 
They found it about six times higher than the rates registered by Centres for 
Diseases Control. With the introduction of MMR vaccination the incidence of 
AM caused by those viruses fell dramatically, but post-vaccinal meningitis and 
encephalitis appeared with the frequency from 1/1000 in Yugoslavia to 
1/100 000 vaccination doses in USA (Hayden et al. 1978; Cizman et al. 1989; 
McDonald et al 1989; Sugiora et al. 1991). The first cases of AM in Estonia 
were described in the Viljandi district — 412 persons fell ill from June to 
September 1953. The etiology of AM remain unknown due to poor facilities of 
virological laboratories at that time, but according to the seasonality, it seems 
that coxsackieviruses A and B were the main causes of this outbreak (Raudam, 
1967). Thereafter only sporadic cases of AM were registered from 1959 to 
1962 in Estonia (Raudam, 1967). The attack rate of AM increased in the late of 
1960s. In the survey performed by Kutsar (1971) in Pärnu, the incidence rate of 
that was 200.1 in 1967 and 60.2/100 000 population in 1968. 
Encephalitis: Two population based studies of viral encephalitis were per­
formed in North and South Finland during the period from 1973 to 1987. The 
incidence rate in those areas was rather similar- encephalitis occurred at a rate 
of 8.6/100 000 in South-Finland and 12.6/100 000 children younger than 
15 years of age in North-Finland (Koskiniemi et al 1989; Rantala et al. 1989). 
With the introduction the immunisations against measles and parotitis the 
incidence of encephalitis declined from 19.8 in 1974 to 2.5/100 000 in 1986 
(Koskiniemi et al. 1989). 
First cases of TBE in Estonia were registered among students of the 
Agricultural Academy in the area of Lake Peipus in 1950 (Raudam et al. 1972). 
The incidence of TBE at 0.4 to 0.8/100 000 population was rather low up to 
1976. A significant rise of the illness was noticed in 1976. The last epidemics 
of the TBE in Estonia occurred in 1980, 1984 and 1987. The incidence ranges 
from 3.1—4.4/100 000 population during epidemic outbreaks versus 1.1-
1.7/100 000 population in periods of remission (Vassilenko et al. 1990). 
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1.1.2. Seasonality of ICNS 
Bacterial meningitis: The number of patients with ICNS increases usually dur­
ing the cold months of year. MM outbreaks peak from November to March 
(Goetz et al. 1980; Djomina et al. 1984; Lennon et al. 1989). Cases of H. 
influenzae diseases are registered throughout the year. A spring peak of H. 
influenzae infection was noticed by Rieske et al. (1985). In the study performed 
in Nordic countries most cases of the illness occurred from June to September 
(Peltola et al. 1990). An unexplained biphasic seasonal pattern of the appear­
ance of H. influenzae meningitis has been observed in USA (Nesheim et al. 
1986). 
Aseptic meningitis: Seasonality of AM depends on that of enteroviruses. In 
temperate climates there is a marked peak of viral infections in August, 
September and October, although some viral activity does occur during the 
winter months (Ratzan 1985; Kirilenko et al. 1990). In a study in Estonia 
Kutsar (1971) found that single cases of viral meningitis were observed over 
the year, but the attack rate raised remarkably from August to October. 
Encephalitis: The vast majority of encephalitis cases in the areas with exis­
tence of arboviral infection occur in the summer. The activity of ticks usually 
raises in the early spring after a short warm winter (Wood et al. 1988). In an 
epidemiological study in Estonia the highest attack rate of TBE was noticed in 
April and May (Vassilenko et al. 1990). 
In countries having no epidemiological activity of arboviruses, sporadic 
cases of encephalitis occur in any season. However the frequency of it is 
slightly higher during the winter (Tardieu et al 1986; Klatte-Mayer 1987; 
Rantalaefa/. 1989). 
1.1.3. Age and sex distribution of ICNS 
Bacterial meningitis: The age distribution of BM depends largely on the epi­
demiological and socioeconomical situation of the country. In the developed 
countries the vast majority of cases are registered among children up to five 
years, whereas less than 50% of BM patients are under five in the developing 
world (Tikhomirov 1987). The greatest incidence of pneumococcal meningitis 
occurs in children between 6 months and four years and in adults over 50 
(Djomina et al. 1984). The age specific attack rate of H. influenzae meningitis 
is highest at one to three years and it frequency decreases beyond 5 years of age 
(Peltola et al. 1990). 
Aseptic meningitis: The data on age distribution of non bacterial meningitis 
are controversial. It was observed in the study performed by Wildin et al 
(1987) that of the total cases of viral meningitis 76% were in children up to one 
year. In another study the rate of children younger than one year was 
significantly lower and consisted only of 25.3% (Tardieu et al 1986). 
The ICNS occur more commonly in male than in female children (Fröber 
et al. 1977; Rantakallio et al 1986; Lennon et al 1989). Only Salwen et al. 
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(1987) noticed a female predominance among children with H. influenzae 
meningitis. 
1.1.4. Etiology of ICNS in children 
The etiology is related to the age of the patient and a number of factors that 
may predispose the host to bacterial infections or alter host response to an 
invading microorganism. 
Bacterial meningitis: Most of BM in children between 2 months and 15 
years of age are due to Neisseria meningitidis, Streptococcus pneumoniae and 
Haemophilus influenzae, which together account for more than 90% of com­
munity acquired BM. The distribution of above noted bacteria differs world­
wide (Table 2). In the area of the former Soviet Union 72.6-83.2% of cases of 
BM in children were caused by meningococci (Djomina et al 1985; Cibiras et 
al 1986; Iljina et al 1990). The rate of pneumococcal meningitis does not 
exceed 20% in most countries except Israel (Rosenthal et al 1988; Rantakallio 
et al 1986). Recently H. influenzae has become the leading cause of BM in 
several areas — 62.0% of the cases of BM were caused by this micro-organism 
in Finland (Valmari et al 1987), 36.8% in Scotland (Carter et al. 1990) and 
28.6% in Brazil (Bryan et al 1990). A considerable number of cases with 
unknown etiology is brought about by early onset antibacterial therapy, 
moreover poor facilities of bacteriological laboratories are also hard to exclude 
(Giustina et al 1985; Kühn et al 1987). A mixed flora was established in no 
more than one per cent of BM cases. Sferra et al (1988) found combinations of 
viruses and bacteria in 5 of276 patients with BM. 
T a b l e  2  
Etiology of BM in children in different countries 
Etiologic agents (%) 
Region (author) Years n S. pneu­ N. menin­ H. inf­ other un­
moniae gitidis luenzae known 
Moscow (1) 1980-89 2165 12 72.6 3.7 2.7 13.6 
Moscow (2) 1986-89 4695 6.8 68.7 3.4 3.6 17.5 
Lithuania (3) 1970-80 37 10.4 83.2 2.6 — — 
Germany (4) — 2323 10.6 8.6 8.6 55.5 55.5 
Israel (5) 1981-85 142 24.0 20.0 42.0 4.0 4.0 
Brazil (6)* 1973-82 4100 15.9 28.9 28.6 17.2 17.2 
Scotland (7) 1946-61 285 10.8 46.6 9.1 29.1 29.1 
1971-86 274 6.2 29.9 36.8 25.2 25.5 
Italy (8) 1960-80 146 15.1 25.3 0.7 52.1 52.1 
West-Australia (9) 1984-88 270 13.3 8.8 68.8 7.0 7.0 
* study involved 3186 children and 914 adults; not recorded 
1 - Djomina et al 1985; 2 - Iljina 1990; 3 - Cibiras et al 1986; 4 - Kühn et al. 1987; 
5 - Rosenthal, et al. 1988; 6 - Bryan et al 1990; 7 - Carter et al. 1990; 8 - Giustina 
etfal. 1985; 9 - Hanna et al. 1991. 
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Aseptic meningitis and encephalitis: The etiologic agents in non bacterial 
ICNS are listed in Table 3. In the prevaccine era, mumps and measles were the 
agents responsible for the majority of cases of AM and encephalitis 
(Koskiniemi et al. 1989). At present the etiologic factor is not identified in 
about 10 to 70% of all cases (Wood et al. 1988). However, intensive 
investigations at some centres indicate that enteroviruses account for approxi­
mately 80% of all cases of AM; the most common specific types are 
coxsackieviruses A and B and echoviruses (Tardieu et al. 1986; Klatte-Mayer 
etal. 1987). 
T a b l e  3  
Etiology of non bacterial ICNS in children in different studies 
Etiologic agents Studies/ frequency in % 
I II III IV V VI 
1. Arboviruses 10.0 
2. Picornaviruses 
- enterovirus 7.7 27.0 — 38.2 
- coxsackievirus A, B 16.5 
- echovirus 0.9 10.4 — — — — 
3. Herpesviruses 
-HSV — 7.3 6.4 — 5.3 — 
-VZV 4.7 25.2 15.4 — 4.0 — 
-CMV — — 1.3 — 0.1 — 
-EBV — — 1.0 — 0.2 — 
4. Myxo- and paramyxo­
viruses 
- influenzae 1.7 — 5.4 1.7 — — 
- parainfluenzae — — 4.2 8.5 — — 
- measles 1.7 4.2 12.8 — 0.9 — 
- mumps 40.9 8.4 16.0 39.0 1.9 22.7 
- rubella — 2.1 1.6 — — — 
5. Adenoviruses 5.2 2.1 8.7 — — — 
6. Postvaccinal — — 1.0 — — — 
7. Unknown 29.6 38.9 18.5 23.7 74.3 39.1 
Only AM is included in study I, IV, VI. 
Only viral encephalitis is included in study II, III, V. 
I Rantakallio et al. (1986) — Finland 1966-1980 
II Rantala et al. (1989) — North Finland 1973-1987 
III Koskiniemi et al. (1989) — South Finland 1968-1987 
IV Tardieu et al. (1986) — France 1983-1985 
V David et al. (1985) — USA 1987 
VI Klatte-Mayer et al. (1987) — Germany 1980s 
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A study conducted in the Pärnu district in the late 1960s and early 1970s 
demonstrated a prevalence of coxsackievirus B 5 and B 3 during the epidemic 
peaks in 1967 and 1968 respectively (Kutsar et al. 1968; Kutsar 1971). 
The group of herpesviruses, HSV in Germany and VZV in Finland, are the 
most common cause of viral encephalitis today — (Lietz et al. 1986; Rantala et 
al. 1989; Koskiniemi al. 1989). 
Neonatal meningitis: Several micro-organisms have been detected to cause 
neonatal meningitis (Meade 1985). Microorganism accounting for the majority 
of BM in the older child and infant, are infrequent etiologic agents in the 
neonatal period, being responsible for only 5.1% of the infections (Abrikossova 
et al. 1991). The three most commonly encountered pathogens are group B 
streptococci, E. coli and Listeria monocytogenes accounting for approximately 
75% of all neonatal BM cases, whereas E. coli Kl is leading at most medical 
centres (Meade 1985; Abrikossova et al. 1991). Since the early 1970s there has 
been a significant increase in serious infections caused by Streptococcus 
agalactiae (GBS). The reasons for this increase have not been quite understood 
yet. In a retrospective epidemiological study in Kuwait GBS was found in 7 out 
of 45 newborns with neonatal meningitis (Zaki et al. 1990). 
1.1.5. Outcome of ICNS in children 
Only few studies investigated outcome of all ICNS, in most other surveys the 
prognosis of BM and AM are represented separately. The mortality rate of 
ICNS in the Finnish cohort study in 1966-1980 (Rantakallio et al. 1986) was 
6.5% and 14.9% of the survivors had some sequalae of their disease. Specific 
sequelae of meningitis that have been observed include cranial nerve involve­
ment, hemi- or quadriparesis, muscular hypertonia, ataxia, permanent seizure 
disorders, deafness, cortical blindness, mental retardation and the development 
of obstructive hydrocephalus (Feigin et al 1992) 
Bacterial meningitis: Appropriate antibiotic therapy has altered the 
outcome of BM remarkably in children who are beyond the neonatal period. A 
retrospective study of BM epidemiology was conducted in Estonia from 1921 
to 1958 (Tulmin 1961). The case fatality rate of MM was 40.4% in the 
preantibiotic era and dropped to 20.7% with the introducing of prontosil in 
1941 and penicillin in 1945. The mortality rate of nonmeningococcal 
meningitis was even higher — 64 and 43% respectively (Tulmin 1961). The 
case fatality rate of BM today ranges from 1.8% in Scotland, in Sweden 
and Finland to 12% in Italy and Israel (Giustina et al. 1985; Salwen et al 1987; 
Valmari et al 1987; Rosenthal et al. 1988; Carter et al. 1990). The outcome of 
BM in diferent studies according to the etiology is outlined in Table 4. 
There are differences in reported mortality and disability rates in various 
types of BM. The greatest mortality and disability was recorded in patients with 
pneumococcal meningitis (Fröber et al 1977; Laxer et al 1977; Grubbauer 
1982) whereas the case fatality and disability rates of MM are the lowest 
(Carters al. 1990). 
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T a b l e  4  
Mortality and disability of BM in children in different studies 
Region Mortality (%) Disability(%) 
N. menin­ S. pneu­ Hib N. me- S. pneu­ Hib 
gitidis moniae ningtidis moniae 
Norway (1) — — 6.3 — — — 
Sweden (2) 2.4 — — 1.06 — — 
New Zealand (3) — — 7.0 — — 7.8 
USA (4) — — 10.3 — — — 
East-Germany (5) 5.0 21.2 0 5.0 42.0 10.0 
Brazil (6) 38.0 59.0 14.0 — — — 
North-Europe (7) 1.0 — — . 3.8 — — 
Scotland (8) 3.0 — 1.2 — — — 
West Germany (9) 8.3 29.0 1.75 26.9 46.0 3.8 
Russia (10) 0 — — 16.0 — — 
Ukraine (11) — — 6.7 — — — 
Canada(12) — 10.8 — — 28.0 — 




— — — 
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—" not recorded 
1 - Haistensen et al 1987; 2 - Trollfors 1987; 3 - Lennon et al. 1989; 4 - Havens et al. 
1989; 5 - Fröber et al. 1977; 6 - Bryan et al. 1990; 7 - Peltola et al 1990; 8 - Carter et 
al. 1990; 9 - Grubbauer 1982; 10 - Pokrovskaja et al. 1983; 11 - Kirilenko et al 1990; 
12 - Laxer et al. 1977; 13 - Botsvadze et al. 1983; 14 - Thompson et al. 1990. 
Neonatal meningitis: The current mortality rate of neonatal meningitis 
ranges from 22 to 49% in most studies and varies depending on the etiologic 
agent, the degree of prematurity of the infant, the presence and severity of asso­
ciated diseases (Apak et al 1983; Bell et al 1989; Zaki et al. 1990). Significant 
neurological sequalae, including hydrocephalus, mental retardation, blindness, 
deafness and motor disability occur in 40-50% of the survivors of neonatal 
meningitis (Bell et al. 1989). 
Aseptic meningitis: The prognosis of AM is usually good, the mortality and 
disability rates are almost zero (Etter et al 1991; Rorabaugh et al 1993). 
Encephalitis: The prognosis of encephalitis depends to some extent on the 
etiology and the age of the child. Case fatality rates of encephalitis vary in dif­
ferent surveys from 1.05 to 9.6% (Rantakallio et al. 1986; Koskiniemi et al. 
1989; Rantala et al 1989). The prognosis of encephalitis due to herpesviruses 
with a mortality of 44-85% is the worst (Lietz et al 1986; Wagner et al 1987). 
Sequelae involving the central nervous system, visual or auditory functions are 
being detected in 7 to 25% following encephalitis (Koskiniemi et al. 1983; 
Rantakallio et al 1986). A study conducted in Estonia showed a mortality rate 
of TBE of 0.28% (Vassilenko et al 1990). 
5 
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1.2. PATIENTS AND METHODS 
The study consisted of a retrospective review of all cases of ICNS in children 
up to 14 years of age inclusively in South Estonia between January, 1, 1980 and 
December, 31, 1989. During this period children with ICNS were treated in 
neurological or intensive care units of Tartu University Hospitals, in the 
Infectious Diseases Hospital of Tartu and in the Tartu University Children's 
Hospital, but also in pediatric units of the districts hospitals located in this area. 
Annual reports and patients records of those hospitals were used. Patients 
included had diagnoses according to the 9th edition of the International classifi­
cation of Diseases listed as follows: 036 (meningococcal infection); 047 
(enteroviral meningitis); 072 (mumps); 063 (TBE); 320 (BM); 321-322 
(meningitis of unknown etiology); 323 (encephalitis). Patients with the above 
noted diagnoses having no affection of the central nervous system were ex­
cluded. Three sudden deaths at home due to BM were traced through pathology 
records. 
Diagnostic criteria: Children were included if a clinical diagnosis of BM, 
AM or encephalitis was made and one of the following criteriae described by 
Scheibe et al. (1983) and Feigin et al.{ 1992) were fulfilled 
1. for bacterial meningitis 
— sterile CSF, but more than 200x106/l WBC, predominantly poly­
morphonuclear leukocytes 
— micro-organism grown from CSF 
— micro-organism grown from blood with more than ten WBC in the 
CSF 
2. for aseptic meningitis 
— above mentioned excluded 
— more than ten WBC in 1 ml of CSF 
3. for encephalitis 
— more than 10 lymphocytes per ml of CSF and typical changes in EEG 
— clinical signs of encephalitis and typical changes in EEG 
— increased protein concentration in CSF and typical changes in EEG 
4. for tick-borne encephalitis 
— four fold rising of the titre of antibodies in complement fixation 
reaction test, history of tick bites and above mentioned criteria of 
encephalitis or aseptic meningitis 
5. for neonatal meningitis 
— above mentioned criteria of BM 
— age up to one months 
Characteristics of the region. 
South Estonia is epidemiological^ a predominantly rural area, with no big 
cities. The biggest town is Tartu with the population of 112 000. The other 
towns located in this area are small with a maximum population of 15 to 
20 000. Six districts of Estonia are included in this study: Tartu, Valga, Võru, 
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Põlva, Viljandi and Jõgeva. The total population of this region is approximately 
400 000 representing less than 1/3 of the total population of Estonia. Rural and 
urban people are almost equal in number to each other. The average childhood 
population (0 to 14 years incl.) has increased from 85 416 in 1980 to 88177 in 
1989. The mean value was 86 593 children during these 10 years. The 
statistical data used were collected from the year books of the Estonian Health 
Ministry in 1980 to 1989. 
For statistical analysis computerised package STATVIEW 512 was used. 
1.3. RESULTS 
1.3.1. Incidence of the ICNS 
A total of 573 cases of ICNS were recorded in a ten year period in children less 
than 15 years (excl.) of age. Of these 223 had infection of bacterial and 350 of 
non bacterial etiology. The annual incidence rate of ICNS ranged from 45.3 in 
1989 to 119.8 in 1984 per 100 000 children amounting to a mean incidence rate 
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Figure 1. Incidence of ICNS, BM, AM and TBE in children in South-Estonia in 1980-1989 
The annual incidence of AM and BM was relatively similar. Figure 1 
shows an antagonistic epidemic course of bacterial and non bacterial ICNS in 
1980-1982: the AM appear to have declined at the time when BM increased. 
From 1983 onwards the figures are becoming more similar. The maximum rise 
of BM as well as AM is to be seen in 1984. 
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The overall incidence of BM was 25.8/100 000 children including occur­
rence rates of MM at 9.0, of pneumococcal at 1.15, of H. influenzae at 1.03, of 
meningitis caused by opportunistic bacteria at 1.49 and of meningitis with un­
known etiology at 15.0/100 000 children. Our data revealed a slight peak of 
MM in 1984 to 1986. The mean incidence of AM was 29.8/100 000 children 
ranging from 11.6 to 64.0. 
The course of the estimated rates of TBE was also intermittent: small peaks 
were registered in 1980; 1986 and 1987 with the incidence rates of 10.5; 11.4; 
and 17.1/100 000 children respectively, whereas the overall annual rate of TBE 
was 7.6/100 000 children up to 14 years. 
There were 24 newborns with bacterial meningitis in this period, an inci­
dence rate of 0.42/1000 live births. The yearly distribution of incidence of 
neonatal meningitis is shown in Table 5 and ranges from zero (1980 and 1985) 
to 1.16/1000 live born babies in 1986. 
T a b l e  5  
Incidence of neonatal meningitis per 1000 live born babies 
in South Estonia in 1980-1989 
Year n of patients incidence 
1980 0 0 
1981 1 0.16 
1982 4 0.66 
1983 3 0.5 
1984 2 0.33 
1985 0 0 
1986 7 1.16 
1987 2 0.33 
1988 1 0.16 
1989 4 0.66 
Total 24 0.42 
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1.3.2. Regional distribution of ICNS 
The ICNS did not occur of an equal frequency in the whole area studied 
(Table 6). The highest incidence rate amounted to 105.9/100 000 children in the 
district of Viljandi, while it was only 40.6/100 000 children in the least affected 
district of Võru. The high incidence was mainly due to the rise of AM and en­
cephalitis especially in 1985-1986. Cases of TBE were only registered in three 
districts (Jõgeva, Tartu, Põlva) which correspond geographically to the zone of 
lake Peipus. The highest attack rate of 17.5/100 000 of TBE was seen in the 
Jõgeva district. 
T a b l e  6  
Regional distribution of ICNS in children in South Estonia in 1980-1989 
(incidence per 100 000 children) 
Region BM Inci­ AM+E Inci­ TBE Inci­ Total Inci­
n dence n dence n dence n dence 
Tartu town 48 20.4 73 31.0 27 11.5 148 62.8 
Tartu distric 24 21.3 30 26.6 11 9.8 65 57.6 
Võru 25 24.3 25 24.6 1 1.0 51 49.7 
Põlva 33 41.1 25 31.2 6 7.5 64 79.7 
Jõgeva 24 24.7 11 11.3 17 17.5 52 53.6 
Valga 31 35.5 52 60.1 2 2.3 85 99.4 
Viljandi 38 37.0 68 66.2 2 1.9 108 105.2 
AM+E included AM and encephalitis except TBE. 
The regional distribution of BM in the area studied was relatively constant 
and varied from 20.8/100 000 in the town of Tartu to 41.5/100 000 in the 
district of Põlva. 
A predominance of rural people among ICNS patients was seen in all forms 
of ICNS, a overall ratio urban versus rural people registered was at 1:1.6 with a 
maximum of 1:1.9 in AM. 
1.3.3. Sex distribution of ICNS 
Comparing both sexes, there is a slightly higher prevalence of ICNS as a whole 
as well as of different forms in males (Table 7). The overall ratio of boys 
versus girls was 1.7:1. 
T a b l e  7  
Sex distribution of different forms of ICNS 
in South Estonia children in 1980-1989 
girls :boys 
Bacterial meningitis 1:1.22 




1.3.4. Seasonal distribution of ICNS 
Figure 2 demonstrates the monthly fluctuation of ICNS in South Estonia over a 
period of ten years. The lowest rate of infection appears to be in January 
(27.6/100 000) and continues with a slight fluctuation until April. A steep in­
crease in the number of cases is being noticed in May persisting into June and 
July. The number of cases gradually falls from August. The monthly incidence 
rate of BM as a whole as of MM in particular is relatively constant demonstrat­
ing only a slight not significant increase in February and in March. The strong 
seasonal variation of ICNS is caused by AM and particularly encephalitis. 
Single cases of encephalitis (1 to 5 cases) have been registered from August to 
April, whereas 70.6% of all cases occur during three months of the year — 
May, June and July. This strictly seasonal distribution of non bacterial 
infections was mainly caused by TBE occurring only in early summer. 
encephalitis 
meningococcal infection 
Jan. Feb. Mar. Apr. May Jun. Jul. Aug. Sept. Oct. Nov. Dec. 
Figure 2. Monthly distribution of encephalitis, aseptic and bacterial meningitis and 
meningococcal infection in children in South-Estonia in 1980—1989. 
1.3.5. Age specific attack rate of ICNS 
The distribution pattern of age specific attack rate of children with BM differed 
considerably from the pattern in non bacterial ICNS. The BM affected mostly 
younger children (84.3% were up to 5 years of age) while non bacterial ICNS 
predominantly occurred in those being older (only 19.7% were up to 5 years of 
age) (Figure 3). 
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• BM DAM • TBE+encephalitis 
< 1 year 0-4 years 5-9 years 10-14 years 
Figure 3. Age distribution of BM, AM and TBE+encephalitis 
in South-Estonia in 1980-1989. 
Table 8 demonstrates the prevalence rates of different forms of ICNS de­
pending on ages. A significantly higher prevalence rate of BM was seen as at 
the age under one year as well up to five years- 207.9 and 65.5 per 100 000 
children of that age respectively (p<0.005). The percentage of infants among 
different forms of BM ranged from 100% of meningitis caused by opportunistic 
bacteria to 48.9% of MM cases. A similar trend was seen among children under 
five years of age too: 100% of opportunistic flora meningitis, 90.2% of MM 
and 77% of H. influenzae meningitis occurred at that age. 
T a b l e  8  
Age specific prevalence of ICNS per 100 000 children in 1980-1989 
Diagnosis <1 year 0-4 years 5-9 years 10-14 years 
BM 207.9* 65.5* 8.3 3.8 
AM+encephalitis 15.3 23.9 41.6 55.6 
ICNS 223.0 89.4 49.9 59.5 
*p<0.005 
The cases of AM were found predominantly in children older than five 
years of age (207 cases and 86.2% of the total) whereas 138 cases (53.8%) of 
the total occurred in the age group between 10-14 years. 
The predominance of children older than five years was less apparent 
among encephalitis (except TBE) patients — 11 cases and 43.3% of the total 
and no cases were diagnosed in the age group between 10-14 years. The cases 
of TBE occurred preferably in schoolchildren — 63 cases (95.4%) of the total 
diagnosed were older than five years of age. 
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1.3.6. Etiology of ICNS 
1.3.6.1. Etiology of bacterial meningitis 
As shown in Table 9 N. meningitidis with 38.1% was the most common micro­
organism causing non-neonatal BM during the study period. H. influenzae and 
S. pneumoniae as causes of nonneonatal BM occurred at similar rates, both in 
4.5% of the cases. An increase of H. influenzae among the etiologic factors to 
12.5% was noticed during the last three years (1987-1989) studied, nev­
ertheless N. meningitidis remained a leading microbe in the etiology of BM 
(30.3%). The microbes responsible for BM were not identified in 101 cases 
(50.7%) and this number was constant throughout the study period. 
Figure 4 demonstrates that the , Gram negative enteric bacteria E. coli, 
P. aeruginosa, P. mirabilis, K. pneumoniae were the predominant causes of 
BM in newborns accounting for 29% of all cases. N. meningitidis, S. pneu­
moniae and H. influenzae were found in three patients (12.4%). Gram positive 
organisms such as S. agalactia and S. aureus were detected in one and two 
cases of neonatal meningitis respectively. The etiology of the neonatal 
meningitis remained unknown in 11 cases (45%) of the total. 
T a b l e  9  
Etiology of nonneonatal BM in South Estonia in 1980-1989 
Etiologic agents (n of patients) 
Year N. meni­ S. pneu­ H. influ­ Other unknown Total 
ngitidis moniae enzae (%) 
1980 5 — — — 8 (38.4) 13 
1981 8 — — — 9 (52.9) 17 
1982 9 1 — 1 8(42.1) 19 
1983 12 4 1 1 5(21.7) 23 
1984 10 — — — 28 (73.6) 38 
1985 6 — — — 12(66.6) 18 
1986 9 — 1 — 5 (33.3) 15 
1987 4 4 3 — 12 (52.1) 23 
1988 4 — 3 2 11 (55.0) 20 
1989 9 — 1 — 3 (23.0) 13 
Total 76 9 9 4 101 (50.7) 199 
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Figure 4. Etiology of neonatal meningitis in South-Estonia in 1980-1989. 
1.3.6.2. Etiology of nonbacterial meningitis 
Table 10 demonstrates the occurrence of different forms of encephalitis in the 
survey. 
T a b l e  1 0  
Etiology of encephalitis in children in South Estonia 
Etiology n of patients % 
TBE 66 71.7 
Mumps 10 10.7 
Varicella 2 2.2 
Rubella 1 1.1 
HSV 1 1.1 
Influenzea B 1 1.1 
Unknown 11 12.1 
Total 92 100.0 
TBE comprising 71.7% of the cases was the most frequent cause of 
encephalitis in this survey. Ten cases of mumps encephalitis (10.7%) of the to­
tal were identified in the prevaccine era only, that was before the 1984. The 
etiology of encephalitis remained unknown in 11 cases. 
A significant number of cases of AM was unidentified in this retrospective 
study. The etiological agent was found in only 12 cases of the total of 252 
(4.6%). There were 6 cases of echovirus type 7-14, four of adenovirus, one of 
coxsackie B and one of influenzae virus infection. 
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1.3.7. Outcome of ICNS 
Among the 573 patients with ICNS 31 children died in the acute period of the 
disease (case fatality rate 5.4%) and 24 (4.4%) among those who survived had 
some sequelae at discharge. 29 patients of the 31 who died were BM patients. 
The mortality rate of BM registered was 13.0% varying from 2.5% in 1984 
to 27.3% in 1986. The disability rate registered at discharge was 8.9% and 
ranged from 1.1% in 1985 to 22.3% in 1982. A considerable difference in 
prognosis was noticed between neonatal meningitis and that in older children. 
13 fatal cases of ICNS were found in children beyond the newborn age (case 
fatality rate 3.6%) and 17 patients had a sequelae at discharge (disability rate 
3.2%) whereas 11 newborn died (45.8%) and 7 of 13 survivors (53.8%) devel­
oped disabilities. 
Figure 5 demonstrates that neither the overall mortality of ICNS nor the 
disability rate varied significantly in the sequence of the 10 years studied, due 
to rising numbers of neonatal meningitis. The case fatality rate beyond the 
neonatal period fell dramatically from 10.1% in the first six years to 2.8% at 
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Figure 5. Mortality and disability of BM in children 
in South-Estonia in 1980-1989. 
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A detailed analysis of mortality and disability of different forms of ICNS is 
demonstrated in Tables 11 and 12. The mortality was organism specific and age 
related with the highest rates of 63.4% for BM caused by opportunistic mi­
crobes. On the other hand all those cases were diagnosed in very young chil­
dren. The case fatality rate of BM beyond the neonatal period was 9.0% (18 
cases of death occurred) and 13 (7.1%) of the survivors were discharged with 
the sequelae (Table 11 and Table 12). S. pneumoniae was the most severe of 
the common causes of BM in infants and older children with a mortality rate of 
20% (2/10) and a disability rate of 12.5% (1/8). The lowest case fatality as well 
as morbidity rates registered were in MM patients — 6.5% and 5.6% 
respectively. One child died and none had a sequelae of nine — H. influenzae 
meningitis patients. A trend towards decreased mortality and disability rates 
with increasing age was identified in general as well as in different forms of 
BM. As an exception the case fatality rate of MM was higher in older children 
in the age group from 5 to 9 years, but only 8 children included were at that 
age. 
There was no fatal outcome among patients with AM. Two children died 
(2.1%) and four (4.4%) of survivors developed disability following encepha­
litis. Younger children were more severely affected than older ones-two died 
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1.4. DISCUSSION 
This study programme analysed the epidemiology of the ICNS. using several 
sources of case ascertaintment for first time in Estonia. Registering only AM, 
TBE and meningococcal infection, the existing surveillance system has been 
seriously underestimating the true incidence of the disease in the community. 
The epidemiological pattern we observed had the incidence rate of 
66.2/100 000 children and is in keeping with comparable data from Spain in 
1988 of 60/100 000 children (Roca et al. 1992). A considerably higher rate of 
105.2/100 000 was demonstrated in a Finnish cohort study covering the period 
from 1966 to 1988 (Rantakallio et al. 1986). The difference from our data 
might be explained by high frequency of mumps encephalitis, while the Finnish 
study was conducted in the prevaccine era. A relatively constant incidence of 
ICNS in South-Estonia during the study-period was revealed by us. The only 
peak registered was in 1984, whereas both bacterial and aseptic meningitis 
were identified to rise. We only can speculate that it was caused by 
meningococcal meningitis, while an increased number of patients with the MM 
in the middle of the 1980s occurred all over the world (Halsensten et al. 1987; 
Lennon et al 1989; Havens et al. 1989; Carter et al. 1990). However, a 
considerable number of unidentified cases .of BM in this study does not allow 
to say that with certainty. 
The annual incidence of BM 25.8/100 000 in South Estonia was rather 
similar to findings from Nordic countries in the 1970s and 1980s — 16.9 — 
19.0/100 000 (Carter et al. 1990; Peltola et al. 1990). With the introduction of 
immunisation in 1989, using the conjugate vaccine of Hib in Finland, the in­
cidence rate of BM has fallen considerably and the number of cases of BM in 
the Helsinki area from 66-77 registered yearly in prevaccine era declined to 4 
cases in the year (Peltola et al. 1992). The decreased number of cases of BM at 
the end of 1980s was also demonstrated by us whereas no "antimeningitis" 
vaccinations were performed. Therefore we agree with Michaels et al. (1993) 
that other unexplained factors than Hib vaccinations have a role in the recent 
decrease in the number of BM cases. 
Our data of the BM etiology are different from those reported in Nordic 
countries, Australia and USA, where Hib was the leading microorganism in the 
etiology of BM in children during last decades (Valmari et al. 1987; Carter et 
al. 1990; Hanna et al. 1991). We, like most investigators from the Central 
Europe and former Soviet Union (Grubbauer 1982; Giustina et al. 1985; 
Djomina et al. 1985; Hensel et al. 1992) still found N. meningitidis as the most 
common pathogen in the etiology of BM in children. However, the high 
number of unidentified cases of BM (50.7%) in this study makes interpretation 
of these data more difficult. To our opinion the main reason for the low number 
of bacteriologically proved cases was that children in the area often had to be 
hospitalised in the district hospitals where the lumbar puncture was performed 
and antibacterial therapy started, but facilities of bacteriological laboratories 
were relatively poor. The situation improved in the late 1980s only and this 
probably contributed to the higher figure for identified microorganisms in the 
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last years of study, nevertheless the changes in the etiological structure were 
not in fact significant. It might be that future studies may show a reversal of the 
current situation. The variation of etiology of BM all over the world is not 
easily explained. It is possible, that the incidence rate of other than 
meningococcal meningitis is relatively constant and different etiological 
structure, is associated with epidemic course of meningococcal infection 
(Kostjukova et al 1992). This view is supported by the study performed by 
Salih et al (1990) in Sudan. The predominance of Hib among the etiological 
factors of 57% of patients has been registered during a nonepidemic period 
whereas in 1988 an epidemic of meningococcus A occurred and a trend 
towards an increased percentage of N. meningitidis of more than 90 was shown. 
The last epidemic of the meningococcal infection in the former Soviet Union 
lasted from 1967 to 1986 and that might also explain the predominance of 
meningococci in this study (Kostjukova et al 1992). Therefore it could be that 
the incidence rate of Hib meningitis was almost 20 times lower in comparison 
to the results from Finland or Sweden (Trollfors 1987; Peltola et al 1990). 
However, at the end of the 1980s, an increase of Hib meningitis cases like by 
Djomina et al (1985) was observed. There has been much discussion of im­
munisation against Hib infection in Estonia. In order to provide accurate epi­
demiological information before introducing vaccination there is an urgent 
need for prospective studies to be set up to assess accurately the incidence of 
systemic Hib disease. 
The average annual incidence (0.41/1000 live births) of neonatal meningitis 
was considerably higher than that in Sweden or Australia, but lower than in 
Kuwait (Bennhagen et al 1987; Zaki et al 1990; Francis et al 1992). The re­
markable yearly variation from 0 to 1.16 was mostly caused by the low number 
of births in the area studied. Contrary to Schattuck et al (1992) showing a de­
crease of BM cases in newborns during 1974—1988 in USA, our data revealed 
an increase in cases of neonatal meningitis. This rise is probably associated to 
the opening of NICU and collecting patients there, using sophisticated methods 
of intensive care and therefore with the increase of nosocomial infections. Like 
in the other surveys (Apak et al 1983; Meade et al 1985; Bell et al 1989) 
Gram-negative facultative flora with the leading role of E. coli were the most 
common causes of neonatal meningitis in South-Estonia. The predominance of 
E. coli K-l strain in the etiology of neonatal meningitis is obviously associated 
with its high colonisation rate (40-50%) in pregnant women. Recently in many 
nurseries over the world S. agalactiea has been the essential part of the causes 
of neonatal meningitis representing over 40% of cases reported in first months 
of life (Francis et al 1992; Schaad 1992). Only one out of 24 cases of GBS 
meningitis was registered in this survey. The low number of GBS infection in 
our study is not explained thus far. Unfortunately there are no data about the 
carriage of GBS in the genital tract of the pregnant women in Estonia. 
In a number of cases (95.4%) as in some other retrospective studies (Hensel 
et al 1992) the etiology of AM remained unknown. However, with the intensi­
ve investigation the etiology might be identified in 60-70% of cases (Tardieu et 
al 1986; Klatte-Mayer et al 1987). The low confirmation of AM had many 
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reasons: (1) low interest of practising doctors in the etiology of AM which in 
most cases has no influence on the therapy, (2) noncomplicated cases of AM 
are mostly treated in pediatric units of district hospitals having no facilities for 
virological diagnostics, (3) there is no opportunity of using rapid immun-
methods for diagnosing of AM at present. As long as results of virological 
investigations will become known in 6 weeks, when the patient has been long 
ago discharged, it is hard to believe, that the interest of practising doctors will 
increase. On the other hand, without knowledge of epidemiological situation in 
certain regions prevention of infection would be impossible. However, 4he 
strong seasonal variation, with the high incidence of AM in summer months, 
which corresponds to the maximal activity of enteroviruses, and studies 
performed in Estonia by Kutsar (1971) in early 1970s allow us to suspect simi­
larly to most others the predominance of enteroviruses in the etiology of AM 
(Tardieu et al. 1986; Klatte-Mayer et al. 1987). 
All cases of mumps encephalitis registered in this survey were diagnosed 
up to 1984 — that is the prevaccine period. In a similar way the findings docu­
mented by Koskiniemi et al. (1989) showed that with the introduction of paroti­
tis vaccination cases of mumps encephalitis have been almost eliminated. 
Contrary to the studies of Cizman et al. (1989) and Fuijnaga et al. (1991) of 
post vaccination encephalitis, no cases of it after mumps vaccination have been 
registered. 
Etiology of encephalitis with the predominance of TBE in 71.7% supports 
the above investigations, that it is a leading cause of the encephalitis in areas 
having high activity of ticks (David et al 1989). Like the previous epi­
demiological studies of TBE in Estonia our also showed the intermittent course 
of the disease - small outbreaks were registered every three years (Pototski 
1988; Vassilenko et al. 1990). Contrary to the data of Wood et al (1988), 
showing that the activity of ticks as well as the incidence of TBE increased 
following a short warm winter our data revealed the highest incidence in 
1986/87, when winter was one of the coldest (unpublished data of meteorology 
service of Tartu). It is interesting that the occurrence of TBE was registered the 
areas around Lake Peipus and which is region of simultaneous appearance of 
two species of ticks — Ixodes ricinus and Ixodes persuculatus. The data 
correspond to those published by Pototski (1988). 
A predominance (84.3%) of children up to five years in BM patients in­
cluded in this study is characteristic to developed countries and is similar to 
studies performed by Halsensten et al (1987) and Peltola et al (1990). A 
significantly increased incidence of BM in comparison to the other age groups 
was found in the age up to one year. The reasons of high attack rate of young 
children are obviously connected to the functionally immature host defence 
mechanisms in infants and young children (Feigin et al 1992). In contrast, the 
frequency of nonbacterial ICNS similarly to Tardieu et al (1986) and Hensel et 
al (1992) was higher among older children constituting 80.8% of the total. The 
reasons are not clear, but they seem to be social rather than connected to the 
immunity systems. Older children visiting schools and kindergartens, have 
closer contact to each other and are therefore mote affected than younger. 
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However, in some studies the high occurrence of enteroviral meningitis among 
infants and newborns is documented (Schattuck et al 1992; Yamashita et al 
1992) and even outbreaks in neonatal nurseries have been reported (Heiin et al 
1987; Gilbert et al 1988). 
The ICNS mortality of 3.6% and disability rate of 3.2% beyond neonatal 
period reported by us were lower than that in the Finnish cohort study in 1966— 
1980 (6.5% and 14.9% respectively) (Rantakallio et al 1986) but case fatality 
rate was higher than that in Spain — 1.4% in 1988 (Roca et al 1992). 
The mortality rate of BM in comparison to a previous study performed in 
Estonia in 1945-1958 has been dropped remarkably (Tulmin 1961) from of 
43% to 9%. Nevertheless, it is considerably higher than that in Finland, Sweden 
or Scotland (Salwen et al. 1987; Valmari et al 1987; Carter et al 1990). The 
case fatality rate was especially high at the beginning of the 1980s, where no 
pediatric intensive care unit existed in this area and single cases of BM were 
treated in several hospitals. With the improving facilities of bacteriological 
laboratories, opening of PICU in Tartu University Children's Hospital and con­
centrating patients with BM to that, mortality of this disease beyond neonatal 
period declined considerably from 10.1% to 2.8%. 
Like previous studies, we found most favourable outcome of MM — 5% of 
patients died and 5.6% of survivors developed disability at the discharge in our 
series. An even lower mortality rate (0-2.4%) has been reported in some other 
studies (Salwen et al 1987; Peltola et al 1990; Thompson et al 1990). Due to 
the low number of pneumococcal meningitis in this study our data with the 
mortality of 20% and disability of 12.5% may have bias towards worse out­
come. However, the fact that similar data have been documented by others also 
lends support to this view (Laxer et al 1977; Grubbauer 1982; Bryan et al 
1990). 
Case fatality and disability rates of neonatal meningitis have been as high 
as 45.8% and of 53.8% respectively in South-Estonia and correspond to some 
other studies (Apak et al 1983; Bell et al 1989). However, there are studies 
with considerably lower mortality rate. Bennhagen et al (1987) in the study in 
Sweden in 1983 reported a mortality rate of 3.5% but 50% of the cases were 
caused by GBS and no cases of E. coli meningitis have been registered. 
Relatively low mortality rate of 7.3% has been documented in another study 
performed in Moscow (Samsõgina et al 1986), but this study constituted 
preferably full-term babies and most common microorganisms documented 
were S. aureus and other Gram-positive microbes. A relatively good prognosis 
of neonatal meningitis caused by Gram-positive microbes in comparison to that 
caused by Gram-negative enteric bacteria is well documented in previous stud­
ies (Unhand et al 1993). Not all reasons of high mortality and morbidity of 
neonatal meningitis in this study are clear. The high rate of Gram-negative bac­
teria being prognostically worse and the high ratio of premature babies (14/24) 
among patients apparent the late diagnosis particularly of ventriculitis and 
therefore the late onset of appropriate antibacterial therapy as well as intensive 
care cannot be excluded. Due to difficulties of therapy of neonatal meningitis 
more attention should be paid to the prevention of neonatal meningitis. It can 
be effective only in hospitals where the epidemiological data are correctly 
documented, that is why a correct registration of neonatal infection in Estonia 
will be necessary. 
The disability rate of BM of 7.1% was registered in similar rates as above 
noted series (Giustina et al. 1985; Valmari et al. 1987) and will be discussed in 
more detail in part III. 
The good prognosis like in most previous studies (Beghi et al. 1984; Etter 
et al. 1991) was characteristic to AM and TBE. The relatively good prognosis 
of encephalitis in contrast to Rantala et al. (1989) with the mortality of 2.1% 
and disability of 4.4% is most of all associated with high number of TBE cases, 
which is known as a mild disease and does not leave permanent sequelae 
(Wahlberg et al. 1989). Despite the introduction of antiviral therapy the out­
come of HSVE with the mortality rate of 44-85% (Lietz et al. 1986; Wagner et 
al. 1987) and disability rate up to 100% (Cameron et al. 1992) is still worse. 
Only one case of HSVE was registered in this study and the outcome was also 
poor. 
In summary: Approximately 50 cases of ICNS were yearly diagnosed in 
children in South-Estonia in the 1980s, whereas each year three of them died 
and two had permanent disabilities. It was characteristic of this area that BM 
occurred preferably in younger children whereas AM and TBE were most often 
seen in schoolchildren. The mosi common microorganism causing BM was N. 
meningitidis but in almost half 'of «.Lc cases the etiology remained unknown. 
The etiology of AM was unidentified in more than 90% of the cases and ac­
cording to the seasonality we can only speculate that enteroviruses could be the 
most common causes of it. To improve the outcome of ICNS (in addition to the 
concentration of patients with serious form of ICNS to the tertiary care hospi­
tals), the facilities of virological and bacteriological laboratories have to be im­
proved and a surveillance system for the registration of all the cases of ICNS 
should be introduced. 
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PART II 
ENZYMATIC CHANGES OF THE 
CEREBROSPINAL FLUID IN PATIENTS WITH THE 
INFECTIONS OF THE CENTRAL NERVOUS SYSTEM 
2.1. REVIEW OF THE LITERATURE 
Damage within the central nervous system causes a leakage of certain 
intracellular enzymes into the CSF. Estimations of AST, LDH, GGT and CPK 
are widely employed as valuable diagnostic aids in diseases involving necrosis 
or damage of tissues characteristically rich in these enzymes (Riekkinen et al. 
1970; Nelson et al. 1975; Landaas et al. 1985; Tammpere et al. 1987; 
Koskiniemi et al. 1988). The results obtained, however, are controversial. 
2.1.1. Lactate dehydrogenase in the CSF in patients 
with ICNS 
LDH (E.C. 1.1.1.27) is one out of four main enzyme systems in the human 
body through which the pyruvate is metabolised to lactate. The active form of 
the enzyme is a tetramer such that in most tissues including brain a spectrum of 
five isoenzymic fonn appear. 
LDH 
Glycose• Pyruvate -*• Lactate 
Brain and heart contain mainly LDH 1 and 2 activity (Popovitch et al. 
1986; Chatterley et al. 1991), while granulocytes predominantly exhibit the 
fraction LDH 5 (Beaty et al. 1968). No significant regional differences could be 
observed for LDH in the human brain (Delanghe et al. 1990). The activity of 
the LDH in the CSF fluid is normally lower than in the blood serum (Maas 
1977; Pasaglu et al. 1989; Chatterley et al. 1991). 
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An elevation of activity of the LDH is shown by several illnesses where a 
brain hypoxia is present — in patients with BM (Riekkinen et al 1970; Nelson 
et al. 1975; Landaas et al. 1985; Pasaglu et al. 1989), with malignant brain tu­
mours (Koskiniemi et al. 1988; Lampl et al. 1990) and with hypoxic-ishaemic 
brain damage (Talvik 1992). Among the patients with viral meningitis the 
raised activity of LDH in the CSF was not demonstrated (Nelson et al. 1975; 
Landaas et al. 1985). 
The question arises whether the raised enzyme activities demonstrated in 
the CSF after brain injury are the results of brain tissue destruction or whether 
they may be caused by seepage of blood enzymes through a severely damaged 
BBB or are granulocytes the main sources of the LDH activity. By comparing 
the characteristic LDH isoenzyme patterns of the tissues in contact with the 
CSF isoenzyme patterns of children with neurological disorders, it has been 
possible to demonstrate more clearly the sources of LDH in the CSF (Nelson et 
al. 1975; Radzavil et al. 1986). Where leucocytosis of the CSF occurs as by 
BM the cells appear to be the source of LDH activity, but in all other cases it 
seems possible that brain cell damage releases the enzyme into the CSF 
(Riekkinen et al. 1970; Nelson et al 1975; Roslõi et al. 1991). 
2.1.2. Aspartate aminotransferase in the CSF in 
patients with ICNS 
AST catalyses the transfer of the alpha-amino groups of aspartate to alpha-
keto group of ketoglutaric acid, resulting in the formation of oxaloacetic acid 
(Zakim et al 1982). AST is present in wide variety of tissues including the 
brain (Awapara et al 1989). It is present in both mitochondria and cytosol of 
the brain. Large increases in mitochondrial AST are found early in diseases 
associated with massive tissue necrosis, perhaps reflecting a sudden release of 
intracellular contents into the circulation (Boyde et al. 1968). The regional 
distribution of the AST in the brain is equal (Delanghe et al. 1990) and the nor­
mal value does not exceed of 12 U/L (Sirkis 1982; Radzavil et al 1986; 
Agrawal etal. 1989). 
L-aspartic acid + alpha-ketoglutaric acid 
AST 
oxaloacetic acid + L-glutamic acid 
Most authors suggest that the origin of the AST activity in the CSF is most 
probably the brain tissue destruction (Sirkis 1982; Radzavil et al 1986). An 
elevation of AST in the CSF during the first hours of illness was found by vari-
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ous neurological diseases — in patients with acute stroke (Haldre 1988), with 
hypoxic-ishaemic encephalopathy in newborns (Tammpere et al 1987) and 
with ICNS (Sirkis 1982; Agrawal et al. 1989). There are differences in AST 
activity among patients with bacterial and viral meningitis. Sirkis (1982) 
studied 512 patients with ICNS and found 2.2 - 2.6 fold raised enzyme activity 
in those with viral meningitis whereas in patients with BM the 3.3 fold in­
creasing of AST activity was documented. Roslõi (1991) described an increase 
of CSF AST in 75% of BM patients and found normal enzyme values in those 
with AM. 
2.1.3. Creatine Phosphokinase activity 
in the CSF by ICNS 
CKP (E.C. 2.7.3.2.) is an energy - transfer enzyme that reversible catalyses the 
phosphorylation of creatine by adenosine triphosphate. CPK is present in many 
body tissues and exists in three isoenzyme form; MB in cardiac muscle; MM, 
in striated muscle and BB, found predominantly in brain (Wiedemann et al. 
1989). 
pH 9.0 
Creatine +ATP « •Creatine phosphate +ADP 
pH 7.0 
The concentration of CK-BB is different in various regions of the human 
brain. Highest tissular CK-BB content was found in the brain cortex and 
Capsula interna while only limited amounts were measured in the pons, 
cerebellum and medulla oblongata (Delanghe et al. 1990). The cellular 
distribution of the CK-BB in human brain is controversial: Worley et al. (1985) 
and Pfeiffer et al. (1983) found it in both neurones and astrocytes but 
Thompson et al (1980) found CK-BB in astrocytes only. Due to the fact that 
the CK-BB is not found in white cells and is present only in minimal quantities 
in red cells it seems to be a good indicator of cellular damage of the brain (Cho 
et al. 1977; Thompson et al 1980). Its normal value in the CSF is low and is 
equal to 2.5 U/L (Radzavil et al 1986; Pasaglu et al 1989). An elevated 
concentration of CPK has been shown in patients who suffered subarachnoidal 
haemorrhage (Maiuri et al. 1989), malignant brain tumours (Bach et al 1989), 
prenatal asphyxia (Praeter et al. 1991; Talvik 1992) and also BM and AM 
(Katz et al. 1970; Bach et al 1989; Smirnov et al 1989). However some 
previous studies indicated that CSF CPK activity is not reliable in differation 
between bacterial and nonbacterial CNS infections (Katz et al. 1970; Briem 
1982; Smirnov et al 1989). 
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2.1.4. Gamma-glutamyl Transpeptitase in the CSF 
in patients with ICNS 
GGT (E.C. 2.3.2.2.) catalyzes the transfer of gamma-glutamyl groups from 
peptides such as glutatione to other amino acids. Characteristic to GGT is 
widespread distribution of the enzyme in the cell membranes of the kidney, 
seminal vesicles, pancreas, liver, spleen, heart, and brain (Zakim et al 1982). 
The concentration of GGT in the CSF is usually almost zero (Radzavil et al 
1986). The CSF GGT is elevated in association with BM, especially within the 
first days of the illness (Radzavil et al 1986; Nand et al 1992). Roslõi et al 
(1991) determined an elevated activity of GGT in all meningococcal infection 
patients with increased ICP and he suggests, that this is connected to the 
increased permeability of BBB. 
2.1.5. Relationship of CSF enzyme concentration to the 
prognosis of patients with ICNS 
The amount of enzymes released from damaged tissue into extracellular fluid 
(Go et al 1976) could be expected to be proportional to the extent of tissue 
damage. Maas (1977) produced experimental brain lesion in cats by cold and 
showed the augmentation of intracellular enzymes in the CSF being 
proportional to the severity and extent of brain damage. Pasaglu et al (1989) 
studying LDH, CK-BB and CPK in the cerebrospinal fluid in 20 head injured 
patients found that all the enzymes correlated with GCS whereas the best 
correlation was found with CK-BB. However, the data of prognostic value of 
the changes in CSF enzyme activity are controversial. Florez et al (1975) on 
35 patients with head injures, showed the AST activity in the CSF to correlate 
well with the severity of brain lesion, but they could not find such correlation 
for the CPK activity. A high prognostic significance of raised AST activity was 
demonstrated also by Agrawal et al (1989) and Roslõi (1991). They found in 
BM patients who either expired or recovered with residual complications very 
high AST values comparing to cases with complete and uneventful recovery. 
Belsey (1969) reported extensive brain lesions on autopsy in patients with very 
high CSF AST levels. 
Brain-specific CPK isoenzyme (CK-BB) seems to be the best marker for 
CNS damage that we have. The concentration of CK-BB in CSF has shown to 
be high in several neurologic diseases and to correlate with the frequency of 
neurologic sequelae (Belton 1970; Praeter et al 1991; Haldre et al 1991; 
Talvik 1992). Sööt (1989) found in asphyxiated newborns with hypoxic-
ishaemic encephalopathy of III degree significantly higher CK-BB levels than 
in those who had it of I—II degree. Briem (1982) showed a correlation between 
high level of CK-BB in the CSF and poor outcome in 5 patients with 
meningoencephalitis. However, in some previous studies no correlation 
between concentration of CK-BB in the CSF and prognosis of patients was 
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found (Katz et al 1970; Florez et al 1975; Maas 1977). Moreover some 
patients can be clinically in a very serious condition and still have a low 
activities of the enzymes in the CSF (Pasaglu et al 1989; Bödvarson et al 
1990). It was shown, that the concentration of CK-BB raises rapidly within the 
first hours of the brain lesion and reaches the maximal level to the 3rd day 
(Maas 1977; Smirnov et al 1989; Bödvarson et al 1990). It must, however, be 
borne in mind that prognosis is not only determined by the degree, but also by 
the site of brain damage, while small lesions in the lifethreating areas could be 
prognostically important (Vaagenes et al. 1980). 
Because the controversy of data concerning intracellular enzymes in CSF 
and their prognostic value of patients with ICNS we undertook this study. 
The patients studied on admission included 16 children with AM and en­
cephalitis, 25 children with BM and 15 patients having no infection of the cen­
tral nervous system, whom lumbar puncture was performed due to meningeal 
syndrome. Diagnostic criteria for BM and AM are listed above (pp. 18). Of 16 
children with AM two had enteroviral meningitis and seven TBE. In 7 cases the 
etiology remained unknown. The etiologic structure of BM was as follows: 
N. meningitidis in 14 children, Hib in 4, S. pneumoniae, E. coli, P. aeruginosa 
and Klebsiella pneumoniae each in one patients and in three cases the etiology 
of BM remained unknown. Fifteen children without ICNS had following diag­
noses — six patients had acute respiratory infection, three diarrhoea, two 
epilepsy; hemolytic-uremic syndrome, polyradiculoneuropathia, malignant 
brain tumour and drug intoxication were diagnosed each in one patient. The age 
and sex distribution of patients studied on admission is shown in Table 13. 
2.2. PATIENTS AND METHODS 
T a b l e  1 3  
Patients characteristics on admission 


















Seizures (n of patients) 









pleocytosis(cells/mm3) 105(43-251) 681 (236-1484) 3(2-6) 




Ultrasonography of the brain was carried out using a scanner of 5 and 
7.5 MHz with sonolayer "Neuroimager" in 15 infants with an open fontanelle. 
Enlargement of the side ventricles (ventriculomegaly) was diagnosed on the ba­
sis of ventricular size on coronal scans as mild if the highest diameter of lateral 
ventricle was 7-14 mm, moderate if it was 15-25 mm and severe if > 25 mm. 
The patients were grouped according to the presence or absence of enlargement 
of lateral ventricles. There were 7 patients who developed ventriculomegaly af­
ter BM and 8 having normal findings. 
The outcome of the survivors was assessed by a multidisciplinaiy team 
(pediatrician, pediatric neurologist, speech therapist, psychologist) at least 
12 months after the acute illness. Children were divided into two groups. The 
good recovery group (n=32); included 17 children with BM and 15 with AM 
being normal or having impairment which did not disturb everyday life. The se­
cond group consisted of nine children (8 with BM and 1 with AM), four dying 
during the acute illness and five having severe impairments (hydrocephalus, 
severe motor disability, deafness, intractable epilepsy). All five children had 
combined disturbances. 
The first CSF was collected on the 1-3rd day of disease and in 15 patients 
with BM the second sample was taken on the 7-10th day of treatment. The CSF 
was sampled Jby lumbar puncture and centrifuged immediately. Samples were 
frozen to -20 C and stored up to three months before analysis. In all cases rou­
tine laboratory investigations i.e. CSF protein, sugar, cell count and bacterial 
cultures were examined. 
The immunoenzymatic technique type "Sandwich" described by Haldre 
(1988) was used for the measurement of CK-BB concentration. The activity of 
CPK, LDH, AST and GGT was measured by photocolorimetric assay using 
commercial kits (Labsystem FP-900). The normal values of enzymes used have 
been found from literature and are shown in Table 14. 
Statistical analysis. The results are given as median with lower and upper 
quartiles. Computerised statistical package STATWIEV 512 was used. This in­
cluded nonparametric Mann-Whitney test for unpaired samples, the Wilcoxon 
test for paired samples and the Spearman's rank correlation coefficient. 
T a b l e  1 4  
Concentartion of CK-BB and activity of CPK, LDH, AST and 
GGT in the CSF in adults with nonneurological diseases 











Pasaglu et al. 1989 
Agrawal et al. 1989 
Nelson et al. 1975 




2.3.1. Activity of AST, LDH, CPK and GGT in the CSF 
on admission and on the 7-1 Oth day of therapy 
Table 15 shows the results of CSF enzyme determinations on admission. An in­
crease in all three diagnostic groups was noted. The activity of AST was two 
fold higher in patients with BM comparing with those without (p<0.05), never­
theless it did not exceed the quoted references range. The median value of ac­
tivity of LDH (33.8 U/l) was highest in those with BM and lowest in patients 
with meningismus, but statistically significant differences was not found. All 
patients had raised activity of the GGT in the CSF. A statistically significant in­
crease (p<0.005) was noted in patients with BM on admission in comparison 
those with AM and meningism. 
T a b l e  1 5  
Activity of the AST, CPK, LDH, GGT and 
concentration of CK-BB in the CSF in patients on admission 
Enzyme AM (quartile) BM (quartile) Meningism 
(reference level) n=16 n=25 (quartile) 
n=15 
CK-BB (ng/1) 37.5 (24.0-43.0) 31.0(15-59) 39 (34-46) 
(5.3±1.2) 
CPK (U/l) 4.3 (2.0-2.9) 4.2 (2.6-5.5) 3.3 (2.6-5.3) 
(0.4-6.3) 
AST (U/L) 4.0 (3.6-7.3) 8.8(6.1-11.0)* 4.7 (3.5-6.3) 
(0-12) 
LDH (U/L) 28.1 (4.8-52.2) 33.8 (19.7-70.2) 15.4 (7.6-20.6) 
(3-17) 
GGT (U/L) 1.7 (0.6-4.5) 5.3 (2.1-8.7)** 1.5(1.0-2.0) 
JO) 
* p< 0.05 in comparison with patients without BM 
** p< 0.005 in comparison with patients without BM 
The activity of AST, CPK, LDH, GGT and concentration of CK-BB in the 
CSF on the 7-10 day of therapy was estimated only in patients with BM. Figu­
re 6 demonstrates that the median activity of AST decreased with the treatment 
from 8.2 to 5.6 U/1, LDH form 33.8 to 27.3 U/l and GGT from 5.3 to 1.6 U/l, 
but that of CPK and the concentration of CK-BB remained the same being on 
the 7-10th day of therapy approximately 6 fold higher than reference value. 
AST activity was simultaneously estimated in the CSF and blood serum in 
40 patients: no correlation was found between the levels of AST in the CSF and 
in serum (r=-0.362), although significantly higher activity of AST in the CSF 
(14.1 U/l) as well in the blood serum (23.5 U/l) was found in patients with poor 
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prognosis in comparison to those with good prognosis 8.4 U/l and 7.3 U/l re­
spectively. 
The activity of LDH correlated with the count of PMNL in the CSF on ad­
mission (r=0.538), but no correlation was found on the 7-1 Oth day of therapy. 
There were 3 patients with E. coli meningitis having more than 1000 PMNL in 
the CSF on the 10th day of therapy, but the activity of LDH was 2.5; 4.3 and 
91.5 U/l respectively. 
2.3.2. Prognostic value of intracellular enzyme 
determinations in the CSF 
The relationship between the enzymatic determinations and the outcome is 
shown in Table 16. 
T a b l e  1 6  
Enzymes data on admission in relation with outcome of ICNS 
Outcome CK-BB (ng/1) CPK AST LDH GGT 
(quartile) (U/l) (U/l) (U/l) (U/l) 
Dead/severely 9.5 3.8 12.1* 60.5 (37.1- 2.7 
impaired n=9 (2-37) (2.6-4.5) (5.0-17.4) 235.4)* (1.8-11.4) 
Good recovery 38.0 4.5 6.7 27.5 2.9 
n=32 (30-49) (1.7-6.5) (4.0-9.0) (15.2-46.3) (0.9-8.1) 
*p< 0.05 
• on admission 
Preference level 
*CK-BB CPK AST LDH GGT 
Figure 6. Activity of CPK, AST, LDH and GGT, and concentration of CK-BB in 
BM patients in CSF on admission and on days 7 to 10 of therapy. 
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The patients of ICNS who died or recovered with residual impairments had 
significantly higher median CSF AST and LDH activity (p<0.05) as compared 
to those with good recovery. Although the concentration of CK-BB was higher 
in patients with good prognosis, the difference was not statistically significant. 
With the therapy the activity of all intracellular enzymes but CK-BB concentra­
tion decreased in both groups. It is interesting to mention that the median con­
centration of CK-BB decreased in patients with good outcome from 49 ng/1 to 
31 ng/1 and increased from 9.5 ng/1 to 37 ng/1 in those with poor prognosis, but 
the difference was not statistically significant. 
2.3.3. Activity and concentration of intracellular 
enzymes and cerebral ultrasound findings 
Table 17 shows the results of CSF enzyme determination according to the cere­
bral ultrasound findings. 
T a b l e  1 7  
Enzyme data in relation to cerebral ultrasound findings in patients with BM 
Sonographic finding CPK AST LDH GGT 
Enzyme activity (U/L) (U/L) (U/L) (U/L) 
V entriculomegaly 4.5 12.1* 71.1* 2.7 
n=7 (3.2-7.7) (10.5-15.1) (69.7-235.4) (2.6-7.2) 
Normal 3.5 8.0 23.4 2.5 
n=8 (2.7-5.4) (7.4-8.9) (18.7-27.5) (1.1-5.2) 
*p< 0.05 
The activity of AST and LDH was significantly higher in patients who de­
veloped ventriculomegaly in comparison to those having normal findings 
(p<0.05). The highest value of AST and LDH activity 211.3 U/l and 14.1 U/l 
respectively was seen in patients with ventriculomegaly developing hydro­
cephalus. 
2.4. DISCUSSION 
In this study our aim was to estimate the level of some intracellular enzymes in 
the CSF in different infections of the central nervous system and to establish 
whether any of the measured enzyme levels would correlate with the CNS dys­
function thus assessing their prognostic value and determing their usefulness in 
clinical practice. An elevation of AST, LDH and GGT activity in patients with 
BM on admission, demonstrating neuronal cell injury as well as altered perme­
ability of BBB, has been reported by several authors (Nelson et al. 1975; Sirkis 
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1982; Landaas et al. 1985; Radzavil et al. 1986; Nand et al. 1992). The in­
creased activity of AST and GGT in BM patients was registered in this study 
also, but no statistically significant increase of median value of LDH activity 
was seen, although some patients with BM had very high levels. 
The data of CSF activity of AST in patients with AM are controversial. We 
in contrast to Sirkis (1982) and like Roslõi (1991) could not find an elevation 
of AST in patients with AM in comparison with the control group. However, as 
Sirkis (1982) and Agrawal et al. (1989) we saw a significant increase in AST 
activity in CSF in patients with BM in comparison with those with AM and 
meningism and pointed to its prognostic value. Differences in enzyme activities 
between AM and BM are most probably connected to the different pathome-
chanisms of those two diseases. By BM the components of bacterial cell walls 
stimulate the local production of inflammatory cytokines in CSF, leading to in­
flammation and alterations in the cerebral microvasculature, causing hypoxic-
ischaemic damage of brain tissue and cytolysis (Quagiliarello et al. 1992). 
Although the activity of AST in patients with a poor prognosis raises rapidly in 
the CSF and in blood serum, we like Sirkis (1982) and Radzavil et al. (1986) 
could not find any correlation between serum and the CSF activity of AST 
(r=-0.362). Therefore we can assume that the main sources of AST activity in 
the CSF is brain tissue, although we can not exclude that in severely ill patient 
the enzyme can cross to BBB due to raised permeability of it. 
The benefit of the measuring of the activity of LDH in differentiation of 
AM and BM was very poor in our study confirming the work of Landaas et al. 
(1985). This is in contrast to others (Neeches et al. 1968; Feldman 1975; 
Knight 1981) who have claimed significantly higher concentration of LDH in 
BM. We also found the activity of LDH higher in BM compared to AM and 
meningismus but the differences has not been statistically significant. The good 
correlation (r=0.538) between CSF PMNL count and the activity of LDH 
confirms the opinion of several studies that PMNL are the main sources of the 
LDH activity in the CSF in BM patients (Riekkinen et al. 1970; Nelson et al. 
1975; Roslõi 1991), although the exact origin of the enzymes may be 
differentiated only by isoenzyme studies. However, the good correlation was 
found only during the acute period of BM. The low activity of LDH on the 7-
10th day of therapy, despite the high amount of PMNL in the CSF also 
suggests a cerebral origin of LDH in the acute period of brain injury. 
The present study like previous ones (Belsey et al. 1969; Maas 1977'; 
Agrawal et al. 1989; Roslõi et al. 1991), establishes a definite relation between 
CSF AST and LDH activity and the extent of the brain injury. The patients who 
either died or recovered with residual complications had significantly higher 
(p<0.05) AST and LDH activity than cases with complete recovery. The higher 
activity of AST and LDH in the CSF (p<0.05) was found also in patients who 
had enlargement of the lateral ventricles during the acute illness, which 
strongly suggests that one of the reasons of enlargement of lateral ventricles 
after BM is brain atrophy developing due to necrosis of brain tissue. 
Raised activity of CPK in the CSF seems to be a reliable factor characteris­
ing a brain damage, because its concentration in the normal CSF is low (Maiuri 
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et al. 1989; Bach et al. 1989; Smirnov et al. 1989). However the present study 
like previous ones (Katz et al. 1970; Briem 1982; Smirnov et al. 1989) 
indicates that CSF CPK activity is not reliable in differentiating between 
bacterial and nonbacterial CNS infections. The three-fold increased activity of 
CPK shows disturbances of the energy balance in the brain tissue in patients 
with BM and AM as well as with meningismus. We in contrary to Pasaglu et 
al. (1989) amd like Florez et al. (1975) could not found any correlation between 
poor outcome of ICNS and raised CPK activity in the CSF. Moreover the 
patients who died or were severely impaired had even lower activity of CPK in 
comparison to those with good recovery, although the difference was 
nonsignificant. 
The high concentration of isoenzyme CK-BB in the CSF seems to be best 
at predicting bad prognosis in head injured patients in several studies (Belton 
1970; Bach et al. 1989; Praeter et al 1991; Haldre et al. 1991; Talvik 1992). It 
was a surprise finding that the concentration of CK-BB in those with a bad 
prognosis was even lower (9.5 ng/1) compared to those with a good outcome 
(38.0 ng/1). The fact that some patients with bad prognosis did not have an in­
crease of CK-BB concentration in the CSF was also shown in previous studies 
(Pasaglu et al. 1989; Bödvarson et al. 1990). The variable increase in CK-BB 
concentration in different patients is not completely understood. The concentra­
tion of CK-BB in the CSF changes rapidly during the first hours of brain injury 
(Smirnov et al. 1989; Bödvarson et al., 1990), thus the results depend up on the 
time of collecting the CSF. In this study the wide time spectrum from 1 to 3 
days of illness could account for that. The various regional distribution of CK-
BB in the brain has also been reported (Maas 1977; Vaagenes et al. 1980), so a 
small focal lesion in functionally important region of the brain may cause 
severe impairment with minimal enzyme release. Raised concentration of CK-
BB in patient with meningismus was an unpredicted finding and shows that 
even in those cases the hypoxic-ischaemic damage of the brain and distur­
bances of the energy metabolism tissue occur. It must, however be born in 
mind that prognosis is not only determined by the degree, but also by the site of 
brain damage. A definite prognosis for the individual patients cannot be estab­
lished on the basis of the enzyme activity of the CSF alone. The prognostic va­
lue of CSF enzyme estimations depends on the consistency with which en­
zymes released into the extracellular fluid and will be transported towards CSF. 
In summary: The increased activity/concentration of intracellular enzymes 
in the CSF caused most probably by cytolysis going on, was found in patients 
with BM as well as with AM, whereas their levels in cases of BM were higher. 
The measurement of activity of AST and GGT seems to be the best in differen­
tiation between AM and BM. The origins of enzyme activity could be either 
CSF PMNL as it was shown for LDH or cells of the brain tissue as for AST, 
CPK and CK-BB. Our study demonstrated that high activity of AST and LDH 
in the acute period of illness will correlate with bad prognosis, whereas surpris­
ingly, the prognostic value of increased concentration of CK-BB was very 
poor. That is why the definite prognosis for individual patient cannot be estab­
lished on the basis of enzyme activities alone, but depends on several factors. 
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PART III 
FOLLOW-UP AND LONG-TERM OUTCOME OF 
CHILDREN AFTER BACTERIAL MENINGITIS 
3.1. REVIEW OF LITERATURE 
It is demonstrated that 11-27% of the survivors of BM had some sequelae at 
the time of hospital discharge (Grubbauer et al. 1982; Giustina et al. 1986; 
Salih et al. 1990), but there is a tendency for even major neurological defects to 
resolve unpredictably with the time. In an large prospective study of BM in 
children Klein et al. (1986) revealed that 32.8% of children had abnormalities 
detectable on neurologic examination at the time of hospital discharge. Five 
years after discharge, however, specific deficits were noted in only 11.1%. 
Table 18 demonstrates the long-term sequelae of BM in children. 
T a b l e  1 8  
Long-term sequelae of BM reported in literature 
Author Sell Lebel et al. Salih et Odio et al. 
Sequelae (%) (1983) (1989) al. (1991) (1991) 
Mortality (%) 13 0.5 19 2 
Patients with sequelae 50 14.4 27 20.2 
Hearing disturbances 10-11 15.9 22 11.9 
Seizures 2-8 ? 11 4.0 
Motor abnormalities 3-7 3.3 7 ? 
Speech delay 15 ? 7 ? 
Mental retardation 10-11 8.5 ? ? 
Behaviour problems 9 ? 7 ? 
Mean IQ 86 ? 92.3 ? 
Ataxia ? 3.7 ? 2 
The most precisely quantified sequela of BM is hearing impairment. In a 
review of the English language literature Fortnum (1992) calculated the occur­
rence of it at an average of 9.6% in survivors after BM, whereas deafness was 
registered in 1-4% of the cases. The prevalence of hearing disturbances in pre­
vious studies is demonstrated in Table 19. The hearing disorders are often bi­
lateral and profound (Overkamp et al. 1982; Schaad et al. 1990) and occur par­
ticularly in children who are younger than 3 years during acute illness 
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(Brookhauser et al. 1989). The reasons for hearing impairment during BM are 
not completely clear. Four pathogenic mechanisms are discussed in literature. 
T a b l e  1 9  
Incidence of hearing disturbances after BM in the literature 
Author Years Age of n of Orga­ Incidence Incidence 
patients patients nism ofSNHI of profound 
during (%) SNHI (%) 
acute BM 
Jadavij et al. 1979-1983 4day-14y 235 All 12.9 — 
(1986) 165 Hib 7.3 
— 
24 men — — 
46 pneum 43.3 — 
Dodge 1973-1977 2mo-14y 185 All 10.3 2.2 
(1986) 118 Hib 5.9 1.7 
19 men 10.5 — 
29 pneum 31 6.9 
19 other 5.3 0 
Salwen et al. 1956-1980 lmo-16y 176 All 11.6 3.9 
(1987) 137 Hib 9.6 • • — 
14 men 10 — 
25 pneum 33 — 
Lebel etal. 1984-1985 2mo-16y 94 All 9.1 — 
(1989) 30 Hib 9.5 — 
51 pneum 21.4 — 
15 Other 0 — 
Salih et al. 1985-1989 ? 181 All 22 11 
(1990) 
Odio et al. 1990 6w-13y 115 All 10.6 — 
(1991) 
men - N. meningitidis, pneum - S. pneumoniae 
Firstly it is assumed, that the cochlear dysfunction is due to a direct 
invasion of bacteria into the cochlea, spread of infection along the auditory 
canal and cochlear aqueduct causing serous or purulent labyrinthitis and 
replacement of the membranous labyrinth with fibrous tissue and new bone 
(Klein et al 1986; Harada et al. 1988; Kaplan et al. 1989; Bhatt et al. 1991). A 
second mechanism of dysfunction may be due to a damage of the eight nerve 
by toxins (Kline et al. 1979). A third possible mechanism is a vascular occlu­
sion and ischemia in the region of the auditory tract (Jiang et al. 1990). A fourth 
mechanism is an eight nerve damage by antibiotics. However, the majority of 
studies do not support the latter argumentation because in most cases hearing 
impairment is diagnosed already before the introduction of antibacterial 
therapy (Friebel et al. 1984; Dodge et al. 1986). 
It has been shown that various microorganisms cause hearing disturbances 
with different frequencies. In their experiments with mice Kaplan et al (1989) 
tried to verify that different types of Hib have different capabilities of invasion 
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into the cochlea but got negative results. In most studies the highest ratio of 
hearing disorders is documented after pneumococcal meningitis (Dodge et al. 
1986; Jadavij et al. 1986; Salwen et al. 1987). 
The second most frequent complications of BM are motor abnormalities re­
ported in of 3-7% of survivors (Gary et al. 1989; Odio et al. 1991). Although 
motor defects are not uncommon during acute infection marked improvement 
occurs weeks to months later. Pomeroy et al. (1990) had 37% of patients who 
had acute neurologic deficits at the time of hospital discharge. In more than 
60% of these patients the abnormalities resolved within 3 months and there 
were only 8 patients (4%) with residual hemi-or quadriparesis. 
Ataxia as the most common motor defect has been reported as a presenting 
symptom of BM in the same children in whom hearing impairment was noted 
to develop at a later stage (Klein et al. 1986). Both may be a sign of a 
dysfunction of the cochlea as well as the labyrinth. Ataxia is mostly a transient 
disorder. Lebel et al. (1989) observed ataxia in 14.4% of BM patients on 
discharge. After 6 weeks it was seen in 3.3% of the patients and after one year 
it persisted in only 0.3% of the survivors. 
Seizures occurring as a late sequelae of meningitis have been reported in 2-
8% (Sell et al. 1983; Pomeroy et al. 1990; Odio et al. 1991). Only Salih (1990) 
in his study in a developing country (Sudan) registered seizures as late compli­
cations more often- in 11% of the survivors. Most of the late seizures occur 
within first five years after meningitis, but an elevated risk remains for up to 20 
years (Annegers et al. 1988). The risk of epilepsy has been six fold higher for 
those having seizures in the acute phase and also for children with persistent 
neurological deficits at the time of discharge (Annegers et al. 1988; Pomeroy et 
al. 1990). 
Visual impairment has been found in 2-4% of survivors (Sell 1983; Jadavij 
et al. 1986). Reversible abnormality of vision is due to vasospasm of the 
arteries while the permanent visual impairment is due to cerebral occipital 
haemorrhage and atrophy (Kabany et al. 1992). 
Mental retardation in various degree have been registered relatively fre­
quently following BM. IQ scores of less than 70 has been reported in approxi­
mately 10-11% (Sell et al. 1983) and in the study of Jiang et al. (1990) even in 
17% of survivors. In their follow-up study of postmeningitic children in 
comparison to their siblings Sell et al. (1972) showed a mean IQ significantly 
lower in the index group, 29% of the survivors scored less than 1 SD below 
their controls. In contrast to these results Lebel et al. (1989) reported no 
differences in the average IQ score between the index group and their siblings 
in a sibling controlled developmental outcome study. 
More subtle findings of attention deficits and behavioural problems have 
been reported in 7-9% of survivors (Sell et al. 1983; Salih et al. 1990) and are 
thought to be more presumptive than documented. The learning problems have 
been investigated in a study by Feldmann et al. (1988). They compared the aca­
demic achievement of 23 children 10 to 12 years after the treatment of Hib 
meningitis to age match sibling controls. Their findings suggest that children 
who recovered from meningitis can maintain scores and grades comparable to 
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their siblings. They also concluded, that their academic success involved more 
school and family support to compensate for the child's IQ deficits. 
The frequency of language disorders or delay has been commented on by a 
number of investigators and varies from 7-23.3% (Lebel et al. 1989; Gary et 
al. 1989; Salih et al. 1990). The language disorders are most likely to be 
associated with a hearing loss occurring before the child has learned to speak or 
with brain damage in the region of the speech centre. 
Prospective studies have permitted the assessment of factors that herald a 
poor prognosis and that may be discernible at or near the time of admission to 
the hospital. The association between high concentration of pathogenic 
microorganisms (Feldmann et al. 1982) or a high concentration of endotoxine 
in the CSF (Mertsola et al. 1991), the delayed sterilisation of CSF (Lebel et al. 
1989), low concentration of glucose in the CSF and seizures at the time of 
admission (Dodge et al. 1984; Klein et al. 1986; Taylor et al. 1990; Letson et 
al. 1992) proved to be the most reliable predictor of permanent sequelae of 
BM. A significant correlation between hearing loss and neurological sequelae 
at the time of discharge as well as on follow up examinations after several 
years has been documented (Jadavij et al. 1986; Taylor et al. 7990). 
The data about the duration of symptoms before therapy and the outcome 
of BM are controversial in literature. In a review of 22 studies Radetsky (1992) 
described that in 13 studies (55%) a relation between the outcome of BM and 
the duration of symptoms before the hospitalisation was found whereas in 9 
(41%) there was none. Bhatt et al. (1991) demonstrated in an animal model that 
the incidence and severity of hearing disturbances correlated strongly with the 
duration of meningitis. A Finnish study showed better outcome of patients 
whose duration of symptoms before the antibacterial therapy was longer, but it 
will be always difficult to determine the exact onset of the disease (Kilpi et al 
1993). 
3.2. PATIENTS AND METHODS 
3.2.1. Patients of follow-up examinations 
Fifty six children (26 girls and 30 boys) treated at Tartu University Children's 
Hospital from 1986 to 1990 for BM were followed up during a period of 12 
months. They were examined if one months and one year passed from acute ill­
ness. Twenty five children (44.6%) had meningococcal meningitis, five (8.9%) 
pneumococcal meningitis, eight (14.2%) Hib meningitis and in 18 (32.1%) 
cases the etiology of BM remained unknown. The median age of children 
during the acute illness was 18 months. 
13 
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3.2.2. Patients of long-term follow-up examinations 
In order to assess the long term outcome of BM we recalled 91 out of 123 chil­
dren treated for BM except neonatal meningitis at Tartu University Children's 
Hospital from 1982 to 1990 and still living in this area (Figure 7). 
123 BM patients 1982-1990 
118 discharged 5 died 
3 died 25 removed 90 lived in this 
/ x 
84 follow-up 6 unknown 
examination 
Figure 7. Characteristic of patients treated with BM in 1982-1990. 
Recalling criteria were an age of at least 4 years and a lapse of 3 or more 
years since the onset of BM. 84 (68.2%) children were included in the follow 
up examination, the median age was 8 years (from 4 to 18 years) and an 
average of 6 years (from 3 to 9 years) had passed since the acute period. 64 
(74.6%) out of 84 were normal, 14 (16.8%) had mild and 7 (8.4%) severe 
damage at the time of discharge. Forty-two children (50%) had meningococcal, 
12 (14.2%) Hib, 7 (8.3%) pneumococcal meningitis and in 23 cases (27.3%) 
the etiology of BM remained unknown. 
3.2.3. Study procedures 
The data of acute period of the disease were obtained from hospital records. 
The children were examined by multidisciplinary team (pediatrician, pediatric 
neurologist, speech therapist) motor defects, language disorders and hearing 
disturbances were estimated using special scoring system described below. 
Children with motor defects were divided into three classes according to 
functional capability as described by Talvik (1992); 
1 - mild changes of muscle tonus and elevated reflexes without functional dis­
turbances, all activities possible without special aids; 2 - function is acquired 
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trough special aids; 3 - limited voluntary action, enable to walk, to sit without 
aid, often bedridden. 
Speech development was estimated using 7 - graded scoring system accord­
ing the age as follows: 
at the age of 18 months: 
0 - no vocalisation; 1 - babbling; 2 - understanding of language; 3 - single 
words with meaning; 4 - one word utterance; 5 - two word utterance. 
at the age of 2 years: 
0 - no vocalisation; 1 - babbling; 2 - understanding of language; 3 - single 
words with meaning; 4 - one word utterance; 5 - two word utterance; 6 -
simple sentence. 
According to the speech development the children were divided as follows: 
normal or mild disturbances — 5-6 class; moderate language disorders — 3-4 
class; severe language disorders — 0-2 class. 
Hearing tests were performed using pure tone audiometry and estimated 
by ENT specialist with a MA-31 audiometer (DDR), Thresholds were 
determined at 500, 1000, 2000, 4000 and 8000 Hz. The divisions are based on 
the hearing level for speech (from 500 to 1000 Hz). The four classes of hearing 
are defined in terms of hearing levels for speech described by Dodge et al. 
(1984) (Table 20) 
T a b l e  2 0  
Hearing classification 
Estimated hearing level 
for speech (dB) 
Hearing class Functional definition 
<30 1 - Normal Hearing that is near or within normal 
limits 
30-55 2 - Mild loss Difficult with conversational speech 
beyond 6 meter; hearing aid helpful 
55-70 3 - Moderate loss Hearing aids and special training in 
speech and language essential 
>70 4 - Deaf Deaf: cannot rely on hearing as pri­
mary channel of communication 
At the time of hospital discharge and during the follow up examination all 
children were divided into the three groups: 
1 — normal or mild disturbances — motor disturbances of first classes, one 
sided hearing disturbances, mild language disorders 
2 — moderate disturbances — motor disturbances of 2 classes, two sided mild 
to moderate hearing disturbances, moderate language disorders, seizures 
controlled by antiepileptic drugs, impairment corrected by rehabilitation 
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3 — severe disturbances — handicapped children who need special aid-
multiple disturbances not corrected with the rehabilitation, MA 3-4 classes, 
deafness, alalia, intractable epilepsy. 
Statistical analysis. The chi-square test and Student's t-test were employed 
to determine whether there were significant differences between variables. The 
Spermann correlation test was conducted to assess the association of outcomes 
and acute period variables. 
3.3. RESULTS 
3.3.1. Follow-up of children after BM 
The follow-up data of 56 children after BM if one and twelve months were 
passed from acute period are shown in Table 21. 
T a b l e  2 1  
Sequelae of BM in children at discharge, one and 
twelve months after the acute illness 
sequelae at the discharge after 1 mo after 12 mo 
n=56(%) n=56(%) n=56(%) 
Ataxia 8 (14.3) 5 (8.9) 2(3.5) 
Hydrocephalus 1 (1.7) 1 (1.7) 1 (1.7) 
Motor defects 16 (28.5) 12 (21.4) 8 (14.3) 
Hearing disturbances 2 (3.5)** 2 (3.5)** 5(8.9) 
Cranial nerve involvement 3 (5.3) 1 (1.7) — 
Seizures 1 (1.7) 5(8.9) 
Cognitive disturbances 1 (1.7) 11 (19.6) 3 (5.3) 
Speech delay* 20 (35.7) 
-moderate 12 (21.4) 
-severe 8 (14.3) 
* Speech development was examined only in children who at the time of acute illness 
were younger than 20 months 
** No audiometry was performed 
Motor abnormalities occurred with the highest frequency at the time of dis­
charge (28.5%) but dropped down to percentages of 21.4% and 14.3% after one 
and 12 months respectively. The same applies also to their severity — at the 
time of hospital discharge 11 (19.6%) children had motor defects 2nd degree 
and 5 (8.9%) of 3rd degree. Hemiparesis was diagnosed in 6 patients, spastic 
quadriparesis or spastic diplegia both in 5 children. Out of the 5 children with 
severe motor disturbances during the follow-up period three improved their 
motor abilities to a 2nd degree motor abnormalities. In two children their 
degree did not change. After one year motor abnormalities persisted in 3 out of 
11 children having moderate disturbances at the time of hospital discharge. 
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Ataxia was a relatively common symptom on discharge diagnosed in 8 pa­
tients (14.3%). The frequency of ataxia decreased during the follow up period, 
after one months it was found in 5 (8.9%) children and after one year it only 
persisted in two children whereas the severity of it decreased remarkably. 
None of children was discharged with seizures. They occurred mostly from 
one to six months after acute illness and were seen in 5 (8.9%) children one 
year after BM. 
Clinically reliable hearing disturbances (audiometry was not performed) 
have been diagnosed in two children at the time of hospital discharge, unilateral 
in one case and bilateral in another. Ataxia was seen in both during the acute 
period. 
Cognitive disorders have been relatively common one month after 
discharge and were found in 11 (19.6%) children. The patients were irritable, 
ill-tempered, had sleeping disturbances. The above mentioned signs persisted 
after one year only in three patients. Mental retardation was diagnosed in two 
patients 12 months after the acute period respectively. 
Cranial nerve involvement (except 8th nerve) was documented in 3 child­
ren (5.3%). One child had facial nerve paresis at the time of discharge, which 
persisted as a mild paresis after one months and has improved after one year. 
Two children had sixth nerve paresis at the time of discharge and slight paresis 
after 12 months. 
One year after BM speech delay was rather common finding diagnosed as a 
mild in 12 children (21.4%) and as a severe in 8 (14.3%) of children. 
According to the general condition of children they were divided into 
3 groups at every examination (Figure 8). Eight children were disabled at the 
time of hospital discharge (14.3%) and five of them remained seriously 
handicapped one year after as well. Figure 8 shows also declining of mild to 
moderate sequelae during the follow up period. 13 children (23.2%) have had 
mild to moderate sequelae at the discharge, one year after they persisted only in 
eight (14.3%). No one of studied the neurologic state did not become worse 
during the study period, that or improved or remained the same. 
T 
1 year after 
3.3.2. Long term outcome of children with BM 
During the long term follow up examination 68 children (80%) have been nor­
mal, 11 (13.3%) had mild to moderate disturbances and 5 (5.9%) children were 
handicapped. Long term sequelae are outlined in Table 22. 
T a b l e  2 2  
Long-term sequelae of BM 
Sequelae number of patients % 
1. Motor disturbances 10 11.9 
- mild to moderate 8 9.5 
- severe 2 2.3 
2. Ataxia 3 3.5 
3. Hydrocephalus 2 2.3 
4. Seizures 6 7.1 
- epilepsy 4 
- febrile seizures 2 4.7 
5. Respiratory affects 2 2.3 
6. Hearing disturbances 7 2.3 
- unilateral 3 8.3 
- bilateral 4 3.5 
7. Hearing level based on the better ear 4.7 
- normal (<30db) 80 
- mild loss (30-50 db) 3 95.2 
- moderate loss (50-70db) — 3.5 
- severe loss (>70 db) 1 — 
8. Cognitive abnormalities 1.1 
- lability 11 
- mental retardation 4 13 
9. Speech delay 8 4.7 
9.5 
Motor abnormalities were the most common finding at that time, diagnosed 
in 10 children (11.9%), 8 of them were classified as 1st and 2nd degree. Two 
patients (2.3%) had severe disturbances 3rd degree (spastic tetraparesis). 
Ataxia was diagnosed in 3 (3.5%) of the children studied combined with the 
hearing disturbances in two cases. 
Of the 84 children followed-up 6 (7.1%) had seizures (Table 23). Febrile 
seizures were registered in two cases, starting at the age of 1.5 to 5 years. 
Nonfebrile seizures were documented in 4 (4.7%) children. The seizures that 
were clearly focal or had focal onset started from half to seven years after the 
acute illness. Good control of seizures was achieved in 3 of the 4 patients with 
monotherapy. Moreover history of affect-seizures was found out in two chil­
dren. One of them had those already before the BM, but after BM they occurred 
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more often, in another child affect-seizures were firstly diagnosed 3 months af­
ter BM. 
T a b l e  2 3  
Characteristics of patients with epilepsy during acute illness and 
the follow-up study 
Acute period Follow-up period 
Pat. Age on Sex nof Orga­ Seizu Uncon Time to Type Neuro­
num­ admis­ days nism res scious seizures of sei­ logic 
ber sion 
(mo) 
before ness onset 
(years) 
zures deficit 
6. 2 m 3 N. menin­
gitidis 




26. 37 f 3 N. menin­
gitidis 
~ 
7 II Normal 
67. 7 m 2 S. pneu­
moniae 
+ + 1 II ~ MR 
Obesity 
HD 
71. 41 m 1 - - - 1 It Cognitive 
disorders 
MR - mental retardatation; HD - hearing deficit 
Seven children (8.3%) had a SNHI at follow-up (Table 24). There was 
bilateral impairment in 4 (4.7%) and unilateral impairment in 3 children 
(3.5%). Two out of seven had profound hearing loss — one uni- and another 
bilateral. Moderate unilateral hearing disturbances were registered in two 
children and bilateral mild hearing impairment in three patients. According the 
estimated hearing level for speech based on the better ear the patients with 
hearing disturbances were divided as follows: three children (3.5%) had mild 
hearing disturbances and one child was deaf (1.8%) using hearing aid. 
Five children out of 15 with sequelae at the follow-up examination had 
combined disturbances (patient n 6, 7, 15, 67, 68 in Tables 23 and 24). In 3 of 
the cases it remained doubtful whether BM was the only etiologic factor for the 
brain damage. Hydrocephalus following congenital toxoplasmosis was diag­
nosed in patient no 7 before the onset of BM. Mucopolysaccharidosis with mo­
tor disturbances was documented in patient n 14. Patient n 60 suffered a traffic 
accident two years after BM, brain contusion was diagnosed. 
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T a b l e  2 4  
Characteristics of patients with hearing impairment following BM during acute 
illness and follow-up period 
Acute period Follow-up period 
Patient Age Sex 
number at 
onset 
No of Orga- Seizu-
days nism res 
sick 
before 
4. 43 f 3 — 
6. 2 m 3 N. menin­
gitidis 
7. 21 m 2 — 
15. 38 f 10 Hib 
42. 6 f 2 Hib 
67. 7 m 2 S. pneu­
moniae 








10 r-4 Normal 
1-1 
1 r-2 Spastic tetraparesis 
1-2 III Ataxia EP 
Hydrocephalus 
9 r-4 Ataxia 
1-4 
1 r-3 Normal 
1-1 
8 r-2 Normal 
1-2 
5 r-3 EP Debility 
1-1 
4 r-3 Diencephalic obesity 
1-3 MR Hydrocephalus 
m - male f - female; 1 • 
Hearing level classes 1 
3 = 50-70 db moderate 
- left r - right 
= <30 db normal; 2 = 30-50 db mild hearing loss; 
hearing loss; 4 = >70 db deaf 
3.3.3. Prognostic value of clinical symptoms and 
syndromes 
Table 25 demonstrates prognostic value of different clinical syndromes and 
symptoms. 
There was a significant correlation between duration of illness before ad­
mission and development of hearing disturbances and motor defects (p<0.05). 
No other differences between hearing disturbances, EP and motor abnor­
malities and the occurrence of unconsciousness, duration of illness, CSF 
findings on admission, etiologic structure of BM and therapy used was 
statistically significant. 
All but one child of those developing hearing disturbances were discharged 
with neurological sequelae — five had severe and one had mild impairments. A 
highly significant correlation between the severe neurologic deficits at the time 
of hospital discharge and hearing impairment at the follow up was found 
(p=0.0001). 
All but one of those with MA had been discharged with sequelae — three had 
mild and six severe disturbances. The correlation between sequelae at the 
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discharge and MA in long term follow up was highly statistically significant 
(p<0.0001). Two out of four children with sequelae on discharge developed EP, 
but a statistically significant correlation did not exist (p=0.532). 
T a b l e  2 5  
Characteristics of the acute phase of BM in a sample of children 
who had hearing disturbances, EP and motor defects after 5 years 
Characteristics Normal Hearing EP Motor defects 
Number of patients n=68 defects n=4 n=10 
n=7 
1. Age on admission 
up to 1 year 
up to 3 years 





temperature on admission 
3. Laboratory findings 
















A high correlation between motor abnormalities and hearing disturbances 
was seen during the follow-up period. So five out of seven children with hear­
ing defects had also motor abnormalities and five out of ten with the motor ab­
normalities had also hearing impairment (p<0.0001). 
EP in combination with hearing disturbances was seen in two children and 
with motor abnormalities in two, but the correlation was weak (p=0.176 and 
p=0.119 respectively). 
31 4 2 5 
53 6 2 9 
2.6 4.1* 2.2 3.7* 
7 2 1 2 
13 3 2 4 
38.5 38.4 38.3 37.8 
8254 3618 1587 8533 
1902 2112 1480 1947 
2.08 1.7 2.6 2.2 
51 4 4 7 
24 5 2 5 
9 1 1 0 
20 1 1 3 
21 2 2 5 
13.0 18.5 15.2 17.1 
37 1 2 2 
5 2 1 2 
7 2 - 3 
19 2 1 3 
1 5  57 
3.4. DISCUSSION 
Sell (1983) reported on extremely poor long term prognosis of BM — 50% of 
survivors had some sequelae at long term follow ups. Our study, however, in 
accordance with other recently published investigations (Jadavij et al. 1986\ 
Lebel et al. 1989; Gary et al. 1989) indicates that the long term prognosis may 
not be as gloomy as initially thought — 80% of the children were normal, 
13.1% had moderate disturbances and only 5.9% were handicapped 5 years 
after BM in this study. 
The frequency of hearing disturbances found by us in 8.3% of children was 
rather similar to that calculated by Fortnum (1992) in the review of the English 
language literature. As suggested in previous studies (Dodge et al. 1984; 
Salwen et al. 1987) the hearing impairment mostly was mild to moderate in our 
study, not disturbing an independent life and only one (1.1%) deaf child using 
hearing aid was found. Due to the fact that no but one audiometric 
examinations were performed in the acute period of the diseases we were not 
able to determine the time of occurrence of hearing impairment. However, the 
early onset of it is shown in most studies. So Vienny et al. (1984) even found 
hearing disturbances in 31.4% of their patients during the first 48 hours of 
hospitalisation, with therapy the hearing disturbances improved. Persistence of 
symptoms were observed in 5.4% of the patients on discharge and no new cases 
were diagnosed during the follow-up-period. While the development of hearing 
defects after acute BM is excluded in most studies (Lütschg 1992), we have to 
stress that the examination of the auditory system should be performed at the 
time of hospital discharge to find out children with hearing disturbances in 
order to start early rehabilitation if needed and to prognosticate children at risk 
for permanent impairment. 
The predominant opinion is that cochlear dysfunction is the most likely 
pathogenic factor of hearing defects (Klein et al. 1986; Kaplan et al. 1989; 
Harada et al. 1988; Bhatt et al. 1991). Our study as the study of Dodge et al 
(1984) revealed a significant correlation between hearing and motor defects 
during the follow-up examination as well as between later hearing disturbances 
and severe neurologic deficits on discharge (p<0.05) and we cannot agree with 
Feigin et al. (1992) that hearing disorders are not associated with brain damage. 
Therefore we assume that hearing disturbances do not arise due to purulent 
labyrintitis alone, but are also caused by extensive brain damage due to vasculi­
tis and ischemia in the region of the auditory tract as demonstrated by Jiang et 
al. (1990). In this study like in most others (Dodge et al. 1984; Jadavij et al 
1986; Salwen et al. 1987) the highest ratio of hearing impairment was 
registered among those with S. pneumoniae meningitis (2 out of 7), but most 
probably due to low number of cases in each group no statistically significant 
association between various microorganisms and hearing disturbances was 
found. 
No statistically significant association between different antibacterial drugs* 
and the development of hearing disturbances was found in our study. There is 
one study showing the highest frequency of hearing loss in those treated with 
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ampicillin in comparison to those with chloramphenicol (Gamstrop et al. 
1974). Recently most studies demonstrated an early occurrence of hearing 
defects, even before antibiotics have been introduced and no association 
between different antibiotics and hearing loss was registered (Friebel et al. 
1984; Dodge et al. 1986; Salwen et al. 1987). 
The overall prevalence of nonfebrile seizures that required medication for 
years (4.7%) was remarkably higher among postmeningitic children than in 
Estonian children's population — 1:1000 (Sander et al. 1991) and was similar 
to the data of the meta-analysis made by Baraff et al. (1993) — 4.2%. Like 
Annegers et al. (1988) we found that mostly seizures occurred within a few 
years after the infection, the relative risk was highest during the first five years. 
Despite the fact that half of those having late seizures and only 18.3% of those 
without had also seizures in the acute period we did not find any statistically 
significant correlation between late and acute seizures as did Annegers et al. 
(1988) and Pomeroy et al. (1990). Neither did we find a correlation between 
other abnormalities and epilepsy like Pomeroy et al. (1990), although from six 
patients with combined disturbances two also had seizures. 
Long term motor abnormalities such as hemiparesis, diplegia or 
quadriparesis and ataxia have been diagnosed more often (11.9% and 3.5% 
respectively) in this study than in others (Sell 1983; Odio et al. 1991; Kabany 
et al. 1992). However, they have been partially of a mild degree and in 3 cases 
of 10 other factors than infection for brain damage (traffic accident, congenital 
disease) are hard to exclude. Our data support the results of the above 
mentioned studies that motor abnormalities, detected soon after the acute ill­
ness, do not always persist (Pomeroy et al. 1990). If 28.5% of survivors had 
some motor defects at time of hospital discharge, after one months these 
persisted in 21.4% and one year later in only 14.3% of the children followed. 
The decrease of severity of motor defects with time was even more prominent. 
While motor abnormalities of third degree were seen in 8.9% of patients 
immediately after the acute period, they persisted in only 2.3% of cases 5 years 
later. Ataxia, occurring concomitantly with hearing disturbances most probably 
as a result of labyrinthitis, was another motor defect having a tendency to 
resolve with time (Kabany et al. 1992; Feigin et al. 1992). In a study by Lebel 
et al. (1989) ataxia was registered in 14.4% at the time of hospital discharge, 
but one year afterwards it only persisted in 0.6% of the survivors. Our data with 
the frequency of ataxia of 14.3% at the time of hospital discharge and 3.5% a 
year later do not show such a dramatic decrease in incidence, nevertheless we 
support the opinion that the severity has a tendency to decrease with time. 
There is no common explanation why motor defects occur and then resolve in 
patients with BM. Recovery after insults to the developing nervous system is 
frequently ascribed to its "plasticity", but this explanation is far from satisfying 
(Pomeroy ef al. 1990). 
Prospective assessment of speech development in young children following 
meningitis has rarely been reported. We like others found language disorders in 
almost 10% of postmeningitic children (Lebel et al. 1989; Gary et al. 1989; 
Salih et al. 1990). The speech delay in previous studies was mostly connected 
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with the hearing disturbances. The results of this study did not reveal any corre­
lation between hearing impairment and language disorders in children after 
nonneonatal meningitis. Therefore we as Letson et al (1993) assume that not 
only the hearing function but also degree of brain damage is important in 
development of speech delay after BM. 
Several studies tried to find prognostically significant symptoms during the 
acute period in order to predict a poor outcome. The youngest age on 
admission, the highest frequency of seizures and unconsciousness were 
documented in this study in those having poor outcome in comparison to those 
with a good outcome, but none of those differences was statistically significant. 
The data about the duration of symptoms before the therapy and outcome 
of BM are controversial in literature. The delay of hospital admission was the 
single characteristic of BM, which correlated with the development of motor 
defects and hearing disturbances (p<0.05). However, Kilpi et al. (1992) in a 
study which consisted of 286 children with BM showed better outcome of those 
patients whose duration of symptoms before the antibacterial therapy was 
longer. It is possible that especially meningococcal meningitis is sometimes 
rapidly progressive and patients die within first hours of illness. However, we 
as Radetsky (1992) believe that the prompt diagnosis and therapy of BM 
remains a clinical challenge, for no physician would knowingly delay the ap­
propriate therapy. 
Like Jadavij et al, (1986) and Taylor et al. (1990) found a significant corre­
lation between hearing disturbances and neurological sequelae at the time of 
hospital discharge as well as during the follow-up examination this study 
showed also a strong correlation between different sequelae but epilepsy during 
the long term follow-up and severe neurologic deficits on discharge 
(p<0.0001). In general it shows that the greater the extent of damage the child 
has suffered, the poorer the long term prognosis. From practical and eco­
nomical point of view this indicates which children need a careful follow-up 
after BM. 
In summary: Our study showed that after BM only 5.9% of survivors are 
handicapped. The most common long-term sequelae of BM are hearing distur­
bances, motor defects and late seizures. The prognosis of patients can be deter­
mined already at the time of hospital discharge, while mild to moderate distur­
bances have tendency to resolve whereas severe defects are permanent. So we 
recommend to follow up only children with severe neurological deficit at the 
time of hospital discharge. 
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PART IV 
SHORT COURSE OF ANTIBACTERIAL THERAPY 
FOR BACTERIAL MENINGITIS IN CHILDREN 
4.1. REVIEW OF LITERATURE 
The variation in length of the therapy of BM in English language literature was 
recently reviewed by Radetsky (1990). There is general consent that MM needs 
shorter therapy, even to an one-dose therapy, than Hib and pneumococcal 
meningitis, which have to be treated for longer periods. Still reports from some 
countries suggest that shorter treatment periods, especially in MM are suf­
ficient and safe in uncomplicated cases (Helwig 1992). In a comparative trial 
Lin et al. (1985) confirmed that there is no significant difference in outcome, 
lenght of fever, complications, or sequelae whether the children with BM are 
treated with ceftriaxone for seven or ten days. A Finnish multicenter study 
which included 220 BM patients and was performed by Peltola et al. (1989) 
concluded that a 7-day course of ampicillin, cefotaxime, or ceftriaxone is 
sufficient in Hib, MM and pneumococcal meningitis in children. The 
prospective Swiss multicenter study randomly assigned 119 children with BM 
to either short course (four, six, seven days) or full course (eight, 12, 14 days) 
ceftriaxone therapy depending on whether they had contracted MM, Hib or 
S. pneumoniae meningitis. The results of this study suggest that short course 
treatment of acute BM in children is as efficacious as full course therapy 
(Martin et al. 1990). A retrospective study which originated from Italy 
described 122 children with BM (N. meningitidis — 47.5%, Hib — 20.5%; 
S. pneumoniae — 15.6%; others — 4.1%) and showed that 90% of patients 
were cured with ceftriaxone monotherapy for from three to six days (Pecco et 
al. 1991). 
The late sequelae of acute BM in children who were treated with ampicillin 
and chloramphenicol for seven days have been investigated for a minimum of 
one year following their illness by Jadavij et al. (1986). The frequency of ob­
served sequelae (20%) among these patients was similar to that previously re­
ported in children treated for ten to 14 days. Our previous study (unpublished 
data) showed that 79% of patients with MM and 71% of those with 
pneumococcal meningitis are in good general condition by day 5 of antibac­
terial therapy. They are afebrile, the meningeal symptoms are gone, and they 
have almost normal findings of CSF examination. A shorter course of 
antibacterial therapy will result in fewer days of hospitalization, lower costs 
and lesser frequency of complications caused by antibiotics. 
61 
76 , 
4.2. PATIENTS AND METHODS 
Throughout October 1990 and June 1994 all children between one month and 
15 years of age admitted to Tartu University Children's Hospital with micro-
biologically confirmed BM were enrolled in this study. 
T a b l e  2 6  
Clinical and laboratory characteristics of the patients on admission 
Characteristic Study group Control group P = 
n = 36 n = 49 
Age (mo) 39.2±7.8 24.6±4.6 0.076 
(range) (8-135) (1-156) 
Sex 
male 21 30 0.63 
female 15 19 
History: 
7 (19.4) 13 (26.5) No given antibiotic therapy before (%) 0.47 
Duration of antibacterial therapy 
before (days) 0.8*1.9 0.5±0.5 0.22 
Duration of symptoms (days) 3.6±0.6 2.9±0.26 0.23 
No (%) with features on admission: 
Temperature > 38.5° 25 37 0.47 
Seizures 7(20) 13 (26) 0.68 
Unconsciousness 3(8) 4(8) 0.76 
Shock 4(11) 7(14) 0.67 
No(%) infected with: 
23 (67) 33 (67) 0.56 N. meningitidis 
H. influenzae type b 7(20) 10 (20) 
Spneumoniae 5(14) 6(12) 
Br.catharralis 1(3) — 
Laboratory findings: 
5591 7958 0.50 CSF WBC 10"6/! 
(range) (612-8540) (1135-9236) 
CSF protein g/1 1077 1780 0.19 
(range) (588-955) (624-3077) 
0.31 CSF glucose mmol/1 2.4 2.1 
(range) (1.8-2.9) (0.7-3.0) 
ESRmm/h 36 (22-58) 40 (29-52) 0.25 
Total WBC 18.8 (13.4-24.0) 16.4(11.6-20.1) 0.1 
During this period 42 patients with BM met the inclusion criteria. A histori­
cal comparison-group consisting of 49 patients with a diagnosis of micro-
biologically confirmed BM treated at our hospital in 1983-1989 was used. 
After initial investigation, the patients were examined at least once a day 
throughout the hospital stay. In addition, several tests of CSF, blood and urine 
were done. There were no significant differences between the groups in patient 
characteristics, clinical and laboratory features (Table 26). Therapeutic regimes 
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for antibacterial therapy used in study and comparison group are shown in 
Table 27. The antimicrobials in study group were given for 5 days. 
T a b l e  2 7  
Duration and choice of antibacterial therapy in children with BM 
Study group Comparison group (n = 49) 
(n = 26) 
Initial therapy Initial therapy Corrected therapy 
Etiology Anti­ n of duration n of dura­ second n of duration 
biotic patient (days) patient tion course patient (days) 
(days) used 
N. menin­ Pen. 18 5.0 21 9.1 4 — — 
gitidis Amp. — — 5 6.4 4 — — 
Pen.+Chl. — — 6 10.2 2 3 9 
Ceph. 
— — 
1 9 1 8 7.8 
S. pneumo­ Pen. 2 5.0 3 9.3 — — — 
niae Amp. — — 1 7 — — — 
Pen.+Chl. — — 2 10.5 2 1 6 
Ceph. 1 5 
H. influen­ Pen. 6 5.0 5 8 4 — — 
zae Amp. — — 4 6.7 4 — — 
Pen.+Chl. 4 11.7 
Ceph. 
— 
1 7 4 10.8 
Pen - Penicillin G; Amp. - Ampicillin; Chi. - Chloramphenicol; Ceph. - Cephotaxime 
Antibiotics were administered intravenously as follows: Penicillini 300 mg/kg/die:6; 
Ampicillini 200 mg/kg/die:6; Chloramphenicoli 100 mg/kg/die:4; Cephotaxime 
150 mg/kg/die:3 
A second lumbar puncture was done on day 5 of AB therapy. The criteria 
for the termination of the AB therapy in the study group were as follows: (1) 
meningeal symptoms mild or absent, (2) body temperature less than 38°C, (3) 
sterile CSF, (4) CSF WBC count < 100 mm3, CSF protein < 1500 g/1, CSF glu­
cose/blood glucose ratio > 0.6. 
The children were followed by a multidisciplinary team (pediatrician, pedi­
atric neurologist, speech therapist and audiologists). The follow-up time was at 
least 6 mo. Follow-up of children was performed according to the criteriae de­
scribed in part III (pp. 50-52). 
Statistical analysis. Values are expressed as means ± 1SD. Differences be­
tween the groups in the frequencies of various findings were tested with either 
the chi-square or t-test. 
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4.3. RESULTS 
Antibacterial therapy was completed as indicated in protocol (for 5 days) in 
36 cases out of 42. The treatment was extended to last longer than 5 days in six 
cases (Table 28). The reasons for extension of antibacterial therapy were par­
ticular either fever (>38.5°C) or persistent CSF leucocytosis (> 100 WBC/ml) 
on day 5. One patient (n 80) had MM which complicated with bilateral coxitis 
and the another (n 77) was in poor condition on day 5. 
T a b e l  2 8  
Cases of extended antibacterial therapy 
Sheduled Age Etiology Duration Reason for extension/ 
antibiotic and (mo) of therapy changes in therapy 
patient no (days) 
Penicillin 
22 2 N. meningitidis 12 Persisting CSF leucocytosis/ 
Cefotaxime 
80 36 N. meningitidis 14 Fever, bilateral coxitis/ 
Cefotaxime 
84* 8 Hib 8 Persisting CSF leucocytosis/ 
Ampicillin 
90 11 N. meningitidis 11 Fever/ Cefotaxime 
Ampicillin 
2 8 Hib 11 Fever/ Chloramphenicol 
Cefotaxime 
44 77 S. pneumoniae 7 Poor condition, VI nerve 
paresis/ — 
* patients was initially treated with Penicillin 
T a b l e  2 9  
Clinical and laboratory findings at the time 
of termination of antibacterial therapy 
Study group Control group 
n = 36 n = 49 
Clinical feature: 
To 37-38° 5 11 
No of seizures — 3 
Negative meningeal syndrome 33 45 
Laboratory findings: 
CSF WBC 10~*/l 45 (4-89) 59 (2-102) 
CSF protein g/1 758(305—1388) 1047 
CSF glucose mmol/1 2.4 (2.1-2.8) 2.6 (2.2-3.6) 
ESRmm/h 34(18-46) 42 
Total WBC 10^/1 1L4 12.1 
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At the time of termination of antibacterial therapy clinical feature and labo­
ratory findings of patients in study and comparison group have been similar 
and are shown in Table 29. The negative meningeal syndrome has been 
registered more than 90% of patients, six children in study group still had fever 
from 37 to 38° C. 
The duration of antibacterial therapy as well as the duration of hospitalisa­
tion and the number of hospital-acquired respiratory infections were signifi­
cantly lower in the study group (p<0.005) (Table 30). 
T a b l e  3 0  
Hospital course of patients studied 
Variable (range) Study group Control group 
n = 36 n = 49 
Duration of antibacterial therapy (days) 5.0 13 (7-43) * 
Duration of hospitalisation 10.2 (7-18) 22.5 (9-116) * 
Number of nosocomial infections — 8 * 
Completely recovered (n) 30 36 
Mild disturbances (n) 4 8 
Severe disturbances (n) 2 5 
Died — 1 
* p < 0.005 
The mean hospital stay with the short-course antibacterial therapy was 
10.2 days in contrast to 22.5 days for conventional therapy. No one from the 
study group received any hospital-acquired respiratory infections whereas there 
were eight cases among those hospitalised longer. The outcome of children at 
the time of hospital discharge was almost the same in both groups: 81% of the 
children in the study group and 75% in the comparison group recovered com­
pletely. There were no relapses in either group. On the examination at 
discharge abnormalities were still present in seven children in the study group 
and 14 in the control group. They included six cases of ataxia in the study and 
three in the comparison group, three cases of other motor defects in the study 
and eight cases in the control group. Three control and one study group 
children were discharged using anticonvulsive drugs. At the time of hospital 
discharge one child was deaf after pneumococcal meningitis, the another had 
bilateral mild hearing disturbances and third child an unilateral severe hearing 
impairment in the study group. The frequency of hearing defects in comparison 
group is not clear while audiometric investigation has not been as a routine in 
our hospital at that time. 
There were 34 children examined in the study and 47 in the control group 
at least 6 mo after hospital discharge (Tabel 31). 
79 % of children in comparison and 88% in the study group were normally 
healthy during the follow-up examination. Four of the children who had re­
ceived five days of antibacterial therapy had sequelae: two had ataxia one of 
them in combination with one-sided moderate hearing impairment, one child 
had learning problems and one was deaf using hearing aid. 
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T a b l e  3 1  
Outcome of BM patients during the follow-up examination 
Study group Control group 
n=34 n=49 
Normal 30 37 
Mild to moderate disturbances 3 8 
Severely impaired 1 3 
Motor abnormalities 2 7 
Hearing impairment 2 3 
Late seizures — 5 
Irritability 1 ? 
4.4. DISCUSSION 
Our preliminary results showed that the short term as well as long term 
outcome in children treated for five days for BM was similar to that when 
treated longer. However, the children treated for five days had a significantly 
shorter duration of hospitalisation (p<0.005) and no cases of hospital-acquired 
respiratory infection were registered. There were no relapses in either group, 
which is not surprising because the bacteria, especially in MM, are usually 
eliminated from the CSF within 24 to 48 hours of initiating parenteral 
antibacterial therapy (Peltola et'al. 1989). 
The limitation of this study was that it was not a prospective double-blind 
study and a historical comparison group was used as a control. The recently de­
creasing number of BM cases in Europe and in North America due to the intro­
duction of vaccination against Hib and nonepidemic period of meningococcal 
infection (Peltola et al. 1992; Kostjukova et al. 1992; Adams et al. 1993) 
makes it difficult to organise any trial with a sufficient number of patients. This 
would require, e.g., approximately 1,400 patients to be randomly assigned to 
two treatment groups and to be followed for 5 years in order to detect a 50% in­
crease in sequelae with an 80% of certainty (Helwig 1992). 
We would also like to stress that six out of 42 children (14%) who met the 
inclusion criteriae did not complete the study according to the protocol. The 
reasons for that were mainly fever or persisting CSF pleocytosis. However, it is 
also shown that children who have received apparently adequate treatment (10 
to 14 days) can show persistent increases in the CSF WBC which was not con­
nected with the sequelae (Connolly 1981). In a series of cases of pediatric BM 
which analysed repeat CSF total WBC counts after completion of a course of 
adequate AB therapy, 62% with Hib and 22% with S. pneumoniae meningitis 
still manifested of persistent CSF pleocytosis (Chartrand et al. 1976). The per­
sistence of fever on day 5 in three patients out of 42 is not suprising while ac­
cording to the data of La Via et al. (1992) by the day 5 of the AB therapy 20 to 
25% of BM patients still have a fever. Although neither persistent pleocytosis 
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nor fever are indications for following AB therapy it is not possible to complete 
AB therapy without special investigations to rule out CNS complications. 
In this study penicillin was used for the therapy of N. meningitidis and 
S. pneumoniae while resistant meningococci and pneumococci are still uncom­
mon in Estonia. Resistant isolates of S. pneumoniae are now being recognised 
in 10% of cases in Estonia (Mikelsaar, personal communications) and it is 
likely that it will be an important factor influencing the selection of antibiotics 
in the future. Tuncer et al. (1988) in a randomised study compared the 
effectiveness of a four-day therapy with ceftriaxone and penicillin in 44 
children with meningococcal infection and did not find any differences 
between the two drugs in the outcome in noncomplicated cases. 
A shorter courses of antibacterial therapy (4-5 days) than recommended in 
the textbooks (McGee et al. 1990; Feigin et al. 1992), have been reported to be 
highly effective in some previous studies in uncomplicated cases of meningo­
coccal meningitis (Viladrich et al. 1986; Tuncer et al. 1988; Pecco et al. 1991). 
Martin et a.l. (1990) used ceftriaxone monotherapy for 4 days in patients with 
MM, for 6 days in cases of Hib meningitis and for 7 days in pneumococcal 
meningitis and showed that these regimes were as effective as longer periods of 
therapy. Although a 5-day therapy in our study was effective also in Hib and 
pneumococcal meningitis, it has to be said that in 7 out of 12 children antibi­
otics had been administered before hospital admission and we agree that Hib 
and S. pneumoniae meningitis may require longer treatment. (Viladrich et al. 
1986; Peltola et al. 1989; Helwig 1992). 
The longer treatment is needed in cases of complicated course of BM. The 
child with bilateral coxitis had fever on day 5 and was treated longer. The 
longer treatment periods may also be needed for children who have moderate 
or severe hearing impairment on day 5, while penetration of AB into labyrinth 
is even worse than it is into CSF (Harrison 1993). 
In summary: We found short and long-term outcome of bacteriologically 
confirmed BM being similar in children treated with antibiotics for five days or 
significantly longer. However, the childern with short course therapy were hos­
pitalised shorter and had no hospital aquired respiratory infections. Thus, we 
suggest five days of antibacterial therapy for children with uncomplicated 




In this study our aim was to answer several questions on which most pediatri­
cians are interested in. They were as follows: 
1. How common are the infections of the central nervous system in Estonia and 
which are the predominant etiological agents? 
2. Is there any additional possibility except common tests to distinguish 
between bacterial and aseptic meningitis? 
3. Would it be possible to prognosticate the outcome already on admission? 
4. How long should be a child with BM treated with the antibiotics? 
5. Do we need to follow up all children after BM or only some and if we do, 
which of them should be followed up? 
Our retrospective epidemiological study based on annual reports of the hos­
pitals where children with ICNS were treated during the study period (from 
1980 to 1989) revealed an incidence rate of ICNS 66.2/100 000 children which 
was very similar to that reported from Spain (Roca et al. 1992). We found it in­
teresting that the incidence rates (29.8 and 25.8/100 000 children respectively) 
as well as the epidemic course of AM and BM were rather similar. We found 
the etiological pattern of BM completely different from that in Nordic 
countries, USA and Australia where the leading cause of community acquired 
meningitis in children is H. influenzae (Wenger et al. 1990; Peltola et al. 1990; 
Hanna et al. 1991). Our data with the predominance of N. meningitidis are very 
similar to studies performed in the former Soviet Union (Djomina ei al. 1985; 
Cibiras et al. 1986; Kostjukova et al. 1992). Due to the fact that in more than 
half of the cases the etiology of BM remained unknown, we can speculate, that 
under diagnosing of Hib meningitis was going on. With the improvment of 
facilities of bacteriological laboratories and introducing new methods the 
number of unidentified cas,es decreased, but meningococci were still most 
frequently found. So we believe that N. meningitidis is still predominant agent 
in the etiology of BM in children but like Iljina et al. (1990) we also saw that 
the importance of Hib raised to the end of the studied period. 
Unfortunately the etiology of AM remained unknown in more than 90% of 
cases, whereas with good laboratory facilities it could be proved in more than 
3/4 of cases (Tardieu et al. 1986; Koskiniemi et al. 1989). The main reason for 
high number of unidentified cases seems to be that AM as a mild disease was 
mostly treated at district hospitals with the poor diagnostics facilities and low 
interest of practising doctors for AM etiology. We feel that the doctors interest 
will increase if rapid methods will become available. 
Like other studies (Nicolosi et al. 1986; Etter et al. 1991) we showed the 
relatively good outcome of AM, whereas the prognosis of BM even at the end 
of the study period when most of children were referred to Tartu University 
Children's Hospital was serious. The mortality rate of BM was 13.0% and dis­
ability rate 8.9%. The worst outcome with the disability and mortality of 53.8% 
and 45.8% respectively was noted like by others after neonatal meningitis (Bell 
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et al. 1989; Zaki et al. 1990). The reasons of extremely bad outcome of neonatal 
meningitis are not clear thus far. We only can speculate that it is connected 
with the immature immune system, but also usually with late diagnosis while 
there are no characteristic symptoms for meningitis in that age (Schaad et al. 
1992). We also saw that during the study period the number of neonatal 
meningitis cases increased and it could be connected to the opening of NICU, 
concentrating patients there and spreading of nosocomial infection. Therefore 
we agree with Schaad et al. (1992) that the most important factor in preventing 
poor outcome will be profylaxis of neonatal infection. 
Despite the fact that from 22 studies only 13 showed that prognosis of BM 
patients depends on the time of onset of antibacterial therapy (Radetsky 1992) 
our study demonstrated that duration of illness before hospitalisation was the 
single clinical characteristic being prognostically important. However, in some 
cases it will be extremely difficult to distinguish between BM and AM using 
common tests of CSF (Rodewald et al. 1991). Our work based on the different 
pathogenesis of BM and AM, measured the activity/concentration of some in­
tracellular enzymes (AST, GGT, LDH, CPK and CK-BB) to differentiate be­
tween BM and AM and tried to found out their prognostic value. We like Sirkis 
(1982); Agrawal et al. (1989) and Nand et al. (1992) found that patients with 
BM had significantly higher activity of AST and GGT than those with AM and 
meningism, however the activity of AST didn't increase the reference levels. 
We also showed as Agrawal et al. (1989) and Roslõi et al. (1991) the 
prognostic value of raised AST activity. Due to the fact that we could not find 
any correlation between the activity of AST in CSF and blood serum we 
suggest that local releasing of AST is going on and its raised activity most 
probably shows the cytolysis of the brain tissue. The benefit of measuring LHD 
activity in differentiation of AM and BM was also very poor in this study 
(Landaas et al. 1985), but a good correlation between bad prognosis and high 
LDH activity on admission was found. It was a surprise that the benefit of 
measuring of CK-BB was poor, while the CK-BB seems to be one of the best 
markers in the estimation of brain damage that we have (Beiton et al. 1970; 
Sööt et al. 1989; Praeter et al. 1991). In contrast to Haldre et al. (1991) and 
Talvik (1992) who found good prognostic value of CK-BB in the CSF in 
patients with head injury and hypoxic-ischaemic brain damage respectively, we 
found even lower concentration of CK-BB in the CSF in children who either 
died or recovered with permanent sequelae on admission. The same was also 
shown by Briem (1982) in patients with meningoencephalitis and we speculate 
that the prognosis of BM patients depends not only on the extent of brain injury 
but also on the site of damage. The ground of pathologic process is diffuse 
vasculitis of the brain (Quagiliarello et al. 1992), but some areas are more 
affected than others. It was demonstrated by Delanghe et al. (1990) that the 
distribution of CK-BB in the brain is different, the highest concentrations were 
found in cortex and Capsula interna, while only limited amounts were measured 
in pons, cerebellum and medulla oblongata. So we suggest that the importance 
of estimation of intracellular enzymes in differential diagnosis of meningitis 
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can not be overestimated, nevertheless they can give us some additional 
information in understanding the pathogenesis of BM and AM. 
The data of the duration of antibacterial therapy vary largely in the 
literature and there are few controlled clinical trials thus far. According to the 
fact that the CSF is sterile in meningococcal meningitis mostly after 24 hours 
of antibacterial therapy and by Hib and pneumococcal meningitis after 72 hours 
we decided to use five-day therapy (Peltola et al. 1989; Lebel et al. 1989). 
From 42 patients who met the inclusion criteria 36 completed the study 
according to the study protocol. Main reasons for extended therapy were either 
prolonged fever, persistent pleocytosis or complicated course of meningitis. 
Although neither the persistent pleocytosis nor fever are indications for 
continuing AB therapy (Chartrand et al. 1976; La Via et al. 1992) it is not 
possible to complete the AB therapy without special investigations. There was 
no differences in outcome at the time of hospital discharge and one year after 
acute illness between children treated for five days and longer. However, the 
patients who got the five-day therapy were hospitalised for significantly shorter 
periods and had no hospital acquired respiratory infections. The disadvantage 
of this study is that it was not a randomised study and historical comparison 
group was used as a control. It would be not possible to set up a randomised, 
double-blind study in any country while this would require e.g., approximately 
1,400 patients to be followed for 5 years in order to detect a 50% increase in a 
sequelae with an 80% of certainty (Helwig 1992). Therefore the experience of 
several small studies could be valuable in elaborating the general rules. Our 
data showed that five-days of AB therapy would be sufficient for noncomplica­
ted meningococcal meningitis, but due to the small number of patients we 
cannot recommend it for patients with pneumococcal and Hib meningitis. 
However, we still believe that in patients treated for five days the second 
lumbar tap is necessary. 
The fact that no antibacterial therapy is needed after fifth day does not 
mean the child's complete recovery. We like Klein et al. (1986) and Lebel et al. 
(1989) showed that at the time of hospital discharge 28.5% of patients had 
changes of muscle tones and 14.3% had ataxia. Both defects were reversible 
and during the long term follow-up they persisted in only 11.9% and 3.5% of 
children respectively and were in most cases of mild degree. Our enzyme 
studies showed also that at the end of antibacterial therapy the activity of CPK 
and the concentration of CK-BB was still over the reference value which most 
probably speaks of cytolysis going on. There are no studies published thus far 
concerning the treatment of BM meningitis if the CSF is sterile and we doubt 
wheather any medicine will be needed at all. Nevertheless, for patients with 
permanent defects (hearing disturbances and severe motor abnormalities) 
rehabilitation had to be started as early as possible. Our study found a highly 
significant correlation between severe neurological defects at the time of 
hospital discharge and motor abnormalities and hearing disturbances during the 
long term follow-up investigation, so we concluded that following up was 
needed only for those children. We like Annegers at al. (1988) demonstrated 
that the BM patients have a higher risk later epilepsy. Nevertheless, it was not 
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possible to prognosticate the development of late seizures, while there was no 
difference neither in clinical symptoms nor in laboratory tests during the acute 
illness and at the time of hospital discharge. 
As in most studies (Baraff et al. 1993) the most common sequelae after BM 
were hearing disturbances, found in 8.3% of children during the long-term fol-
low-up investigations. Although we didn't find any differences between lan­
guage disorders and hearing defects however^ we as Brookhauser et al. (1989) 
believe that hearing disorders should be diagnosed immediately after the acute 
illness and early rehabilitation should be started. The fact that in two children 
ataxia was combined with the hearing disturbances supports the opinion of 
Harada et al. (1988); Kaplan et al. (1989) and Bhatt et al. (1992) that they are 
results of labyrinthitis. However, the significant correlation between hearing 
disturbances and motor defects supports the data of Jiang et al. (1990) that is-
chaemia in the area of auditory tract may be also important for the development 
of hearing disturbances. 
In conclusion this study of more than ten years demonstrated that although 
the annual number of patients with ICNS in South-Estonia is not high perma­
nent sequelae and deaths still occur. Therefore patients with BM, complicated 
forms of AM and encephalitis should be concentrated to the hospitals with 
better laboratory facilities, possibilities for sophisticated methods of intensive 
care and with the doctors experienced in the care of such patients. 
CONCLUSIONS 
1. Our data revealed a constant incidence rate of infections of the central ner­
vous system of 66.2/ 100 000 children in the 1980s in South-Estonia, which in­
cludes 25.8 for bacterial meningitis, 29.8 for aseptic meningitis, 7.6 for tick-
borne encephalitis and 3.0/100 000 children for encephalitis caused by other 
viruses. 
2. Bacterial meningitis in contrast to the aseptic meningitis was predominantly 
a disease of the early childhood — 84.3% of the patients with bacterial 
meningitis were younger than five years whereas among aseptic meningitis and 
encephalitis patients more than 80% were over 5 years. 
3. Neisseria meningitis which caused 34.9% of bacterial meningitis cases 
during the study period was the leading micro-organism among the etiologic 
factors. The importance of Haemophilus influenzae in the etiology of bacterial 
meningitis increased from 0.9% at the beginning of the 1980s to 8.9% at the 
end of it. 
4. A significant rise in AST and GGT activities in CSF was found in patients 
with bacterial meningitis during the first days of illness. The significantly in­
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creased activities of AST and LDH could be an indicator of the extent of brain 
damage and therefore prognostically important. 
5. For children with non complicated cases of meningococcal meningitis a five-
day antibacterial therapy will be adequate, but due to a small number of 
patients we can not recommend it for Hib and pneumococcal meningitis. 
6. Motor abnormalities, hearing impairment, late seizures and cognitive disor­
ders have been the most common long-term sequelae of bacterial meningitis 
found out in 20% of children. 
7. Motor defects detected soon after acute illness in 27.3% of patients had ten­
dency to resolve with the time and were seen during the long term follow-up 
examination in only 13.1% of children. 
7. There was a significant correlation between different sequelae (but for 
epilepsy) during the long term follow-up and severe neurologic defects at the 
time of hospital discharge. It means that only children with severe neurological 
deficits are at a higher risk for permanent neurological sequelae and hearing 
disturbances. Those showing no or only mild disturbances have an excellent 
chance of escaping serious sequelae except epilepsy. 
8. The' mortality rate of ICNS was 5.4% and 4.1% of the survivors were dis­
charged with sequelae. The vast majority of those who died or developed dis­
abilities were children after bacterial meningitis. The mortality rate of bacterial 
meningitis was 13% and the disability rate 10.3%. With the concentration of 
patients to the Tartu University Children's Hospital, the mortality as well as the 
disability rates decreased dramatically during these 10 years, which shows that 
the concentration of patients to the tertiary care hospitals is necessary. 
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ISELOOMUSTUS JA KAUGTULEMUSED) 
Kokkuvõte 
Kesknärvisüsteemi põletikulised haigused (meningiidid ja entsefaliidid) kuulu­
vad oma tõsise lõppe tõttu raskeimate nakkushaiguste hulka lapseeas. Uute an-
timikroobsete ravimite kasutuselevõtu ja intensiivravi arenguga on bakteriaalse 
meningiidi suremus tänapäeval arenenud maades langenud 3-7%-ni, kuid 17-
26%-l paranenutest esinevad haiguse põdemise järgselt jääk-nähud, nagu kuul­
mishäired, epilepsia ja psühhomotoorse arengu peetus (Salwen ja k.a. 1987; 
Valmari ja k.a. 1987; Carter ja k.a. 1987). Viimastel aastatel on paljudes are­
nenud maades haigestumus bakteriaalsesse meningiiti märgatavalt langenud, 
mida peamiselt seostatakse Hib infektsiooni vastase vaktsineerimisega (Peltola 
et ai. 1992). Eestis on mädaste meningiitide etioloogiat ja ravi aastatel 1921— 
1958 kirjeldanud E.Tulmin (1961). Enim on uuritud aseptilise meningiidi ja 
puukentsefaliidi epidemioloogiat (Raudam, 1967; Kutsar, 1971; Raudam ja k.a. 
1972; Vassilenko ja k.a. 1990), kuid andmeid selle kohta missugune on 
kesknärvisüsteemi põletikuliste haiguste esinemisagedus, etioloogiline struk­
tuur ja prognoos lastel Eestis tänapäeval publitseeritud ei ole. 
Meningiidi prognoos sõltub peamiselt õigeaegsest diagnoosist ja adekvaat­
sest ravist. Sageli osutuvad igapäevases diagnostikas kasutuselolevad rutiin-
meetodid (leukotsüütide arvu, suhkru ja valgu kontsentratsiooni määramine 
seljaajuvedelikus) väheinformatiivseks eriti just prognoosi hindamise seisu­
kohalt (Lindquist ja k.a. 1988). Eelnevad uurimused on näidanud, et aju 
haiguste korral, millega kaasneb hüpoksia ja nekroos, tõuseb intratsellulaarsete 
fermentide kontsentratsioon seljaajuvedelikus (Riekkinen ja k.a. 1970; Maas, 
1977; Nelson ja k.a. 1975; Landaas ja k.a. 1985; Talvik, 1992). Andmed nende 
kasutamisest kesknärvisüsteemi põletike diagnostikas ja haigete prognoosi hin­
damisel on kirjanduses vasturääkivad. Samuti puudub kirjanduses ühene vastus 
küsimusele, kui kaua ravida bakteriaalset meningiiti. Enamuse käsiraamatute 
(Feigin ja k.a. 1992; McCracken ja k.a. 1992) soovitus antibakteriaalse ravi 
kestuse kohta — 7 päeva meningokokilise, 10 päeva hemofriluse ja 14 päeva 
pneumokokilise meningiidi korral — ei põhine mitte kontrollitud kliinilistel 
uuringutel, vaid lihtsalt arvamustel (Radetsky, 1992). Ometi on mõned autorid 
näidanud, et lühemad antibakteriaalse ravi kuurid on sama efektiivsed, eriti 
menigokokilise meningiidi korral, võimaldades haigete ravi muuta tunduvalt 
odavamaks (Linjak.a. 1985; Tuncer ja k.a. 1988; Peccojak.a. 1991). 
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Antud töö eesmärgiks oli: 
— analüüsida retrospektiivselt kesknärvisüsteemi põletike epidemioloogiat 
Lõuna Eesti lastel aastatel 1980-1989; 
— määrata mõnede intratsellulaarsete fermentide (AST, LDH, GGT, CPK, CK-
BB) aktiivsust/ kontsentratsiooni seljaajuvedelikus ning hinnata nende prog­
nostilist tähtsust; 
— uurida bakteriaalse meningiidi lühi-ja pikaaegset prognoosi ning teha kind­
laks ägeda perioodi sümptoomid, mis omavad prognostilist tähtsust; 
— hinnata 5-päevase antibakteriaalse ravi efektiivsust bakteriaalse meningiidi 
ravis lastel; 
Aastatel 1980-1989 registreeriti Lõuna Eestis kesknärvisüsteemi põletikke 
573 lapsel, nendest 223 olid bakteriaalsed ja 350 aseptilised meningiidid ja 
entsefaliidid. Seega haigestumus bakteriaalsesse meningiiti oli 25,8/100 000 
lapse kohta. Aseptilise meningiidi ja puukentsefaliidi sagedus oli vastavalt 29,8 
ja 7,6/100 000 lapse kohta. Neonataalne meningiit esines sagedusega 0,42/1000 
elusalt sündinu kohta. Nii bakteriaalne kui ka aseptiline meningiit esinesid üht­
lase sagedusega kogu Lõuna Eestis, kuid puükentsefaliiti täheldati vaid Peipsi 
järve ümbritsevates piirkondades s.t. Tartu linnas ja maakonnas ning Jõgeva 
maakonnas. Valdav osa bakteriaalse meningiidi juhte (84,3%) diagnoositi alla 5 
aasta vanustel lastel, seevastu aseptilisse meningiiti ja puukentsefaliiti haiges­
tusid peamiselt koolilapsed, kes moodustasid vastavalt 80,2% ja 95,4% 
haigetest. Mädase meningiidi juhud esinesid aastaringselt ühtlase sagedusega, 
kuid aseptilise meningiidi ja puukentsefaliidi sagedus tõusis oluliselt suve- ja 
sügiskuudel s.t. ajal, mil ühelt poolt on puugid aktiivsed ja teisalt esineb en-
teroviiruslike nakkuste kõrgperiood. Bakteriaalse meningiidi etioloogilises 
struktuuris, sarnaselt andmetele endisest Nõukogude Liidust, prevaleerus 
Neisseria meningitidis 34,9%-ga, Steptococcus pneumoniae ja Haemophilus in­
fluenzae esinesid vastavalt 4,4% ja 4,0% haigetest, kuid 1980ndate aastate 
lõpuks täheldati Hib osatähtsuse tõusu meningiiditekitajate hulgas. Neonataalse 
meningiidi tekitajatena olid valdavaks Gram-negatiivsed tinglikult patogeensed 
mikroobid, milledest E. coli esines kõige sagedamini. Kahjuks jäi aseptilise 
meningiidi etioloogia 95,4% juhtudest ebaselgaks. 
Kesknärvisüsteemi põletike letaalsus uurimiperioodi vältel oli 5,4% ning 
4,1% põdenutest jäid invaliidiks, halvim oli sealjuures bakteriaalse meningiidi 
prognoos — letaalsus 9% ja invaliidsus 7,1%. Tõsiseks probleemiks oli neona­
taalne meningiit oma kõrge letaalsuse ja invaliidsuse tõttu vastavalt 45,8% ja 
53,8%. Bakteriaalse meningiidi kaugprognoosi hinnati vähemalt 3 aasta möö­
dudes 84 bakteriaalset meningiiti põdenud lapsel. 80% uuritutest olid täiesti 
terved, 13,3% esinesid kerged kõrvalekalded normist ning 6,6% olid invaliidid. 
Sagedaseimateks jääknähtudeks olid motoorika häired ning kuulmislangus 
esinedes vastavalt 11,9% ja 8,3%-l lastest, epilepsiat ja vaimse arengu maha­
jäämust diagnoositi 4,7% uuritutest. Antud uurimus leidis statistiliselt tõenäose 
seose väljakirjutamisel esinevate neuroloogiliste komplikatsioonide ja hilise­
mate jääknähtude (välja arvatud epilepsia) vahel?(p<0,005). Seega on haigete 
prognoosi võimalik määrata juba väljakirjutamisel ning edasist jälgimist bakte­
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riaalse meningiidi järgselt vajavad vaid neuroloogilise sümptomatoloogia 
(ataksia, lihastoonuse muutused) või kuulmishäiretega lapsed. 
Intratsellulaarsete fermentide (LDH, AST, GGT, CPK ja CK-BB) aktiiv-
sust/konsentratsiooni määrati seljaajuvedelikus 25 bakteriaalse, 16 aseptilise 
meningiidiga haigel ning 15 meningismiga lapsel. Bakteriaalse meningiidi kor­
ral oli haiguse alguses AST ja GGT aktiivsus liikvoris olulist kõrgem võrreldes 
aseptilise meningiidi ja meningismiga (p<0,05). Kõikide intratsellulaarsete fer­
mentide aktiivsus seljaajuvedelikus langes ravi käigus. Huvitav on märkida, et 
CK-BB isoensüümi kontsentratsioon liikvoris oli haiguse alguses tõusnud nii 
bakteriaalse kui ka aseptilise meningiidi aga ka meningismi haigetel. 
Prognostilist tähtsust omas AST ja LDH aktiivsuse tõus haiguse alul, olles tun­
duvalt kõrgem neil, kes surid või invaliidistusid (p<0,05). Samas esinesid antud 
uurimuses halva prognoosiga haiged, kelle seljaajuvedeliku intratsellulaarsete 
fermentide aktiivsus oli madal. See näitab, et- ensüümuuringute tähtsust liik­
voris ei tohi üle hinnata, kuna haigete prognoos ei sõltu ainult protsessi ulatu­
sest, vaid ka asukohast ja nimelt ka minimaalne elutähtsate piirkondade kahjus­
tus võib olla prognostiliselt väga tõsine. 
Antud uurimus näitas, et 5-päevane antibakteriaalne ravi 23-1 meningokoki-
lise, 7-1 hemofiilus ja 5-1 pneumokokilise meningiidi haigel lapsel oli sama 
efektiivne kui pikem ravi, kusjuures hospitaliseerimise aeg oli tunduvalt lühem 
5-päevase ravi korral (p<0,005). 
Kokkuvõtteks võib öelda, et kesknärvisüsteemi põletikud ei ole küll sage­
dased haigused, kuid nende lõpe on endiselt tõsine. Prognostiliselt osutuvad 
ebasoodsaks nii intratsellulaarsete fermentide (AST, LDH) kõrge aktiivsus 
seljaajuvedelikus haiguse alul kui ka väljendunud neuroloogilise sümptoma­
toloogia esinemine haiglast väljakirjutamisel. Mittekomplitseeritud meningo-
kokilise meningiidi raviks lastel on 5-päevase antibakteriaalse ravi küllaldane, 
kuid haigete väikese arvu tõttu antud uuringus me ei saa seda soovitada 
pneumokokilise ja hemofiilus meningiidi haigetele. 
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mädane meningiit, vastsündinu meningiit, esi­
nemissagedus, meningokokkinfektsioon, le­
taalsus, invaliidsus 
Vaatamaita meditsiini arengule ja jär­
jest uute mikroobidevastaste ravimite ka­
sutuselevõtule, on mädane meningiit jää­
nud tõsiseks lapseea probleemiks. Ka vii­
mastel aastatel on letaalsus bakteriaalse 
meningiidi tagajärjel püsinud 1,8... 12% 
piires (4, 5, 17,18). Eestis on mädase me­
ningiidi epidemioloogiat veel vähe uuri­
tud, viimased kirjanduse andmed pärine­
vad 1961. aastast (22). Ametlikule regist­
reerimisele on siiani kuulunud vaid 
meningokokkmeningiidi juhud. 
Käesoleva töö eesmärk oli uurida lap­
seea mädase meningiidi epidemioloogiat, 
etioloogilist struktuuri, haigusest põhjus­
tatud letaalsust ning invaliidsusjuhte 
Lõuna-Eestis aastail 1980... 1991. 
Uurimismateqal ja-metoodika. Uurimi­
ne korraldati Lõuna-Eestis (Tartu linn, Tartu, 
Jõgeva, Põlva, Valga ja Võru maakond), kus 
keskmine elanike arv sel ajal oli 400 000, neist 
lapsi 86 000. Linna- ja maaelanike suhe oli 
1:1. Uuriti haiguslugusid, lahanguprotokolle 
ning haiglate ja osakondade aastaaruandeid 
ajavahemikust 1980... 1991. Uurimisrühma 
kuulusid 0...14 aasta vanused mädast menin­
giiti põdenud, keda oli ravitud Lõuna-Eesti 
maakondade keskhaiglates, Tartu Kliinilises 
Haiglas, Tartu Linna Nakkushaiglas või Tar­
tu Lastekliinikus ja kes elasid nimetatud piir­
konnas. Mädase meningiidi diagnostiliseks 
kriteeriumiks oli kas mikroobi leidmine selja­
ajuvedelikus või liikvori pleotsütoos üle 100 
raku milliliitris. 
Haiguslugusid ja lahanguprotokolle analüü­
siti retrospektiivselt järgmiste tunnuste alu­
sel: lapse vanus, sugu, elukoht, haigestumise 
aeg, haigusetekitaja, haiguse kestus ja lõpe. 
Eraldi analüüsiti mädase meningiidi esi­
nemissagedust, etioloogilisi faktoreid ja lõpet 
aastail 1980... 1986 ja 1987... 1991. Demo­
graafilised andmed on saadud Eesti Tervis­
hoiuministeeriumi statistikakogumikest 
(1980... 1991). 
Uurimistulemused ja arutelu. Aja­
vahemikul 1980... 1991 diagnoositi mä­
dast meningiiti 250 Lõuna-Eesti lapsel. 
Nendest 29 olid 0...29 päeva vanused ja 
221 last 30 päeva kuni 15 aasta vanused 
Tabel. Mädase meningiidi etioloogiline struktuur eri vanuses lastel aastail 1980...1991 
Tekitaja Vanus 
0...29 0...11 0...4 5.. .9 10...14 Kokku 
päeva kuud aastat aastat aastat 
(*) (%) (%) (%: ) (%) (%) 
Neisseria 
meningitidis 2 (6,8) 39 (30,0) 74 (35,0) 8 (33,3) 6 (50,0) 88 (35,2) 
Streptococcus 
pneumoniae 1 (3,4) 8 (6,2) 10 (4,7) 1 (4,1) — 11 (4,4) 
Haemophilus-
influenzae B — 7 (5,4) 9 (4,2) 2 (8,3) — 11 (4,4) 
Tinglikult 
patogeenne 
mikrofloora 14 (48,2) 17 (13,2) 17 (8,0) — — 17 (6,8) 
Muud 1 (3,4) 3 (2,3) 3 (1,4) — — 3 (1,2) 
Tundmata 11 (37,9) 62 (48,4) 101 (47,8) 13 (54,1) 6 (50,0) 120 (48,0) 
Kokku (%) 29 (11,6) 136 (51,2) 214 (85,6) 24 (9,6) 12 (4,8) 250 (100) 
408 
24 
(excl.). Haigestumus moodustas 23,5 
100 000 lapse kohta, kõikudes 12,7-st 
1990. aastal 46,5-ni 1984. aastal (vt. joo­
nis 1). Haigestumus oli kõige suurem Põl­
va ja Viljandi maakonnas ning kõige väik­
sem Tartu linnas, vastavalt 41,1, 37,0 ja 
20,3 juhtu 100 000 lapse kohta. Poiss- ja 
tütarlaste suhe oli 1,7:1 ning maa- ja lin­
nalaste suhe 1,3:1. 
Meningiidi esinemissagedus vastsündi­
nute hulgas oli 0,41 juhtu 1000 elusalt 
sündinu kohta, kõige väiksem oli see 
1980. ja 1985. aastal, mil ei diagnoositud 
ühtegi haigusjuhtu, ja kõige suurem 1986. 
aastal, mil diagnoositi 1,16 juhtu 1000 
kohta. 29 vastsündinust haigestus kuue 
esimese elupäeva jooksul 15 (50%) ilmse 
intrauteriinse või intranataalse infekt­
siooni tõttu. 3 last haigestus esimese elu­
kuu jooksul kodus ning 12 last (40%) na­
katus intensiivraviosakonnas või vast­
sündinute osakonnas. Nende puhul on 
ilmselt tegemist haiglasisese nakkusega. 
Enamik mädase meningiidi juhte 
(85,6%) esines alla viieaastastel lastel, 
kusjuures 51,2% haigetest olid esimese 
eluaasta lapsed. Vanemas eas esines vaid 
üksikuid haigusjuhte (vt. tabel). Peamine 
mädase meningiidi tekitaja oli Neisseria 
meningitidis, mis põhjustas 1/3 haigus­
juhtudest kõigis vanuserühmades, välja 
arvatud vastsündinuiga. Streptococcus 
pneumoniae ja Haemophilus influenzae B 
esinesid võrdse sagedusega, põhjustades 
4,4% mädastest meningiitidest. Suur oli 
tundmatu tekitajaga haigusjuhtude arv 
(48%), eriti esimese viie uurimisaasta 
jooksul (vt. joonis 2). Uurimise lõpp-pe-
rioodil (ajavahemikul 1987... 1991) para­
nesid bakterioloogilise diagnoosimise või­
malused tunduvalt ning vaid 1/4-1 juhtu­
dest jäi mädase meningiidi tekitaja 
avastamata. Võrreldes bakteriaalse me­
ningiidi tekitajaid 1980-ndate aastate al­
gul ja lõpul, selgub, et mõlemal perioodil 
oli peamiseks haigusetekitajaks Neisseria 
meningitidis, põhjustades vastavalt 
22,9% ja 51,3% haigusjuhtudest. 
Haemophilus influenzae osatähtsus 
bakteriaalse meningiidi etioloogias suure­
nes 1,4%-lt uurimise algperioodil 16,8%-le 
selle lõpul. 
Mädase meningiidi etioloogia vastsün­
dinumas lastel oli erinev. Uuritud ajavahe-' 
mikul oli 48,2%4 juhtudest haiguse teki­
tajaks tinglikult patogeenne floora: E. coli 
8 juhul, Staphylococcus aureus 2 juhul, 
Pseudomonas aeruginosa, Klebsiella 
pneumoniae, Proteus mirabilis, Strepto­
coccus B ja Citrobacter freundii igaüks 
ühel juhul. Klassikalisi meningiidi tekita­
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Joonis 1. Bakteriaalse meningiidi esinemissagedus Lõuna-Eesti lastel aastail 1980...1991. 
I us influenzae B ja Streptococcus pneumo­
niae — esines kolmel juhul (vt. joonis 3). 
Ajavahemikul 1980... 1991 suri mädase 
meningiidi tagajärjel 30 last (letaalsus 
12%), neist 11 vastsündinut. Seega oli le­
taalsus bakteriaalse meningiidi tagajärjel 
vastsündinuperioodil 37,9% ja alates tei­
sest elukuust 8,5%. Suurimat letaalsust 
täheldati tinglikult patogeense mikrofloo­
ra põhjustatud meningiidi tagajärjel 
(41,1%), järgnesid pneumokokkmeningiit 
(18,1%), tundmatu etioloogiaga (10,0%) ja 
Haemophilus influenzae B meningiit 
(9,0%). Väikseim oli letaalsus meningo-
kokkmeningiidi korral (6,8%). 
Raskeid neurootilisi jääknähte esines 
21 lapsel, s.o. 9,1%-I ellujäänuist, nendest 
8 olid vastsündinud (27,5%) ja 13 (6,4%) 
üle ühe kuu vanused lapsed. Sagedamini 
oli invaliidsuse põhjuseks progresseeruv 
hüdrotsefaalia, mis tekkis 9 lapsel; kahel 
lapsel täheldati kliiniliselt olulist kuulmi­
se nõrgenemist, kolmel lapsel arenes epi­
lepsia ning 7 lapsel hemi- või tetraparees 
koos tunduva psühhomotoorse arengu 
mahajäämusega. 2/3-1 lastest oli mitu 
sündroomi üheaegselt. 
Uurimise algperioodi (1980...1986) 
andmeid lõpp-perioodi (1987... 1991) and­
metega võrreldes täheldasime üle ühe 
kuu vanuste laste puhul nii letaalsuse 
langust kui ka invaliidsusjuhtude vähene­
mist vastavalt 11,8%-lt 2,6%-le ja 7,6%-lt 
2,6%-le. Samal ajal jäid neonataalse me­
ningiidi ravi tulemused kogu uurimise 
ajaks muutumatuks. 
Arutelu. Mädase meningiidi haigestu­
mus Lõuna-Eestis 1980-ndail aastail — 
23,5 juhtu 100 000 lapse kohta — oli üsna 
sarnane haigestumusega kapitalistlikes 
riikides, näiteks Šotimaal 17,8 (4) ja Root­
sis 22,4 juhtu 100 000 lapse kohta (18). 
Madala sotsiaal-majandusliku tasemega 
elanike hulgas on täheldatud tunduvalt 
suuremat haigestumust. Nii oli haigestu­
mus Ameerika indiaanlaste hulgas ja Aaf­
rikas vastavalt 180 ja 517 juhtu 100 000 
elaniku kohta (20, 23). Nüüdisajal on pal­
judes riikides alustatud vaktsineerimist 
Haemophilus influenzae B vastu. Seoses 
sellega on näiteks Soomes bakteriaalse 
meningiidi haigestumus oluliselt vähene­
nud, sest meningiiditekitajate hulgas on 
seal esikohal Haemophilus influenzae B 
(15). Arenenud riikides on mädane menin­
giit põhiliselt alla viieaastaste laste 
haigus, kes moodustavad kuni 72% haige­




influenzae B pneumoniae 
Joonis 2. Mädase meningiidi etioloogšline struktuur Lõuna-Eesti lastel aastail 1980...1991. 
andmed kinnitavad alla viieaastaste 
laste suurt osatähtsust haigestunute hul­
gas (84,4%). 
Bakteriaalse meningiidi etioloogiline 
struktuur on paikkonniti erinev. Nii on 
1960-ndatest aastatest alates täheldatud 
Ameerikas ja 1970-ndatest aastatest ka 
Euroopa riikides Haemophilus influenzae 
B osatähtsuse suurenemist meningiidite-
kitajate hulgas. Võrrelnud mädase me­
ningiidi tekitajaid Šotimaal kahel perioo­
dil, aastail 1947... 1961 ja 1971... 1986, 
leidsid P. E. Carter ja kaasautorid (4), et 
kui esimesel perioodil Haemophilus in­
fluenzae B põhjustas vaid 9,1%, siis teisel 
perioodil juba 36,8% kõigist lapseea bak­
teriaalsetest meningiitidest. Eriti suur oli 
selle tekitaja tähtsus alla viie aasta va­
nuste laste puhul, põhjustades kuni 70% 
kõikidest haigusjuhtudest (10). 
Meie käsutuses olnud venekeelses kir­
janduses bakteriaalse meningiidi etioloo­
gia kohta endises Nõukogude Liidus oli 
kõigi uurimuste järgi peamiseks menin­
giidi tekitajaks meningokokk, esinedes 
72,6...83,2%-l haigetest (5, 11, 21), kuid 
samal ajal oli seal täheldatud ka Haemo­
philus influenzae B osatähtsuse suurene­
mist (6). Neisseria meningitidis'e preva­
leerimise põhjuseks on N. Kostjukova ja 
kaasautorite (14) arvates meningokokk-
infektsiooni epideemia, mis NSV Liidus 
kestis aastail 
1967... 1984. Taolist 
epideemiat ei ole 
kiijeldatud mitte 
kõigis maailma rii­












NSV Liidus, erineb aga Lääne-Euroopa ja 
Ameerika andmetest (4, 11, 18). 
Suur oli meie uurimuse põhjal tundma­
tu haigusetekitajaga juhtude arv, eriti 
uurimise algperioodil. Võib tekkida arva­
mus, et ka Haemophilus influenzae B põh­
justatud meningiit võis olla nende hulgas. 
Kuigi bakterioloogiline diagnoosimine II 
uurimisperioodil paranes, jäi mädase me­
ningiidi etioloogiline struktuur oluliselt 
muutumatuks. Neisseria meningitidis jäi 
ikkagi mädase meningiidi valdavaks teki­
tajaks Lõuna-Eestis. 
Võrreldes letaalsust mädase meningiidi 
tagajärjel Eestis aastail 1940... 1950, kui 
see E. Tulmini (22) andmeil oli 32,9%, ilm­
neb tunduv langus viimase 30 aasta jook­
sul. Letaalsus 12% on küll võrreldav G. C. 
Yosti ja kaasautorite (23) andmetega 
(12%), kes uurisid bakteriaalse meningii­
di epidemioloogiat Ameerika indiaanlaste 
hulgas, jääb aga tunduvalt kõrgemaks le-
taalsusest Šotimaal (1,2%) ja Rootsis 
(3,4%) (4, 18). 
Bakteriaalse meningiidi korral ei ole 
probleemiks mitte ainult letaalsus, vaid 
ka haiguse tagajärjel tekkiv invaliidsus. 
Raskeid neuroloogilisi jääknähte esines 
meie andmeil 9,1%-1 paranenuist, mis on 
lähedane kirjanduse andmetele — 
5,4... 11,9% (2, 3, 4, 7, 17, 18). Sagedama­








on ajuvatsakeste laienemine ja kuulmise 
nõrgenemine (7, 8, 12). Hüdrotsefaaliat 
diagnoositi 4%-l ellujäänuist. See on lähe­
dane D. Giustina ja kaasautorite (7) and­
metele, kes leidsid hüdrotsefaaliat 4,7%-l 
paranenuist. Enamik autoreid on kuulmi­
se nõrgenemist leidnud 2,7...9%-l bakte­
riaalset meningiiti põdenud lastest (8,10, 
18,19,28), kuid meie andmeil esines seda 
ainult 0,9%-i paranenuist. Kuulmise nõr­
genemine on põhjustatud kas mikroobi ot­
sesest kahjustavast toimest (tekib mäda­
ne labürintiit) või aju isheemiast (2). An­
tibiootikumide osa kuulmiskahjustuse 
kujunemisel meningiidi korral eitatakse, 
sest enamikul haigetel on seda esinenud 
juba hospitaliseerimise ajal (12, 18). Üks 
kuulmishäirete vähesuse põhjusi võis olla 
see, et audiomeetrilisi uuringuid ei tehtud 
meil süstemaatiliselt. Seetõttu registree­
riti ainult lapsed, kellel oli kuulmise nõr­
genemine kliiniliselt väljendunud. Vara­
jaseks kuulmiskahjustuse avastamiseks 
tuleks audiomeetrilisi uuringuid teha kõi­
gil bakteriaalset meningiiti põdenuil juba 
siis, kui nad haiglast välja kirjutatakse. 
Letaalsus«; ja invaliidsusjuhtude tun­
duv vähenemine üle ühe kuu vanuste las­
te hulgas oli uuringuperioodil ilmselt tin­
gitud nii diagnoosimis- kui ka intensiivra­
vi võimaluste paranemisest 1980-ndatel 
aastatel. Muret tekitav oma halva pro­
gnoosi tõttu on neonataalne meningiit. 
Vastsündinu meningiit Lõuna-Eestis sa­
gedusega 0,41 juhtu 1000 elusalt sündinu 
.kohta sarnaneb kirjanduses avaldatuga: 
0,37...0,67 juhtu 1000 kohta (2, 3, 19). 
Neonataalse meningiidi tekitajana on pal­
judes maailma riikides ja ka meie and­
meil ülekaalus E. coli Kl (1,2, 13). Alates 
1960-ndate aastate algusest on vastsündi­
nu meningiidi tekitajate hulgas tähelda­
tud B-grupi streptokoki osatähtsuse tun­
duvat suurenemist. Ebaselgeks jääb, 
miks nimetatud mikroobi esines meie 
andmeil ainult ühel juhul. Letaalsus oli 
kõrge neonataalse meningiidi tagajärjel 
(37,9%), seda. on täheldanud ka teised 
autorid. Nii oli S. Apaki ja kaasautorite 
(1) andmeil letaalsus Saksa DV-s 45,3% ja 
A. H. Belli ja kaasautorite (2) andmeil 
Inglismaal 49%. Erinevalt teistest leidis 
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R. Bennhagen kaasautoritega (3) vastsün­
dinute meningiidi letaalsuseks Rootsis 
vaid 3,5%, kuid see uurimus hõlmas 
ainult ühte aastat (1983) ning valdavaks 
tekitajaks ei olnud mitte gramnegatiivne 
tinglikult patogeenne mikrofloora, vaid B-
grupi streptokokk. Vastsündinu meningii­
di ravi äärmisest komplitseeritusest rää­
gib fakt, et vaatamata intensiivravi või­
maluste paranemisele ei oie 
uurimisperioodil täheldatud ei letaalsuse 
langust ega invaliidsusjuhtude vähene­
mist. Probleemiks jääb küllaltki suur no-
sokomiaalinfektsiocni osatähtsus, meie 
andmeil pooled vastsündinuist haigestu­
sid ravil olles. Kiijanduses on avaldatud 
arvamust, et neonataalse meningiidi 
prognoosi parandamiseks tuleks rohkem 
tähelepanu pöörata profülaktikale, s.t. 
vältida haiglasisest nakkust ja otsida im-
munoprofülaktika rakendamise võimalu­
si (13, 19). 
Järeldused. 
1. Sarnaselt endise NSV Liiduga ja eri­
nevalt Euroopa ja Ameerika riikidest oli 
aastail 1980... 1991 Lõuna-Eestis valda­
vaks bakteriaalse meningiidi tekitajaks 
lastel meningokokk, kusjuures 1980-nda-
te aastate lõpust täheldati Haemophilus 
influenzae B osatähtsuse suurenemist. 
2. Paremaks ülevaate saamiseks ja või­
malikuks immunoprofülaktikaks oleks 
ametlikult vaja registreerida kõik mäda­
se meningiidi juhud. 
3. Ehkki 1940... 1950 aastate andmete­
ga võrreldes on mädase meningiidi pro­
gnoos tunduvalt paranenud, jäävad le­
taalsus ja invaliidsus Eestis suhteliselt 
kõrgeks, mistõttu mädast meningiiti põ­
devaid lapsi peaks ravitama haiglas, kus 
on nüüdisaegsed diagnoosimis- ja inten­
siivravi võimalused . 
4. Endiselt jääb probleemiks neonataal­
ne meningiit oma halva prognoosi tõttu. 
Et ravi on äärmiselt komplitseeritud, tu­
leks rohkem tähelepanu pöörata neona­
taalse infektsiooni profülaktikale. 
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Summary 
Epidemiology of bacterial meningitis in 
children in South-Estonia in 1980—1991. Epi­
demiology of bacterial meningitis (BM) in children 
in South-Estonia was investigated. In the period 
1980—1991 250 children (29 newborns and 221 
children over two months) with BM were identified. 
The average incidence rate of BM was 23.5 per 
100,000 children. Neisseria meningitidis caused 
35.2% of the BM in older children, Haemophilus in­
fluenzae B and Streptococcus pneumonia 4.4% both, 
other microorganisms 1.2% and in 48.8% of BM the 
etiology was unknown. The incidence rate of neona­
tal meningitis was 0.41 per 1000 births. E. coli was 
the most common bacteria isolated in 30% of the 
cases of neonatal meningitis. Among those over two 
months there were 19 meningitis associated deaths 
(case fatality rate 8.5%) and 13 (6.4%) those who sur­
vived developed disability. The mortality and the 
disability rate in newborns was higher-11 newborns 
died (case fatality rate 37.9%) and 8 (27.5) developed 
disability. The overall mortality rate fell dramati­
cally from 11.8% at the beginning of study to 2.6% 
in the end of it among older children, but showed no 
changes in newborns. The same applies to the dis­
ability rate, decreasing from 7.6% to 2.6% and re­
maining the same respectively. 
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Difteeria Eestis 
Ants Jõgiste Toomas Trei • Tallinn 
difteeria, immunoprofülaktika, epidemioloogi­
line järelevalve 
Käesoleva töö eesmärk oli anda epide­
mioloogiline käsitlus difteeria kohta Ees­
tis. Selle ajendiks oli vajadus analüüsida 
kujunenud olukorda seoses haigestumise 
taastumisega põhjendamaks profülaktika-
meetmeid. 
Uurimismaterjal ja -metoodika. Epidee-
miaprotsessi tundmaõppimiseks on analüü­
situd statistikaandmeid. Uurimismaterjal 
XVIII.. .XIX sajandi ja käesoleva sajandi kahe-
kümnendate-kolmekümnendate aastate kohta 
on trükis avaldatud (1, 7, 8). Andmestik 1945. 
aasta ja järgmiste aastate kohta asub Riigi 
Tervisekaitsekeskuse arhiivis ja on avaldatud 
ositi. 
Haigestumise iseloomustamiseks on kasuta­
tud tavanäitajaid: haigestumus 100 000 inime­
se kohta, tsüklilisus, sesoonsus, geograafiline 
levik, haigete vanus. Süvakäsitluse huvides on 
lisatud andmeid immuunsus tausta ja tekitaja 
ringluse kohta. Et nakkushaiguste epidemio-
loogilistes käsitlustes keskendub tähelepanu 
eelkõige epideemiaprotsessi mõjutamise või­
malustele, siis on ka käesolevas töös vaadeldud 
haigestumusnäitajaid seoses ajajooksul täius­
tunud profülaktikavõimalustega. 
Uurimistulemused ja arutelu. 
Difteeria XVIII...XIX sajandil. Sta­
tistikaandmeid haigestumuse kohta sel­
lest ajast ei ole, kuid epidemioloogilist olu­
korda on võimalik põhijoontes hinnata 
meetrikaraamatuisse talletatud surma­
põhjuste kaudu (8). Nendel andmetel ei ol­
nud difteeria osatähtsus surma põhjusena 
suur (0,3...0,4%). Enam ohvreid nõudsid 
rõuged, tüüfus, düsenteeria ja siberi katk. 
Epideemiaprotsessi intensiivsus muu­
tus perioodiliselt. Haigestumise tsüklili­
sed tõusud kordusid nähtavasti 8...9 aas­
ta järel. Sesoonne tõus vältas augustist 
jaanuarini maksimumiga novembris. Neil 
kuudel esines 60% aastas registreeritud 
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Enzymatic changes in the cerebrospinal fluid in patients with 
infections of the central nervous system 
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Enzymatic determinations in cerebrospinal fluid (CSF) of aspartate aminotransferase (AST), lactic 
dehydrogenase (LDH), gammaglutamyl transpeptidase (GGT), creatine Phosphokinase (CPK) and 
creatine kinase BB (CK-BB) were performed in 16 patients with aseptic meningitis (AM), in 25 children 
with bacterial msningitis (BM) and in 15 patients with meningism. The activity of AST and GG1 was 
significantly higher in patients with BM on admission compared with those with AM and meningism 
(p < 0.05 and p < G.005, respectively) and decreased with therapy. The highest concentration of AST 
and LDH appeared in patients with poor outcome as well as in those with ventriculomegaly on 
neurosonography (p < 0.05). The concentration of CK-BB increased in all patient groups on admission 
and remained higher on termination of therapy. The present study confirms the high activity of AST 
and GGT in BM patients in the CSF whereas the increased activity of AST and LDH reflects the 
extent of brain injury. Nevertheless, the prognosis for individual patients cannot be established on the 
basis of enzyme activity alone, but depends on several factors. • Aseptic meningitis, aspartate 
aminotransferase, bacterial meningitis, cerebrospinal fluid, creatine kinase, gamma-glut amy I transpepti­
dase, lactic dehydrogenase 
I Lutsar, Department of Pediatric Infectious Diseases> University Children's Hospital, Lunini 6, EE2400 
Tartu, Estonia 
Disturbances of the enzymatic system are caused by 
several pathologic processes. Estimations of serum 
aspartate aminotransferase (AST), lactate dehydrogen­
ase (LDH), gamma-glutamyl transpeptidase (GGT) 
and creatine kinase (CPK) are widely employed as 
valuable diagnostic aids in diseases involving necrosis 
or damage to tissues characteristically rich in these 
enzymes. The activities of these enzymes have been 
measured in the cerebrospinal fluid (CSF) of patients 
with a variety of neurological disorders (1-6). The 
results obtained, however, were controversial. 
The purpose of the present study was to measure the 
activity of AST, LDH, GGT, CPK and the concentra­
tion of its brain type isoenzyme, CK-BB, in the CSF in 
patients with bacterial and aseptic meningitis and 
encephalitis, as well as in patients with meningism, to 
establish if any of these enzymes correlates with brain 
damage of different etiology and to assess their useful­
ness in clinical investigations and prognosis. 
Patients and methods 
The patients studied included 16 children with aseptic 
meningitis (AM), 25 children with bacterial meningitis 
(BM) and 15 patients with no infection of the central 
nervous system (ICNS) in whom lumbar puncture was 
performed due to meningism. BM was diagnosed if at 
least one of the following criteria was fulfilled: (1) 
bacterial grown from CSF, (2) bacterial grown from 
blood with more than 10 white blood cells (WBC) per 
mm3 CSF, (3) sterile CSF, but more than 200 x 106 
polymorphonuclear leukocytes (PMNL) per mm3. The 
etiologic structure of BM was as follows: Neisseria 
meningitidis in 14 children, Haemophilus influenzae B 
in 4, Streptococcus pneumoniae, Escherichia coli, 
Pseudomonas aeruginosa and Klebsiella pneumoniae in 1 
patient each and in 3 cases the etiology of BM remained 
unknown. 
AM was considered if no bacterial infection (as 
defined above) was found or suspected for patients 
with clinical signs of meningitis and more than 10 
WBC per mm3 CSF. Of 16 children with AM, 2 had 
enteroviral meningitis and 7 tick-borne encephalitis, 
and in 7 cases the etiology was unknown. 
Fifteen children with no ICNS had the following 
diagnoses: 6 patients had acute respiratory infection, 3 
diarrhea, 2 epilepsy; hemolytic-uremic syndrome, poly­
radiculoneuropathy, malignant brain tumoi and drug 
intoxication were diagnosed in 1 patient each. Patient 
characteristics on admission are shown in Table 1. 
The first CSF sample collected on admission was, in 
most cases, on the first to third day of the disease. In 15 
patients with BM, the second sample was collected on 
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Table 1. Patient characteristics on admission. 
AM BM Meningism 
Characteristic (n = 16) {n = 25) («=15) 
Age 
0-29 days 0 2 1 
1-12 months 0 15 5 
1-5 years 7 7 4 
6-15 years 9 1 5 
Sex 
Male/Female 11/5 15/10 7/8 
Seizures (n) 1 8 3 
Unconsciousness (n) 1 5 2 
CSF 
Pleccytosis 
(WBC/mm3) 105(43-251) 681(236-1484) 3(2—6) 
Protein (g/1) 0.58(0.47-1.0) 1.22(0.67-2.1) 0.5(0.19-1.0) 
days 7-10 of treatment. The CSF was sampled by 
lumbar puncture and centrifuged immediately. Sam­
ples were frozen to - 20 °C and stored for up to three 
months before analysis. In all cases, routine laboratory 
investigations, i.e. CSF protein, sugar, cell count and 
bacterial cultures, were examined. The activity of CPK, 
LDH, AST and GGT was measured by photocolori-
metric assay using commercial kits (Labsystem FP-900). 
The method of enzyme-linked immunosorbent assay 
used for measurement of CK-BB concentration was 
an original one, described by Haldre (6). The mean 
concentration of CK-BB in the control group, including 
30 adults with no neurological disorders from whom 
CSF was taken during spinal anesthesia, was 
5.3 ± 1.2ng/l. 
The outcome of the survivors was assessed by a 
multidisciplinary team (pediatrician, pediatric neurol­
ogist, speech therapist, psychologist) at least 12 months 
after the acute illness. Children were divided into two 
groups. The good recovery group (n = 32) included 
normal children and those with impairment which did 
not disturb everyday life. The second group consisted of 
9 children; 4 died during the acute illness and 5 had 
Table 2. Activity of AST, CKP, LDH, GGT and CK-BB in CSF in 
patients on admission. 
Enzyme AM BM Meningism 
(quartiles) (n = 16) (« = 25) («=15) 
CK-BB (ng/1) 37.5 31.0 39.0 
(24.0-43.0) (15.0-59.0) (34.0-46.0) 
CPK (U/l) 4.3 4.2 3.3 
(2.0-9.0) (2.6-5.5) (2.6-5.3) 
AST (U/l) 4.0 8.8* 4.7 
(3.6-7.3) (6.1-11.0) (3.5-6.3) 
LDH (U/l) 28.1 33.8 15.4 
(4.8-52.2) (19.7-70.2) (7.6-20.6) 
GGT (U/l) 1.67 5.3** 1.5 
(0.6-4.45) (2.1-8.7) (1.0-2.0) 
severe impairments (hydrocephalus, severe motor 
disability, deafness, intractable epilepsy). All 5 children 
had combined disturbances. 
Statistical analysis 
The results are given as median with upper and lower 
quartiles. A computerized statistical package, Statview, 
was used. This included the non-parametric Mann-
Whitney test for unpaired samples, the Wilcoxon test 
for paired samples and Spearman's rank correlation 
coefficient. 
Results 
Table 2 shows the results of CSF enzyme determinations 
on admission. An increase in CK-BB concentration in 
*p < 0.05, **p < 0.005. 
Fig. 1. Activity of CPK, AST, LDH and GGT, and concentration of 
CK-BB in CSF on admission and on days 7—10 of therapy. The 
activities of CPK, AST, LDH and GGT are expressed in U/l, and 
CK-BB concentration in ng/1 (• on admission, • 7-10th day). 
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Table 3. Enzyme data on admission in relation to outcome of infections of the central nervous system. 
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Outcome CK-BB CPK AST LDH GGT 
(quartiles) (ng/1) (U/l) (U/l) (U/l) (U/l) 
Dead/severely impaired 9.5 3.8 12.1* 60.5* 2.7 
(n = 9) (2-37) (2.6-4.5) (5.0-17.4) (37.1-235.4) (1.8-11.4) 
Good recovery 38.0 4.5 6.7 27.5 2.9 
(n = 32) (30-49) (1.7-6.5) (4.0-9.0) (15.2-46.3) (0.9-8.1) 
*p < 0.05. 
all three diagnostic groups was noted. The activity of 
AST was two-fold higher in patients with BM compared 
with those without (p < 0.05). The median value of the 
activity of LDH (33.8 U/l) was highest in those with BM 
and lowest in patients with meningism, but statistically 
significant differences were not found. A significant 
increase in the activity of GGT {p < 0.005) was noted 
in patients with BM on admission compared with those 
with AM or meningism. 
The activity of intracellular enzymes after 7-10 days 
of treatment was measured in only 15 patients with BM. 
Figure 1 shows that the concentration of CK-BB and 
activity of AST, LDH and GGT decreased with treat­
ment, but that of CPK remained the same. AST activity 
was estimated simultaneously in CSF and serum in 40 
patients (25 with BM and 15 with AM): no correlation 
was found between the levels of AST in CSF and serum 
(r = -0.362). The activity of LDH correlated with the 
count of PMNL, in CSF on admission (r = 0.538), but 
no correlation was found on days 7-10 of therapy 
(r = -0.224). There were 3 patients with E. coli menin­
gitis with more than 1000 PMNL in CSF on day 10 of 
therapy, but the activity of LDH was 2.5, 4.3 and 91.5 
U/l, respectively. 
As shown in Table 3, patients with ICNS who died or 
recovered with residual impairments had significantly 
higher median CSF AST and LDH activities (p < 0.05) 
compared with those with good recovery. Although the 
concentration of CK-BB was higher in patients with a 
good prognosis, this difference was not statistically 
significant. 
Table 4 shows that the CSF activity of AST and LDH 
was significantly higher in patients who developed 
ventriculomegaly in comparison with those with 
normal findings (p < 0.05). The highest value of AST 
and LDH activity was seen in 4 patients who developed 
hydrocephalus. 
Discussion 
In this study, our aim was to estimate the level of some 
intracellular enzymes in different ICNS and to establish 
if any of the measured enzyme levels correlated with 
central nervous system dysfunction, thus assessing their 
prognostic value and determining their usefulness in 
clinical practice. An increase in AST, LDH and GGT 
activities in patients with BM on admission, demonstrat­
ing neuronal cell injury as well as altered permeability 
of the blood-CSF barrier, has been reported by several 
authors (1-5). The increased median value of activity 
and also the appropriate displacement of quartile inter­
vals of AST and GGT in BM patients in comparison 
with AM and meningism were seen in this study also. In 
contrast with others (7-9) who have claimed signifi­
cantly higher concentrations of LDH in BM, the benefit 
of measuring the activity of LDH, similar to Landaas & 
Lippe (3), was very poor in our study. Although we 
found that the activity of LDH was higher in BM 
compared with AM and meningism, this difference 
was not statistically significant. 
Possible sources of increased enzyme activity in 
ICNS could be either blood serum or brain tissue. The 
activity of AST in patients with a poor prognosis was 
increased in blood serum also, nevertheless we, similar 
to other authors (2, 4), could not find any correlation 
between serum and CSF activity of AST (r = -0.362). 
We can assume that the main source of AST activity in 
Table 4. Enzyme data in relation to cerebral ultrasound findings in patients with BM. 
Neurosonographic 
finding CPK AST LDH GGT 
(quartiles) (U/l) (U/l) (U/l) (U/l) 
Ventriculomegaly 4.5 12.1* 71.1* 2.7 
(n = 7) (3.2-7.7) (10.5-15.1) (69.7-235.4) (2.6-7.2) 
Normal 3.5 8.0 23.4 2.5 
(n = 8) (2.7-5.4) (7.4-8.9) (18.7-27.5) (1.1-5.2) 
*p < 0.05. 
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the CSF is brain tissue, although we cannot exclude the 
possibility that in severely ill patients, the enzyme can 
cross through the CSF-blood barrier due to increased 
permeability. The good correlation (r — 0.538) between 
CSF PMNL count and the activity of LDH confirms the 
opinion of several studies that PMNL are the main 
source of LDH activity in the CSF in BM patients (1, 
10,11), although the exact origin of the enzymes may be 
differentiated only by isoenzyme studies. However, a 
good correlation was found only during the acute 
period of BM. The low activity of LDH on days 7-10 
of therapy, despite the high amount of PMNL in the 
CSF, also suggests a cerebral origin of LDH in the acute 
period of brain injury. 
This study, similar to previous ones (11—15), estab­
lished a definite correlation between raised AST and 
LDH activities in acute illness and poor prognosis 
(p < 0.05), which most probably is associated with the 
extent of brain damage. Not only was an increased level 
of the median value of enzyme activity seen but also a 
shift of quartile intervals. Augmentation of intracellular 
enzymes in the CSF being proportional to the severity 
and extent of brain damage was clearly shown by Maas 
(16), who produced experimental brain lesions in cats 
with extremely low temperatures. 
Significantly higher activities of AST and LDH in 
CSF (p < 0.05) were found also in patients with enlarge­
ment of the lateral ventricles during acute illness. 
Simultaneous findings of ventriculomegaly on ultra­
sonography and raised activities of LDH and AST in 
CSF, strongly suggest that one of the reasons for 
enlargement of the lateral ventricles after BM is brain 
atrophy developing after necrosis of brain tissue. 
The present study, as well as previous ones (17-19), 
indicated that CSF CPK activity was not reliable in 
differentiating between bacterial and non-bacterial 
CNS infections. 
High concentrations of the brain-specific isoenzyme, 
CK-BB, in CSF seemed to be the best predictor of poor 
prognosis in patients with head injury in several studies 
(6, 20-23), while its concentration in other organs than 
brain was very low (24-27). It was a surprise to find that 
the concentration of CK-BB in those with a poor 
prognosis was even lower (9.5 ng/1) compared with 
those with a good outcome (38.0 ng/1). The fact that 
some patients with a poor prognosis did not have 
increased CK-BB concentrations in the CSF was also 
shown in previous studies (28,29). The variable increase 
in CK-BB concentration in different patients is not 
completely understood. It might be related to the 
various regional distributions of CK-BB in the brain. 
This enzyme is localized on astrocytes (30) as well as on 
neurons (31). The highest tissue CK-BB content was 
found in the brain cortex and Capsula interna, while only 
small amounts were measured in the pons, cerebellum 
and medulla oblongata (32). Therefore, a small focal 
lesion in a functionally important region of the brain 
may cause severe impairment with minimal enzyme 
release (15, 33). On the other hand, the concentration 
of CK-BB in the CSF changes rapidly during the first 
hours of brain injury (19,29), thus the results depend on 
the time of collection of CSF. In this study, the time 
spectrum from one to three days of illness could account 
for this. Raised concentration of CK-BB in patients 
with meningism was an unpredicted finding and shows 
that even in those patients, hypoxic-ischemic damage of 
brain tissue can occur. 
In conclusion, a significant increase in AST and GGT 
activities in CSF was found in patients with bacterial 
meningitis during the first days of brain injury. The 
remarkably increased activity of AST and LDH in the 
acute phase of the brain injury may be an indicator of 
the extent of brain damage and therefore prognostically 
important. A definite prognosis for an individual 
patient cannot be established on the basis of enzyme 
activities alone, but depends on several factors. 
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I. Lutsar, A. Gontmacher, M. Närska, V. Rüütel, M. Topman, P. Ilves, T. Siirde, A. Beilmann 
Five Days of Antibacterial Therapy for Bacterial Meningitis in Children? 
Summary: We evaluated the effectiveness of 5-day antibacterial therapy for bacterial 
meningitis in children. The study group included 26 children from 2 months to 15 years of 
age, admitted with microbiologically confirmed bacterial meningitis in 1990-1993 and treat­
ed for 5 days. A historical comparison group of 49 patients treated for 8 to 15 days was 
used. Penicillin monotherapy (300 mg/kg body weight) was used for meningococcal and 
pneumococcal meningitis and ampicillin (300 mg/kg body weight) for Haemophilus influ­
enzae b meningitis. On day 5 of therapy the activity of aspartate aminotransferase (AST), 
lactic dehydrogenase (LDH), creatine phosphokinase (CPK) and gamma-glutamyl-trans-
peptidase (~yGT) in the CSF was determined by photocolorimetric assay and the concen­
tration of creatine kinase BB (CK-BB) by ELISA. IL-6 was analysed using EIA technique 
and a cerebral ultrasound was performed at the time of the termination of the antibacteri­
al therapy. The mean follow-up time was 1.3 years for children in the study group and 3.2 
in the control group. The time of hospitalisation was shorter in children treated for 5 days 
(p<0.005). Complete clinical recovery was 81% in the study group and 66% in the compar­
ison group at the time of the termination of antibacterial therapy. No relapses occurred. The 
activity of AST, CPK, LDH, and 7GT in the CSF had returned to normal by the 5th day of 
therapy, but almost a 7-fold higher concentration of CK-BB was registered. The concen­
tration of IL-6 in the CSF decreased with the therapy from 1,800 pg/ml to 685 pg/ml hut still 
remained high. Long term follow-up did not differ between the two groups. We conclude 
that 5 days of antibacterial therapy is adequate for the treatment of meningococcal menin­
gitis in children. 
Introduction 
A treatment period of 7 days for meningococcal, 10 days 
for Haemophilus influenzae b, and 14 days for pneumo­
coccal meningitis are the recommendations in most man­
uals and standard publications [1-5] but they are not bas­
ed on controlled clinical trials. Reports from some coun­
tries suggest that shorter treatment periods, especially in 
meningococcal meningitis, are sufficient and safe in un­
complicated cases [6-8], Our previous study showed that 
79% of patients with meningococcal and 71% of those 
with pneumococcal meningitis are in good general condi­
tion by day 5 of antibacterial therapy. They are afebrile, 
the meningeal symptoms are gone, and they have almost 
normal findings on cerebrospinal fluid (CSF) examina­
tion. A shorter course of antibacterial therapy will result 
in fewer days of hospitalisation and lower costs. Never­
theless, the question still arises whether the child has com­
pletely recovered after a 5-day course of antibacterial 
therapy. An elevation of activity of intracellular enzymes, 
demonstrating neuronal cell injury and altered permeability 
of the blood-CSF barrier [9—11], high levels of interleukin-
6 (IL-6), playing a central role in host defence mechanisms 
[12,13] and a changing neurosonography pattern [14,15] 
have been demonstrated in bacterial meningitis patients 
during the first days of illness. 
The aims of the present study were: 1) to determine 
whether the incidence of early complications and long 
term sequelae of bacterial meningitis in children treated 
for 5 days with intravenous antibiotics was similar to that 
seen in children treated longer; and 2) to characterise the 
situation of the brain tissue on days 5-6 by estimating 
some intracellular enzymes and cytokines in the CSF as 
well as by neurosonography. 
Patients and Methods 
Between October 1990 and April 1993 all children between 1 
month and 15 years of age consecutively admitted to Tartu Uni­
versity Children's Hospital with microbiologically confirmed 
bacterial meningitis were enrolled in this study. During this peri­
od 28 patients with bacterial meningitis met the inclusion crite­
ria. Two children were excluded from the study: one with menin­
gococcal meningitis due to penicillin resistance of Neisseria 
meningitidis group B; the other with meningitis caused by H. in­
fluenzae b had high fever on day 6 and was treated for 10 days. A 
historical comparison-group consisting of 49 patients with a diag­
nosis of microbiologically confirmed bacterial meningitis treat­
ed at our hospital in 1983-1989 was used. There were no signifi­
cant differences between the groups in patient characteristics, 
clinical and laboratory features (Table 1). Therapeutic regimens 
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Table 1: Clinical and laboratory characteristics of the study 
groups on admission. 
, . .  ,  .  Study group Control group 
n = 26 n -49 
P 
Age (months) 39.2 ±7.8 24.6 ± 4.6 0.076 
(range) (8-135) (1-156) 
Sex: 
Male 14 30 0.63 
Female 12 19 
History: 
No. given previous 
antibiotic therapy (%) 5 (22.3) 13 (26.5) 0.47 
Duration of previous 
antibacterial therapy 
(days) 0.8 ± 1.9 0.5 ± 0.5 0.22 
Duration of symptoms 
(days) 3.6 ± 0.6 2.9 ± 0.26 0.23 
No. (%) with features 
on admission: 
Temperature 
> 38.5°C 18 37 0.47 
Seizures 6 (22) 13 (26) 0.68 
Unconsciousness 3 (11) 4 (8) 0.76 
Shock 3 (11) 7 (14) 0.67 
No. (%) infected with: 
Neisseria meningitidis 18 (69) 33 (67) 0.56 
Haemophilus 
influenzae b 6 (23) 10 (20) 
Streptococcus 
pneumoniae 2 (7) 6 (12) 
Laboratory 
characteristics: 
CSF WBC (10"6/1) 5,591 7,958 0.50 
(range) (612-8540) (1,135-9236) 
CSF protein (g/1) 1077 1,780 0.19 
(range) (588-955) (624-3,077) 
CSF glucose (mmol/1) 2.4 2.1 0.31 
(range) (1.8-2.9) (0.7-3.0) 
ESR (mm/h) 36 (22-58) 40 (29-52) 0.25 
Total WBC 18.8 16.4 0.19 
(13.4-24.0) (11.6-20.1) 
Serum sodium 
(mmol/1) 137.1 135.7 0.49 
Platelet count 206.3 • 198.8 0.93 
(range) (171-262) (151-227) 
for antibacterial therapy used in the study and the comparison 
group are shown in Table 2. 
Criteria for the termination of the antibacterial therapy in the 
study group were as follows: 1. meningeal symptoms mild or ab­
sent, 2. body temperature less than 38°C, 3. CSF WBC count 
< 100/mm3, CSF protein < 1,500 g/1, CSF glucose/blood glucose 
ratio > 0.6. On admission to the hospital cultures and routine ex­
aminations of blood and CSF were done. A second lumbar punc­
ture was performed on day 5 of antibacterial therapy. Samples 
of the CSF were centrifuged and stored at -20°C for up to 6 
months until they were assayed. CSF samples from day 5 were 
examined: 1. The activity.of aspartate aminotransferase (AST), 
lactic dehydrogenase (LDH), creatine Phosphokinase (CPK) 
and gamma-glutamyl-transpeptidase (-yGT) in the CSF were de­
termined by photocolorimetric assay in the biochemical labora­
tory of Tartu University Children's Hospital in 25 patients. 
2. The CSF concentration of CK-BB was estimated by ELISA in 
the laboratory of the Institute of General and Molecular Patho­
logy of Tartu University. 3. IL-6 was analysed in 15 patients in 
the study group by enzyme immunoassay in the bacteriological 
laboratory of Danderyd Hospital (Stockholm). 4. Ultrasonogra­
phy of the brain was carried out using a scanner of 5 and 7.5 MHz 
with sonolayer "Neuroimager" in 21 infants with an open fonta-
nelle. Enlargement of the side ventricles was diagnosed on the 
basis of ventricular size on coronal scans as mild if the highest 
diameter of lateral ventricle was 7-14 mm, moderate if it was 
15-25 mm and severe if > 25 mm. 5. Electroencephalograms 
(EEG) were obtained by a Medicor electroencephalograph 
(EEG-80, "Medicor", Hungary) and a 21-lead montage, record­
ed during wakefulness for 30 min in 29 patients (14 children in 
the study and 15 in the control group). The EEGs were classified 
according to the presence or absence of dysrhythmia, generalis­
ed delta waves, generalised suppression, epileptiform dis­
charges, focal findings (focal suppression, focal delta waves, 
background asymmetry). 
The children were followed by a multidisciplinary team (paedia­
trician, paediatric neurologist, speech therapist and audiolo-
gists). The follow-up time was at least 1 year. At their discharge 
from the hospital and during the follow-up examinations, all 
children were divided into three groups: 1: normal or mild dis­
turbances: mild changes in the muscle tone or elevated reflexes 
without functional disturbances, one-sided hearing disturbances, 
mild speech disorders; 2. moderate disturbances: motor function 
corrected by rehabilitation, two-sided mild to moderate hearing 
disturbances, moderate language disorders, late seizures con­
trolled by antiepileptic drugs; 3. severe disability: handicapped 
children needing special aid; limited voluntary action, inability to 
walk, not corrected by rehabilitation, deafness, alalia, late sei­
zures not controlled with antiepileptics. 
Statistical analysis: Values are expressed as means ± 1 SD. Dif­
ferences between the groups in the frequencies of various findings 
were tested with either the chi-square or t-test. 
Results 
At the time of termination of antibacterial therapy, clini­
cal features and laboratory findings of patients in the stu­
dy and comparison groups were similar and are detailed in 
Table 3. 
The duration of antibacterial therapy as well as the dura­
tion of hospitalisation and the number of hospital-acqui­
red respiratory infections were significantly lower in the 
study group (p < 0.005) (Table 4). The mean hospital stay 
with the short-course antibacterial therapy was 10.2 days 
in contrast to 22.5 days for conventional therapy. None of 
the study group contracted hospital-acquired respiratory 
infections, whereas there were eight such cases among 
those hospitalised longer. The outcome of children at the 
time of hospital discharge was almost the same in both 
groups: 81% of the children in the study group and 75% in 
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* Pen. = Penicillin G; Amp. = Ampicillin; Chi. = Chloramphenicol; Cef. = Cefotaxime. Antibiotics were administered intravenously as follows: Pe­
nicillin 300 mg/kg/day divided every 4h; Ampicillin 300 mg/kg/day divided every 4h; Chloramphenicol 100 mg/kg/day divided every 8h; Cefotaxime 
150 mg/kg/day divided every 8h. 
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Table 2: Duration and choice of antibacterial therapy in children with bacterial meningitis. 
Study group n = 26 Comparison group n = 49 
Initial therapy Initial therapy Second 
course used 
Corrected therapy 






































































Table 3: Clinical and laboratory findings at the time of termina­
tion of antibacterial therapy. 
Study group Control group 
n = 26 n-49 
Clinical feature: 
Temperature 37.5-38.5°C 1 11 
No. of seizures - 3 
Negative meningeal 
syndrome 25 45 
Laboratory findings: 
CSF WBC (10-15/!) 45 (4-89) 59 (2-102) 
CSF protein (g/1) 758 (305-1,388) 1,047 
CSF glucose (mmol/1) 2.4 (2.1-2.8) 2.6 (2.2-3.6) 
ESR (mm/h) 34 (18-46) 42 
Total WBC (lO"6/!) 11.4 12.1 
Table 4: Hospital course of patients studied. 
' V^Hhbie (range), Study-group - Control group 
D =?6 n = 49 
Duration of antibacterial 5.0 13 (7-43)* 
therapy (days) 
Duration of hospitalisation 10.2 (7-18) 22.5 (9-116)* 
Number of nosocomial _ 8* 
infections 
Completely recovered (No.) 21 36 
Mild disturbances (No.) 4 8 




*p < 0.005. 
Table 5: Outcome of children after bacterial meningitis during 
the follow-up examination. 
Study group 
n = 23 
Control group 
n = 48 
Normal 21 37 





Motor abnormalities 2 7 




the comparison group recovered completely. There were 
no relapses in either group. On the examination at dis­
charge, abnormalities were still present in five children in 
the study group and 14 in the control group. They included 
three cases of ataxia in each group, three cases of other 
motor defects in the study group and eight cases in the con­
trol group. Three control group children were discharged 
using anticonvulsive drugs. 
Long Term Follow-Up 
There were 23 children examined in the study and 48 in the 
control group. During the follow-up examination, 79% of 
the children in the control group and 91% in the study 
group were normally healthy. Two of the children who had 
received 5 days of antibacterial therapy had sequelae: one 
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• on the 5th day 
• normal 













Figure 1: Activity of AST, CK-BB, CPK and GGT on the 5th day Figure 2: Concentration of IL-6 in the CSF on admission and 
of therapy. on day 5. 
Table 6: EEG findings on the 5th day of therapy (n = 29). 
EEG abnormalities No. of patients 
Background dysrhythmia 16 
Generalised delta waves 8 
Generalised suppression 4 
Epileptiform discharges 1 
had ataxia in combination with one-sided moderate hea­
ring impairment and the other slight hemiparesis (Table 
5). 
Activity/Concentration of Intracellular Enzymes in the 
CSF 
The median activity of AST, CPK and -yGT did not exceed 
the normal reference values at the time of the examination 
whereas the concentration of CK-BB was markedly in­
creased (34.0 vs. 5.3 ng/1) (Figure 1). 
Concentration of IL-6 in the CSF 
The median level of IL-6 in bacterial meningitis patients 
decreased with therapy from 1,800 pg/ml (95% confi­
dence interval [CI], 991-2,265 pg/ml) to 685 pg/ml, (95% 
CI, 178-1,811 pg/ml), nevertheless it remained significant­
ly higher than in patients with meningismus even on day 5 
(p < 0.005) (Figure 2). 
Cerebral Ultrasound Picture 
Abnormal patterns of cerebral ultrasound characterised 
as mild (n=ll) or moderate (n=l) ventriculomegaly were 
seen in 12 out of 21 patients on days 5-6 of therapy. There 
were no statistically significant differences in outcome 
between those with or without ventriculomegaly. 
EEG Findings 
Slight changes of the EEG pattern, mostly characterised 
by background dysrhythmia were seen in all children stud­
ied on day 5 of therapy (Table 6). There were no focal ab­
normal findings. Only the child with epileptiform dis­
charges had seizures and recovered with sequelae. 
Discussion 
Our preliminary results showed that the short term as well 
as long term outcome in children treated for 5 days was si­
milar to that when treated longer. The children treated for 
5 days had a significantly shorter duration of hospitalisa­
tion (p < 0.005) and no case of hospital-acquired respiratory 
infection was registered. There were no relapses in either 
group, which is not surprising because the bacteria, espe­
cially in meningococcal meningitis, are usually eliminated 
from the CSF within 24-48 h of initiating parenteral anti­
bacterial therapy [16]. 
The limitation of this study was that it was not a prospec­
tive double-blind study and a historical comparison group 
was used as a control. The recently decreasing number of 
bacterial meningitis cases in North America and in Europe 
due to the introduction of vaccination against H. influ­
enzae b and nonepidemic period of meningococcal infec­
tion [17-20] makes it difficult to organise any trial with a 
sufficient number of patients. This would require, for ex­
ample, approximately 1,400 patients to be randomly assign­
ed to two treatment groups to be followed for 5 years in or­
der to detect a 50% increase in sequelae with 80% certain­
ty [21], 
In this study penicillin was used for the therapy of menin­
gococcal and pneumococcal meningitis while resistant 
meningococci and pneumococci are still uncommon in 
Estonia. Tuncer et al. [7] in a randomised study compared 
the effectiveness of 4-day therapy with ceftriaxone and pen­
icillin in meningococcal infection and did not find any dif­
ferences between the two drugs in the outcome. Interme­
diately resistant isolates are now being recognised and it is 
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likely that it will be an important factor influencing the sel­
ection of antibiotics in the future. 
A shorter course of antibacterial therapy than recommend­
ed in the textbooks [22,23], has been reported to be high­
ly effective in some previous studies. Martin et al. [24] used 
ceftriaxone monotherapy for 4 days in patients with 
meningococcal meningitis, for 6 days in cases of H. influ­
enzae b meningitis and for 7 days in pneumococcal menin­
gitis and showed that these regimens were as effective as 
longer periods of therapy. Repofts about meningococcal 
meningitis suggested that shorter treatment periods (4-5 
days) are sufficient and safe in uncomplicated cases 
[6,7,25]. Although 5-day therapy in our study was effective 
also in H. influenzae b and pneumococcal meningitis, it has 
to be said that in five out of eight children, antibiotics had 
been administered before hospital admission and we agree 
that H. influenzae b and pneumococcal meningitis may re­
quire longer treatment [16,21,25]. 
Because an increased concentration of intracellular en­
zymes in body fluids is evidence of cytolysis and because 
IL-6 plays a central role in host defence mechanisms, we 
used these as additional parameters of CNS dysfunction. 
The activity of AST and -yGT in the CSF, which was in­
creased during the first days of bacterial meningitis, was 
almost normal [9]. However, it is interesting to mention 
that the concentration of CK-BB in the CSF was still high. 
This isoenzyme is highly specific for the brain tissue and its 
raised concentration probably shows that damage of the 
cell membranes is still present [10,11]. The concentration 
of IL-6 at the time of the termination of antibacterial ther­
apy was still significantly higher in children receiving 5 
days of therapy (p < 0.001). Persisting IL-6 activity during 
the first 5-6 days of bacterial meningitis was also shown by 
Rusconi et al. [22]. The exact role and source of IL-6 in the 
pathogenesis of bacterial meningitis is not clear; a local 
production of IL-6 in the CNS seems to occur [13,26]. 
Enlargement of the brain side ventricles was seen in 60% 
of infants on the 5th-6th day of therapy and was in all but 
one case mild. Mild to moderate ventriculomegaly, which 
developed mostly by the second week of acute bacterial 
meningitis, has also been seen in previous studies. It is be­
lieved to be caused by a decreased compliance of the brain 
tissue and is normally reversed within 6 months [14,15,27], 
Despite the good general condition of patients on day 5, 
all children had slight changes in their EEG patterns, in 
that background dysrhythmias and generalised delta ac­
tivity have been predominant findings. However, Pike et 
al. [28] described the above mentioned findings in most of 
their bacterial meningitis patients on the 7th-21st days of 
illness and showed that these were not connected with an 
unfavourable prognosis. 
Thus, despite the fact that the patient has no fever and is 
already in a good general condition on day 5 of therapy, 
the processes in the brain tissue have not ended. Never­
theless, we believe that for patients with uncomplicated 
meningococcal meningitis, 5 days of antibacterial therapy 
is adequate, although due to the small number of patients 
we cannot recommend it for H. influenzae b and pneumo­
coccal meningitis. Our preliminary results of 5 days of an­
tibacterial therapy for bacterial meningitis in children are 
promising, but before changing the general rules control­
led prospective trials with a larger number of patients are 
needed. 
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Zusammenfassung: 5-Tages-Therapie für die antimikrobielle 
Behandlung deir bakteriellen Meningitis im Kindesalter? Die 
Wirksamkeit einer 5tägigen antibakteriellen Therapie wurde 
bei bakterieller Meningitis im Kindesalter geprüft. Die Studi­
engruppe umfaßte 26 Kinder im Alter von 2 Monaten bis 15 
Jahren, die 1990-1993 mit mikrobiologisch gesicherter bakteri­
eller Meningitis aufgenommen und 5 Tage lang behandelt wur­
den. 49 Patienten, die 8-15 Tage lang behandelt wurden, dien­
ten als historische Vergleichsgruppe. Bei Meningokokken- und 
Pneumokokken-Meningitis wurde eine Monotherapie mit Pe­
nicillin (300 mg/kg KG) durchgeführt, die Haemophilus influ-
enzae-Meningitis wurde mit Ampicillin (300 mg/kg KG) be­
handelt. Am Behandlungstag 5 wurden die Aktivitäten von 
Aspartataminotransferase (AST), Laktatdehydrogenase 
(LDH), Kreatinphosphokinase (CPK) und gamma-Glutamyl-
Transpeptidase (7 GT) im Liquor fotokolorimetrisch bestimmt. 
Die Kreatinkinase BB-Konzentration (CK-BB) wurde mittels 
ELISA gemessen. IL-6 wurde mit einer EIA Technik bestimmt 
und zum Zeitpunkt des Therapieendes mit Antibiotika wurde 
eine zerebrale Ultraschalluntersuchung vorgenommen. Die 
mittlere Verlaufsbeobachtung betrug bei den Kindern der Stu­
diengruppe 1,3 Jahre, bei der Kontrollgruppe 3,2 Jahre. Kinder, 
die die 5-Tages-Therapie erhielten, blieben kürzer in stationä­
rer Behandlung (p < 0,005). Eine vollständige klinische Wie­
derherstellung war bei Kindern der Studiengruppe bei Thera­
pieende in 81% und bei der Vergleichsgruppe in 66% der Fäl­
le eingetreten. Rezidive ereigneten sich nicht. Am 5. Thera­
pietag hatten sich AST, CPK, LDH und -yGT im Liquor nor­
malisiert, die Konzentration von CK-BB war noch fast 7fach 
erhöht. Die IL-6 Konzentration im Liquor nahm mit der The­
rapie von 1,800 pg/ml auf 685 pg/ml ab, blieb jedoch noch er­
höht. Die Langzeit-Verlaufsbeobachtung zeigte keine Unter­
schiede zwischen den Gruppen. Wir folgern, daß eine antibak­
terielle 5-Tages-Therapie für die Behandlung der Meningo-
kokkenmeningitis bei Kindern adäquat ist. 
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Brief Reports 
LONG TERM FOLLOW-UP OF ESTONIAN CHILDREN 
AFTER BACTERIAL MENINGITIS. 
With the general accessibility of rapid clinical diagnosis, 
appropriate antimicrobial therapy and modern intensive care 
facilities, the mortality of bacterial meningitis (BM) has de­
creased dramatically during last decades to less than 5%*' . A 
significant number of patients however develop sequelae, i.e. 
an average of 17% of survivors in developed countries and 
26% in the developing world^. Hearing disturbances, motor 
abnormalities, late seizures and psychological problems are 
the most common sequelae. At least 45 studies characterising 
long term outcome of BM have been published in English^ 
and various prognostically significant factors have been 
found. 
The aim of the present study was to evaluate the late seque­
lae of BM in Estonian infants and children and to establish 
which features of acute illness predict long term outcome. 
Materials and methods. The medical records of children 
treated for BM at the Tartu University Children's Hospital 
(Estonia) from 1983 through 1990 were retrospectively re­
viewed. In 123 cases at least one of the following diagnostic 
criteria had to be fulfilled: (1) bacteria grown from cereb­
rospinal fluid (CSF) culture, (2) bacteria grown from blood 
culture with more than 10 polymorphonuclear (PMN) white 
blood cells (WBC) per mm^ of CSF, (3) no bacteria from CSF, 
but more than 500x10® PMN WBC per mm' 
At the time of hospital discharge children were retrospec­
tively divided into three classes according to motoric func­
tional capability as described by Talvik^: (1) mild changes of 
muscle tonus and elevated reflexes without functional distur­
bances, all activities possible without special aids; (2) func­
tion is acquired through special aids; (3) limited voluntary 
action, enable to walk, to sit without aid, often bedridden. 
All children still living in this area, who were at least 4 
years old and had documented BM at least 3 years ago were re­
called. Of 90 children 84 (94.3%) had follow-up examinations. 
The median age during the follow-up was 8 years (range, 4 to 
18 years) and in average 6 years (range, 3 to 9) had passed 
since acute illness. 
Standard neurologic examination was performed and esti­
mated using above mentioned criteria. Pure tone audiometry 
with the audiometer MA-31 (DDR) was performed. The thresh­
olds were determined at 500, 1000, 2000, 4000 and 8000 Hz. 
The four classes of hearing were defined in terms of hearing 
level for speech as: (1) < 30 dB- normal; (2) 30-55 dB-mild 
loss; (3) 55-70 dB- moderate loss; (4) > 70 dB-severe loss. 
Speech development was estimated by a speech therapist by 
8 classes scoring system as follows: (0) no vocalisation; (1) 
understanding of language; (2) babbling; (3) single words 
with meaning; (4) one word utterance; (5) two word utterance; 
(6) three words together, (7) normal speech. The children were 
divided as follows: normal or mild, Classes 6 and 7; moderate 
language disorders Classes 4 and 5; Classes 0 to 3, severe lan­
guage disorders. 
During the follow up examination all children were divided 
into the three groups: (1) normal or only mild disturbances, 
i.e. motor disturbances of first classes and/or one-sided hear­
ing disturbances and/or mild speech disorders; (2) moderate 
disturbances, i.e. motor disturbances of 2nd classes and/or 
two-sided mild to moderate hearing disturbances and/or mod­
erate speech disorders and/or seizures controlled by 
antiepileptic drugs (impairment corrected by rehabilitation); 
(3) handicapped children needing special aid- i.e. multiple 
disturbances not corrected with the rehabilitation: 3 third 
class motor abnormalities, deafness and/or severe speech dis­
orders and/or seizures not controlled with antiepileptics. 
Chi-square test were used to compare differences in propor­
tions and the t-tests to compare the means in normally dis­
tributed continues data. Logistic regression was used to 
assess the relative importance of the various prognostic fac­
tors. 
Results. The retrospective review of hospital charts showed 
that 42 children (50%) had meningococcal, 7 (8.3%) pneumo­
coccal, 12 (14.2%) Haemophilus influenzae type b meningitis 
and in 23 cases (27.3%) etiology of BM remained unknown. 
The median age of patients on admission was 15.5 months 
(range, 1 to 144), 17 had seizures, 9 were unconscious and 8 
patients were hospitalised with septic shock. 
The most common therapy was penicillin G 400 mg/kg 
daily for meningococcal or pneumococcal meningitis and 
ampicillin 300 mg/kg daily for H.influenzae trype b 
meningitis. Mean duration of antibacterial therapy was 13.8 
days. Dexamethasone as adjunctive therapy was used in 16 
cases. The mortality rate of BM was 4%. Of 84 children 63 
(75%) had no or only mild motor defects (Class 1), 14 (16.7%) 
had moderate (Class 2) and 7 (8.3%) severe (Class 3) damage 
at the time of hospital discharge. Demographics and 
neurologic status of children with (n=84) and without (n=31) 
follow-up examinations were similar. 
Three children, died after hospital discharge, one had pro­
gressive hydrocephalus, one died due to respiratory infection 
complicated with brain oedema and the third child drowned. 
The results of the long term follow-up of BM of 84 children 
are shown in Table 1: 68 (80%) of children were regarded as 
normal, 11(13.3%) had moderate disturbances and 5(5.9%) 
were handicapped during follow-up examination. 
Motor abnormalities were the most common finding at that 
time, diagnosed in 10 children (12%); two patients had severe 
disturbances (third degree spastic quadriplegia); and moder­
ate to mitd abnormalities were seen in 8 cases. Ataxia was di­
agnosed in 3 (3.5%) of children studied, combined with 
hearing disturbances in 2 cases. 
Of the 84 children 4 (4.7%) had nonfebrile seizures. They 
were clearly focal or had focal onset and started from half to 7 
years after the acute illness. Good control of seizures was 
achieved in 3 of the 4 patients with a single anticonvulsant 
drug. Febrile seizures were registered in three cases. Moreover, 
history of breath-holding spells was found out in two chil­
dren. One of them had those already before the BM, but after 
BM they occurred more often, in another child breath-holding 
spells were firstly diagnosed 3 months after BM. 
Seven children (8.3%) had a sensoneural hearing deficit in 
speech area (from 1000 to 4000 Hz). There was bilateral im­
pairment in 4 of them (4.7%). Two out of seven had profound 
hearing loss. Moderate unilateral hearing disturbances were 
found in two children and bilateral mild hearing deficit in 
three patients. 
TABLE 1. Long term sequelae of BM in 84 Estonian infants 
and children. 
Sequelae No. of Patients % 
Motor disturbances 10 12 
Ataxia 3 3.5 
Hydrocephalus 1 1.1 
Epilepsy 4 4.7 
Hearing disturbances 7 8.3 
Mental retardation 4 4.7 
Speech delay 8 10 
Speech delay was observed in nine (10.7%) children. It was 
diagnosed only in children who had BM during the first year 
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of life, before the speech development. There was no associa­
tion- between speech delay and hearing disturbances. 
There was a significant correlation between seizures on ad­
mission and poor outcome (p=0.018). No other differences be­
tween late sequelae and age, sex, the severity of unconscious­
ness, CSF findings on admission, etiologic structure of BM or 
therapy used were statistically significant. 
All but one child of those who developed either hearing dis­
turbances or motor defects had been discharged with neuro­
logical sequelae (p<0.0001). A significant correlation between 
motor and hearing disturbances during the follow-up was also 
seen as 5 of 7 children with hearing impairment had also mo­
tor defect and 4 of 10 with motor abnormalities had also hear­
ing impairment (pcO.OOOl). No correlation was found either 
between late seizures and other abnormalities at the follow-up 
or between late seizures neurological defects of the patients at 
the time of hospital discharge. 
Discussion. Our data are consistent with published re­
sults^-? indicating, that the long term prognosis/of BM may 
not be as gloomy as initially thought. We found abnor­
malities in 20% of the children studied, but 13% were 
considered to have mild to moderate sequelae. 
We found that severe neurological deficits at the time of 
hospital discharge are good predictors of other long term se­
quelae but epilepsy (pcO.OOOl). 
Hearing impairment is the most common complication of 
BM in children^'®. Our study did not confirm the opinion that 
hearing disorders after BM are mostly unassociated with the 
brain damage^. Like Dodge et al.'® we observed a significant 
correlation between hearing disturbances and motor defects 
during the follow up examinations. We, as others,""^ sug­
gest that hearing disturbances are in association with 
labyrinthitis, since some of the patients had ataxia and hear­
ing deficit. Speech disorders with the frequency of 7-23% in 
previous studies are thought to be connected to hearing 
deficit 6>7,14 Qn the contrary no association between hearing 
impairment and speech delay was found by us. 
The overall prevalence of nonfebrile seizures in this survey 
(4.7%) was similar to the data of meta-analysis made by Baraff 
et alA Like other authors'^ we found the highest risk of un­
provoked seizures during first five years after BM. In agree­
ment to previous reports 15-17 we f0UIUj seizures on admis­
sion being risk factors for the development of late sequelae. In 
contrast to Pomeroy et al. 1® no correlations between other ab­
normalities and late seizures was found during the follow-up. 
In conclusion only children with severe neurological deficits 
at the time of hospital discharge after BM seem to have a high 
risk for permanent neurological sequelae and hearing distur­
bances. Those showing no or only mild disturbances have an 
excellent chance of being normal or having only mild se-
qualae or late seizures on follow-up. 
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Figure 2. Monthly distribution of encephalitis, aseptic and bacterial meningitis and 
meningococcal infection in children in South-Estonia in 1980-1989. 
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Figure 3. Age distribution of BM, AM and TBE+encephalitis 
in South-Estonia in 1980-1989. 
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Figure 8. General condition of children at discharge, one months and one year after BM 
ISSN 1024-3 95X 
ISBN 9985-56-119-8 
